Dignity therapy: a psychotherapeutic intervention to enhance the end of life experience for people with Motor Neurone Disease and their family carers by Bentley, Brenda
  
School of Psychology and Speech Pathology 
 
 
 
 
 
Dignity Therapy: A Psychotherapeutic Intervention to Enhance the 
End of Life Experience for People with Motor Neurone Disease and 
their Family Carers 
 
 
 
 
 
 
Brenda Bentley 
 
 
This thesis is presented for the Degree of 
Doctor of Philosophy  
of 
Curtin University 
 
 
August 2014 
  
Declaration 
 
To the best of my knowledge and belief this thesis contains no material previously 
published by any other person except where due acknowledgement has been made. 
 
This thesis contains no material which has been accepted for the award of any other 
degree or diploma in any university. 
 
 
 
 
 
 
Brenda Bentley 
 
Signature: …………………………………………. 
 
Date: ………………………... 
  
i 
 
 
Abstract 
 
 A diagnosis of motor neurone disease (MND) is a devastating experience for 
people with MND and their families.  People with MND experience unremitting loss 
during the course of the disease as they gradually lose physical function and abilities.  
Because there is no curative treatment, care goals for people with MND and their 
families focus on maintaining quality of life (QOL).  Research has shown that QOL for 
people with MND and their family carers is not related to physical decline and 
impairment, but rather to psychological, psychosocial and existential factors.  As a result 
of psychosocial distress, people with MND are at an increased risk of suicide and seek 
out hastened death more frequently than people with other terminal illnesses.   
 Development of interventions that address psychological, psychosocial and 
existential distress in people with MND and their caregivers have often been suggested 
in the research literature.  However, there is a lack of intervention studies and an absence 
of research and direction for providing this type of care.  Dignity therapy, which is based 
on an empirical model of dignity at the end of life, was developed to reduce 
psychosocial and existential distress in palliative care populations and it has been shown 
to benefit people dying of cancer in previous research.  However, these results are not 
transferable to people with MND as characteristics of this group differ from cancer, 
including baseline levels of distress, ability to communicate, physical impairment, and 
cognitive acuity. 
 This study used a cross-sectional one group pre-test post-test design to explore 
the feasibility, acceptability and potential benefits of dignity therapy on 29 people with 
MND and 18 of their family carers in Australia.  For people with MND, outcomes 
measured hopefulness, spirituality and dignity.  For MND family carers, outcomes 
measured caregiver burden, anxiety, depression, and hopefulness.  Acceptability was 
measured in both groups with a self-report feedback questionnaire used in previous 
dignity therapy research.  Feasibility was assessed by examining how common MND 
symptoms affected the therapy, family carers’ involvement in the therapy, the length of 
time needed to complete dignity therapy, and any special accommodations or deviations 
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from the dignity therapy protocol.  In addition, demographic data was collected from 
people with MND and their family carers, people with MND completed a health related 
QOL measure, family carers assessed physical impairment of the care recipient with the 
ALS Functional Rating Scale, and people with MND completed a cognitive screening 
instrument developed specifically for people with MND.  Generalized linear mixed 
models were used to analyze the data on the group level, and reliable change scores were 
computed to investigate the presence of reliable pre-post change at the individual level.  
Descriptive statistics were used to summarize demographic variables and feedback 
responses.  SPSS Version 20 was used. 
 There were no changes in the outcomes on the group level for both groups, 
people with MND and MND family carers.  However, there were increases and 
decreases for both groups in hopefulness when data was analyzed on the individual level 
using Reliable Change scores.  For MND family carers, there were also reductions in 
anxiety and depression for 3 family carers after dignity therapy.  Dignity therapy was 
acceptable to both people with MND and MND family carers, who reported similar 
benefits on the feedback questionnaire as found in previous research with people with 
cancer.  However, some MND family carers also expressed negative effects as a result 
of the intervention which require further exploration in future studies. 
 Dignity therapy was feasible with people with MND, though 80% of participants 
had symptoms that affected the intervention and required accommodation, including 
speech loss, speech impairment, cognitive impairment, emotional lability and paralysis.  
Emotional lability was encountered most often, but speech impairment presented the 
greatest difficulty.  People with speech loss were able to complete the intervention 
through email, a modification to the therapy.  Mild to moderate cognitive impairment 
had little impact on dignity therapy in all cases except one, where behavioral variant 
FTD was suspected.  Dignity therapy took an equivalent number of sessions and 
therapist hours to complete with people with MND compared to figures reported in 
previous research, but an extended time frame was needed to complete the intervention 
on average.   
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 Recommendations for the clinical use of dignity therapy with people with MND 
include:  
• The use of screening measures for cognitive-behavioral impairment, speech 
impairment, and emotional lability; 
• Providing choices for people with MND about how to complete dignity 
therapy, including the use of e-health methods; and  
• Care when dealing with families who have complex histories, conflictual 
patterns of relating or other dysfunction, with families who are struggling 
to accept the terminal nature of MND, and with participants and family 
members from non-Western cultures. 
 The findings suggest that dignity therapy, an end of life intervention developed 
and tested for people with cancer, may also benefit people with MND and their families.  
However, psychotherapists need education and training about MND prior to engaging in 
therapy, and flexibility is needed to accommodate symptoms.   
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CHAPTER ONE 
1.  Introduction 
  
 
 
 
 
 
 
 
 
 
 
 
 
You matter because you are you. You matter to the last moment of your life, 
and we will do all we can, not only to help you die peacefully, but also to 
live until you die. (Saunders 1976 p. 1005)  
Dame Cicely Saunders 
 
1.1 Thesis introduction 
Where can people turn when diagnosed with a life-limiting illness where they 
gradually become paralyzed and lose the ability to move without help, speak to friends 
and family, swallow their food, and breathing itself becomes difficult?  How do partners 
and spouses cope with watching their loved ones become increasingly impaired and with 
becoming full-time carers?  This thesis presents a study of the effects of dignity therapy, 
a palliative care psychosocial intervention designed to address psychosocial and 
existential distress, on people who have motor neurone disease (MND) and their family 
Chapter One provides an introduction to the thesis 
examining the feasibility, acceptability, and 
potential effectiveness of dignity therapy to 
enhance the end of life of people with motor 
neurone disease and their family carers.  This 
chapter provides definitions for psychosocial care 
and palliative care.  It presents the three main 
challenges facing palliative care today, which are 
the provision of psychosocial care, the 
incorporation of care and supports for family 
carers, and the inclusion of people with illnesses 
other than cancer.  The researcher will be 
introduced and experiences of the researcher 
relevant to this study are shared.  This chapter 
concludes with the study background and funding, 
the aims and significance of the study, and the 
overall structure of the thesis. 
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carers.  MND is a fatal and rapidly progressing neurodegenerative disease (to be 
discussed in more detail in Chapter Two).  People with MND and their families 
experience exceptional strain from symptom onset to death and have significant unmet 
psychological needs.  This thesis hypothesizes that dignity therapy may help to address 
these needs. 
1.2 What is palliative care? 
Dame Cicely Saunders, the founder of the modern hospice movement, 
introduced a holistic philosophy surrounding end of life care. Her influential perspective 
and work at St. Christopher’s hospice in London emphasized that quality care at the end 
of life must seek to relieve all areas of pain experienced by people as they approach 
death when cure is no longer an option.  Saunders introduced the idea of ‘total pain,’ 
which included not only physical pain but also emotional, psychosocial and spiritual 
dimensions of distress (Saunders 1964).  Palliative care, a term originally used by 
Balfour Mount in the early 1970s (Mount 1997, Watson, Lucas et al. 2009), embraces 
the hospice philosophy.  The terms palliative care and palliative medicine have become 
inclusive terms applied to terminally ill people and encompasses those cared for in 
hospice facilities, people in hospital who seek symptom relief rather than curative 
treatment, and people who wish to be cared for and die at home or within the community 
(Billings 1998).  There are three spheres of concern for palliative care providers – 
symptom control, psychosocial care, and disease management.  In order to provide 
holistic care, each sphere must be considered in relation to the other two, each sphere 
has overlap with the others, and all three spheres of concern are equally important 
(Watson, Lucas et al. 2009).   
The World Health Organization (2014) defines palliative care as: 
 …an approach that improves the quality of life of patients and 
their families facing the problems associated with life-
threatening illness, through the prevention and relief of suffering 
by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and 
spiritual. (World Health Organization 2014 para. 1) 
The US National Consensus Project for Quality Palliative Care (2014) presents this 
vision: 
2 
 
Palliative care is both a philosophy of care and an organized, 
highly structured system for delivering care. The goal of 
palliative care is to prevent and relieve suffering and to support 
the best possible quality of life for patients and their families, 
regardless of the stage of the disease or the need for other 
therapies. Palliative care expands traditional disease-model 
medical treatments to include the goals of enhancing quality of 
life for patients and family members, helping with decision-
making, and providing opportunities for personal growth. 
(National Consensus Project for Quality Palliative Care 2014 
para. 1) 
Palliative Care Australia (2014) provides the definition “Palliative care is specialist care 
provided for all people living with, and dying from a terminal condition and for whom 
the primary goal is quality of life” (Palliative Care Australia 2014 para. 6).  What is 
clear from these definitions is that enhancing the quality of life of patients and family at 
the end of life is a paramount concern in palliative care. 
The palliative care field is currently facing challenges in three major areas.  The 
first of these challenges is providing end of life care to all people equitably regardless of 
disease.   Modern day palliative care is deeply rooted in cancer care due to the historical 
influence of Dame Cicely Saunders’ St. Christopher’s hospice which cared for people 
with cancer (Watson, Lucas et al. 2009).  As a consequence, the field has neglected other 
terminal disease populations (Potter, Hami et al. 2003) and over 90% of people in the 
UK currently receiving specialist palliative inpatient care have a cancer diagnosis 
(Watson, Lucas et al. 2009).  However, palliative care practitioners recognize the need to 
offer care to people with other life-limiting illnesses (Rosenwax, McNamara et al. 2005) 
who also suffer from distressing symptoms and have extensive palliative care needs 
(Addington-Hall, Fakhoury et al. 1998, Murtagh, Preston et al. 2004).  As such, efforts 
are being made to extend palliative care equitably to all people at the end of life 
(Kristjanson, Aoun et al. 2005, Ostgathe, Alt-Epping et al. 2011, Johnston 2014).    
The second challenge is providing support to family members of the terminally 
ill (Aoun, Bentley et al. 2013).  The holistic definition of palliative care states that the 
unit of care comprises the dying person and their carers and family members (Billings 
1998, World Health Organization 2014).  Traditionally, and in years past, the care 
extended to family members was bereavement support, which remains an important 
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component of end of life care (Watson, Lucas et al. 2009, Breen, Aoun et al. 2014).  
However, because the majority of people prefer to be cared for by their families and die 
at home (Grande, Stajduhar et al. 2009, Wilson, Cohen et al. 2013), the role of family 
has taken on increasing importance (Watson, Lucas et al. 2009).  Home-based palliative 
care would be impossible for most of the terminally ill without the support of family 
(Hudson 2003) who relieve public institutions of substantial economic burden by 
providing care (Chai, Guerriere et al. 2013).  Family carers often find the complex 
caring role stressful (Aoun, Kristjanson et al. 2005) and research has documented the 
significant burden placed on them (Harding and Higginson 2003, Goldstein, Atkins et al. 
2006, McCabe, Firth et al. 2009).  As a result, the palliative care field has increased its 
focus on understanding and meeting the needs of family members who provide care for 
the terminally ill (Grande, Stajduhar et al. 2009, Hudson and Payne 2011, Harding, List 
et al. 2012). 
The third challenge is providing psychosocial care.  Despite Dame Cicely 
Saunders’ early definition of total pain, which includes physical, emotional, 
psychosocial and spiritual dimensions of distress, and ongoing calls to address total pain 
(Chochinov 2007), palliative care has advanced most quickly in the areas of physical 
pain and symptom management as these areas were easier to address using medical 
science and technology.  Psychosocial, existential, and spiritual aspects of well-being at 
the end of life are less understood, but research has revealed that these types of distress 
are often more significant to a person’s quality of life during a terminal illness than 
physical pain and physical symptom relief (Clarke, Hickey et al. 2001, Robbins, 
Simmons et al. 2001).  Psychosocial and existential distress is related to quality of life, 
depression, hopelessness and suicidal ideation in people receiving palliative care 
(Breitbart, Rosenfeld et al. 2000, Chochinov 2006).  As a result, there is an increased 
focus on understanding psychosocial needs at the end of life (Pulchaski 2007, Ventura, 
Burney et al. 2014), and more resources are being developed to provide improved 
psychosocial care (Breitbart, Gibson et al. 2004, Chochinov 2005, Rodin 2013, Waldron, 
Janke et al. 2013).  Nonetheless, there are few empirically supported psychosocial 
interventions for use at the end of life (Hudson and Payne 2011, Pagnini 2012).  These 
three challenges inform, and will be informed by, this thesis which details a 
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psychosocial intervention for people living with MND and their family carers. 
1.3 What is psychosocial care?  
Palliative psychosocial care specifically seeks to address the emotional, social, 
spiritual, and psychological issues that occur when a person has a terminal illness and is 
facing death, when emotional distress and existential suffering are commonly 
encountered (Breitbart, Gibson et al. 2004).  Psychosocial care focuses on the 
psychological and emotional wellbeing of people with illness and their families to 
optimize quality of life: it covers a broad area including spirituality, existential concerns, 
self-esteem, family issues, psychological distress, social supports, relationships, and 
day-to-day concerns about the impacts of illness (McLeod 2003).  These broad 
overlapping areas result in psychosocial care being vaguely defined and often poorly 
understood (Pulchaski 2007, Daaleman, Usher et al. 2008, Vachon, Fillion et al. 2009).   
Questions such as “Why me?” “What is the purpose of life,” and “What will 
happen after I die?” are primary existential questions for people facing death (Boston, 
Bruce et al. 2011).  Existential psychotherapist Irvin Yalom identified death anxiety as a 
universal human phenomenon and theorized that facing death is not only emotionally 
terrifying but also a catalyst for reflection on existential meaning (Yalom 2009).  
Spirituality is a source of meaning for most people throughout the world and research 
shows it becomes even more important in people facing serious illness (Breitbart 2001, 
Kaut 2002, Pulchaski 2007, Vachon, Fillion et al. 2009).  Dimensions of spirituality 
include meaning in life; connection to something greater than oneself; values, morals 
and beliefs; and connection to others (McGrath 2002, Pulchaski 2007).  Peaceful 
relationships with loved ones, concerns about the impact of death on others, and 
relieving burden on family carers are also important psychosocial concerns at the end of 
life (Breitbart, Gibson et al. 2004).  Significant distress in any of these areas can result in 
psychological distress, including depression, anxiety and suicidality (Boston, Bruce et 
al. 2011).  
Not only is there a lack of agreement about the exact nature of psychosocial care 
but there is also a lack of consensus about which members of the multidisciplinary 
palliative care team should provide this care (Pulchaski 2007, Daaleman, Usher et al. 
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2008, O'Connor and Fisher 2010).  Palliative care physicians and nurses are often cited 
as the providers of psychosocial care because they are the most closely connected to 
people with terminal illnesses and families (Edwards, Pang et al. 2010), but it is 
questionable whether clinicians can or should take on these tasks in addition to their 
other roles (Daaleman, Usher et al. 2008, O'Connor and Fisher 2010).  Hospital 
chaplains and pastoral care providers are also suitable providers of psychosocial care 
based on their expertise in the area of spirituality and religion (Kaut 2002), but the 
terminally ill often underutilize these providers at the end of life (Edwards, Pang et al. 
2010).  Psychiatrists, psychologists, counselors and social workers also have a role to 
play in the provision of psychosocial care by providing counseling, psychotherapy and 
psychological interventions (Chochinov and Breitbart 2012), although many in these 
disciplines feel conflicted about the sometimes spiritual nature of psychosocial care and 
are reticent to approach such issues (Johnson 2003).  A report from the American 
Psychological Association in 2000 stated, “There is little evidence that the discipline of 
psychology as a whole has considered end of life issues to be an important area that 
deserves substantial professional time and attention” (as cited in Haley, Larson et al. 
2003 p. 627).  Uncertainty among palliative care providers about how should provide 
psychosocial care may leave a large number of palliative care patients and family 
members with unmet psychosocial needs (Schulman-Green 2003).   
1.4 The researcher 
 This section is included to share with the reader my personal research orientation 
and the ways my background and experiences have influenced my views and decision to 
research this topic.  As all research has a subjective component (Ercikan and Wolff-
Michael 2006) that is influenced by culture and values, it is common for researchers to 
clarify their personal motivation for embarking on their research (Prilleltensky 1997, 
Creswell 2009).  This is my goal here. 
 My journey began in 2008 when I undertook a Master’s degree in Counseling 
Psychology from the University of San Francisco, in California, United States (US).  
When our practicum began in 2009, I chose to work in a community hospice.  Initially, I 
(along with the other counselors) performed bereavement counseling with family 
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members after the death of hospice patients.  We held sessions in a comfortably 
furnished office tucked into a far corner at the hospice base, often on nights and 
weekends, and we rarely came into contact with the other staff and clinicians.  Over 
time, I developed a deep curiosity about their work.  Voicing that curiosity, I was invited 
to sit in on weekly two-hour interdisciplinary group (IDG) meetings where the case of 
each hospice patient was discussed.  At this hospice, these meetings were attended by 
the hospice physician, pharmacist, nurse case managers, social workers, spiritual care 
worker, volunteer manager, and bereavement manager.  I observed that psychosocial 
support was provided to the hospice patient and family primarily by the social worker, 
spiritual care worker, and volunteers, although everyone involved played a role to some 
degree.  After a patient died, bereavement counselors were introduced to all significant 
family members, and they continued to provide grief support to family members for up 
to one year. 
 Through attending the IDG meetings, I formed an opinion that the psychosocial 
needs of the hospice patients and families were not being adequately met.  First, I 
observed how everyone at the hospice was stretched in their roles.  For example, there 
was one chaplain for 40-50 patients placed throughout the community.  The chaplain’s 
role mostly involved spiritual counseling and performing rituals such as communion.  
Due to practical and logistical issues services were only available to a few.  Harried 
social workers attended to the bureaucratic needs of families such as helping to prepare 
advance care planning documents, assisting with caring arrangements, and planning 
funerals.  Volunteers were called on to provide companionship, if and when they were 
available.  As I listened to various stories in the meetings about psychosocial, existential 
and emotional distress experienced by both patients and carers, and heard these stories 
again during bereavement counseling, I wondered about my role as a counseling 
psychologist and the discipline of psychology more generally in helping patients and 
their families in the transition from life to death.  I asked my supervisor if I could help, 
and I was given permission to counsel hospice patients and their families. 
 My first challenge in this new task was identifying empirically based 
psychotherapeutic modalities or interventions designed to alleviate distress at the end of 
life.  The hospice framework did not involve psychologists or counselors before 
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bereavement, so there were very few resources.  I asked several of my professors what 
they would do, but I received little guidance in response.  One instructor memorably 
answered he would do nothing as the patient would soon die and instead he would 
concentrate on the needs of the family members.  I performed a review of the literature 
but found very little.   
 The most promising intervention I encountered was dignity therapy.  It was 
designed to be used with palliative care patients, it was brief, it showed benefit to both 
patients and family members, and it was based on empirical research.  I began to use 
some of the dignity therapy questions while counseling patients, such as “Tell me about 
a time when you felt most alive” and “What have you learned about life?”  These 
conversations appeared to provide therapeutic benefits as patients were engaged, 
uplifted, and an improved mood was observed by the end of the session.  As a result, I 
became more intrigued about the intervention.  
 Around this time, my practicum was ending and graduation was near.  I had to 
make a decision about my future plans, including whether to continue clinical work or 
embark on further study.  On a whim, I sent an email to Professor Harvey Max 
Chochinov who developed dignity therapy.  I shared that I was considering the pursuit of 
a PhD and that I was interested in dignity therapy.  I asked if he knew of any 
opportunities in dignity therapy research.  I anticipated that my email would go 
unanswered, but I was pleasantly surprised when Professor Chochinov offered his 
encouragement and responded that he knew of one opportunity in Perth, Australia.  He 
put me in touch with the researchers, and soon I was offered the opportunity to obtain a 
PhD through a research project of dignity therapy with people who had motor neurone 
disease (MND) as it is known in Australia, or amyotrophic lateral sclerosis (ALS) as I 
knew it in the US.   
 When offered this opportunity, I reflected on my experiences counseling people 
with MND and their families at the hospice.  These cases were some of our most 
challenging.  One case stood out in particular.  A man in his 50s who rode a motorcycle 
and enjoyed an active, outdoor lifestyle could not come to terms with losing his physical 
abilities from MND.  Though he retained some mobility and could function better than 
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other people with MND I had encountered at the hospice, he was experiencing such 
psychological distress as a result of his deteriorating condition that he stopped eating and 
drinking to hasten his death.  After a week, the palliative care physician intervened.  
With the agreement of the man’s wife, the doctor performed palliative sedation where 
the man with MND was sedated to an unconscious state until he died from dehydration.  
I had encountered palliative sedation before but not where it was used as a solution to 
psychological pain rather than physical pain.  This was an eye opening experience.  Not 
long after, his wife became my client for bereavement counseling.  I learned in more 
detail about the difficulty of her caring experience and her complex bereavement needs.  
At the time, I wondered why we couldn’t have done more to help this couple.  As a 
result of this experience, I realized the opportunity to perform dignity therapy with 
people who had MND would be challenging but it would also offer a substantial reward 
by providing an intervention that had the potential to alleviate distress in people with 
MND and their families. 
 1.5 Study background and funding 
 In 2009, Professor Samar Aoun of the Western Australian Centre for Cancer and 
Palliative Care (WACCPC) at Curtin University received a Linkage Grant (LP 0991305) 
from the Australian Research Council (ARC) to fund the current research.  Professor 
Chochinov was a co-investigator on the grant.  Linkage projects provide funding to 
support research projects that are collaborative, acquire new knowledge, and involve risk 
or innovation (Australian Research Council 2014).  A partner organization must also 
make a financial contribution to the project, and in the case of this research, the Motor 
Neurone Disease Association of Western Australia (MNDAWA) was the partner.  As 
part of the research costs, an Australian Postgraduate Award Industry (APAI) was 
awarded to provide a stipend to a PhD student to perform the research, which I received.  
The research commenced on 25 October 2010. 
1.6 Aims of the study 
Dignity therapy is an end of life psychotherapy and psychosocial intervention 
designed to enhance quality of life and moderate existential and psychosocial distress. 
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The objectives of this study were to assess the feasibility, acceptability, and potential 
effectiveness of dignity therapy for people with MND and their family carers.   
The specific aims were to determine whether: a) dignity therapy increases hope, 
meaning, and dignity for people with MND; b) dignity therapy decreases perceived 
caregiver burden, anxiety and depression, and increases hope for MND family carers; c) 
dignity therapy is acceptable to people with MND and their family carers; and d) it is 
feasible to provide dignity therapy to people with MND. 
1.7 Significance of the study 
This study supports the growth and extension of palliative care research in 
relevant ways which directly address the three current challenges facing the provision of 
palliative care today.  These challenges, as mentioned earlier, include providing 
psychosocial care; providing care and supports to family members; and providing 
palliative care to people with illnesses other than cancer.  First, this study extends 
research and understanding in the area of psychosocial care at the end of life by 
advancing the research on dignity therapy.  Next, this study is the first study to explore 
the impact of dignity therapy on family carers during their caring experience.  Finally, 
this research examines a psychosocial intervention previously used with the traditional 
palliative care population – cancer patients – and extends it to a new palliative care 
group – people with MND, and it is the first study to examine the practical aspects of 
delivering psychosocial care to people with MND in light of the challenging physical 
symptoms often found in this population.   
Moreover, this research responds to calls to develop and test psychosocial and 
spiritual interventions in the Report of the Quality Standards Subcommittee of the 
American Academy of Neurology 2009 ALS Practice Parameter update (Miller, Jackson 
et al. 2009) which has been endorsed by MND Australia (MND Care Net 2014).  It also 
responds to the Palliative Care Australia’s Standards on Providing Quality Palliative 
Care to All Australians by seeking to relieve suffering and improve the quality of living 
and dying through improved psychosocial care to people with life limiting conditions 
(Palliative Care Australia 2005). 
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1.8 Structure of the thesis 
 This thesis is presented in the form of a “hybrid” thesis by publication (Curtin 
University 2011 p. 5).  In this format, the thesis is a typescript but some chapters are 
papers which have been published.  Each chapter will begin with a brief introduction of 
what is contained within the chapter.  A relevant quotation will also begin the chapter to 
provide a human voice and historical aspect to the thesis. 
 Chapter One has introduced and provided an overview of the research reported in 
the thesis.   It has provided background information, including definitions for 
psychosocial and palliative care.  This chapter has presented the three main challenges 
facing palliative care today, which include the provision of psychosocial care, the 
incorporation of care and supports for family carers of the terminally ill, and the 
inclusion of people facing death who have  illnesses other than cancer.  The researcher 
has been introduced and relevant experiences of the researcher were shared.  The chapter 
concludes with the study background and funding, the aims and significance of the 
study, and the structure of the thesis. 
 Chapter Two describes the research setting and provides an overview of MND, 
including its diagnosis, symptoms and treatment.  Best practice management is 
examined, including service provision in the research setting of WA.  Key symptoms 
and management points along the MND trajectory related to psychosocial distress in 
people with MND and their family carers are explored. 
 Chapter Three is the literature review and is divided into three parts.  The first 
section examines the psychosocial needs and stressors of people with MND.  The second 
section examines the psychosocial needs of MND family carers.  Because MND has no 
cure, maintaining quality of life for people with MND and their family carers is a 
primary treatment goal.  Previous research has shown that quality of life for people with 
MND and their family carers is related to psychosocial and existential distress rather 
than physical impairment and decline.  Despite this, psychosocial interventions have not 
been developed to treat distress.  The third section provides a comprehensive review of 
the literature on dignity therapy, an end of life psychotherapeutic intervention designed 
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to alleviate existential distress, enhance quality of life, create spiritual peace, strengthen 
relationships, and increase meaning, purpose and dignity at the end of life. 
 Chapter Four is the research methodology.  It is comprised of a paper entitled, 
“Is dignity therapy feasible to enhance the end of life experience for people with motor 
neurone disease and their family carers?” This manuscript details the study protocol and 
was published in the peer-reviewed journal BMC Palliative Care.  The design is a cross-
sectional one group pre/post-test design.  Outcomes for participants included 
hopefulness, spirituality/meaning and dignity.  Outcomes for family carers included 
caregiver burden, hopefulness and anxiety/depression.  Acceptability with both groups 
was to be determined through a feedback questionnaire, which was the same measure 
used in the original pilot study and the international randomized controlled trial (IRCT) 
of dignity therapy.    
 Chapters Five, Six, and Seven present the research findings.  Chapter Five is a 
paper examining the impacts of dignity therapy on people with MND published in the 
interdisciplinary journal PLoS One entitled “Feasibility, acceptability, and potential 
effectiveness of dignity therapy for people with motor neurone disease.”  The results of 
the study on 29 people with MND showed no significant changes on the outcome 
measures on the group level, but there were increases in hope on the individual level.  
Dignity therapy was acceptable and the results of the feedback questionnaire were 
similar to the results found in the IRCT.  Dignity therapy is feasible if the therapist can 
overtime time and communication difficulties. 
Chapter Six contains a paper examining the impacts of dignity therapy on MND 
family carers published in BMC Palliative Care entitled “Feasibility, acceptability and 
potential effectiveness of dignity therapy for family carers of people with motor neurone 
disease.”  The results showed no significant changes on the outcome measures on the 
group level, but there were some decreases in anxiety and depression in data analyzed on 
the individual level.  These findings suggest dignity therapy may moderate or reduce 
anxiety and depression in distressed MND family carers.  Family carers saw benefits 
from dignity therapy to people with MND and to themselves after bereavement, but 
acceptability was mixed at the time of the intervention and some family carers indicated 
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negative experiences from the therapy.  Dignity therapy involving family carers is 
feasible and involvement of family carers had minimal impact on the therapy. 
 Findings on the feasibility of dignity therapy with people with MND and their 
family carers is included in Chapter Seven, specifically examining how common MND 
symptoms can affect the provision of dignity therapy and psychotherapeutic 
interventions more generally.  The chapter also provides detail on the practical aspects 
of delivering dignity therapy, including the time and costs involved.  Also contained in 
this chapter is a personal reflection related to feasibility issues and the length of time 
taken to perform dignity therapy which was published in the Journal of Palliative 
Medicine entitled “It takes the time that it takes.”  This chapter is presented in 
manuscript format with a brief introduction, details of the methodology, and a discussion 
to mirror the format used in Chapters Five and Six.   
 Chapter Eight is the discussion, which contains an overview of the key findings, 
a discussion of these findings in light of previous literature, implications for future 
research, strengths and limitations of the study, recommendations for clinical practice, 
and overall conclusion.   The study’s contribution to the three challenges in palliative 
care outlined earlier is discussed.   
 
  
13 
 
CHAPTER TWO 
2.  Setting 
 
 
 
 
 
 
 
 
 
 
I’m quite often asked, ‘How do you feel about having ALS?’  The answer 
is, ‘Not a lot.’  I try to lead as normal a life as possible, and not think 
about my condition, or regret the things it keeps me from doing, which are 
not that many. (Hawking 2008 at 0:22) 
 
Stephen Hawking is a well-known British physicist who has written extensively on the 
origins of the Universe.  Stephen Hawking has MND, is paralyzed and wheelchair-
bound, has a tracheostomy and is dependent on a respirator to aid breathing, and 
communicates by using a computer with eye-gaze technology and a voice synthesizer. 
 
2.1 Motor neurone disease 
Motor neurone disease (MND), also called amyotrophic lateral sclerosis (ALS), 
is an incurable neurodegenerative disease.  While MND and ALS are often used 
synonymously, use tends to vary by country with MND used in Australia and the UK, 
and ALS common in the US and Japan.  MND is also sometimes called Lou Gehrig’s 
disease in the US after a famous American baseball player who developed the disease.  
Motor neurones are specialized nerve cells that transmit information via electrical 
impulses from the brain and spinal cord to muscles resulting in movement (Kent 2012).  
When motor neurones are damaged, messages can no longer be carried by the nerve 
cells to the muscles.  As a result, muscles become weak and atrophy.  In MND, almost 
Chapter Two provides an overview of MND, 
including diagnosis, physical symptoms and 
treatment.  Best practice recommendations for 
the management of MND are examined, 
including service provision and challenges to 
service provision in the research setting of 
WA.  Key symptoms and management points 
along the MND trajectory related to 
psychosocial distress in people with MND 
and their family carers are explored. 
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all skeletal muscles are eventually affected (Kent 2012).   
MND is always progressive with no periods of remission, although presenting 
symptoms and disease course vary between people (Mitsumoto and Rabkin 2007).  A 
staging system for MND to help provide a universal and objective measure of disease 
progression has been developed in recent years, but research to validate this system is 
just beginning (Roche, Rosas-Garcia et al. 2012).  As such, there is currently no staging 
system in MND with easily identifiable clinical milestones.  On average, a person with 
MND will survive two to three years after being diagnosed (Mitchell and Borasio 2007, 
McDermott and Shaw 2008).  Fifty percent of people with MND die within 14 months 
of diagnosis (Orrell 2010), and approximately 10% survive 10 years or more (Talbot, 
Turner et al. 2010).  Noted theoretical physicist Stephen Hawking is an exceptional case, 
surviving over 50 years after being diagnosed at age 21 (Harmon 2012).  Older age at 
symptom onset, early respiratory dysfunction, and bulbar-onset are associated with 
reduced survival, while limb-onset and younger age predict prolonged survival (Kiernan, 
Vucic et al. 2011).  People with MND endure progressive paralysis and most die from 
respiratory failure, often precipitated by pneumonia and usually during sleep 
(McDermott and Shaw 2008, Kiernan, Vucic et al. 2011).   
The cause of MND is unknown, although in 5-10% of cases there is a family 
history of the disease and a known genetic link (Mitchell and Borasio 2007). The mean 
age of onset is 59 years; however, the mean age of onset in people with familial MND is 
younger, from 47-52 (Andersen, Borasio et al. 2005).  The age range of onset is from 18 
to 90 (MND Australia 2010), but incidence decreases rapidly after age 80 (Kiernan, 
Vucic et al. 2011).  Men are affected more often than women at a ratio of 1.6 to 1 
(Borasio and Miller 2001, Mitchell and Borasio 2007), and whites are affected more 
than non-whites (Mitsumoto and Rabkin 2007).  The annual incidence of the disease is 
1.5 to 2 in 100,000, with an annual prevalence of about 7 per 100,000 population 
(Borasio and Miller 2001, McDermott and Shaw 2008) and a lifetime risk of 1 in 350-
500 (Andersen, Abrahams et al. 2012).  There is only one medication approved for 
treatment, Riluzole, which has numerous side effects and extends life by only a few 
months (Mitchell and Borasio 2007, Mitsumoto and Rabkin 2007).  Recent MND 
research has focused on understanding the general pathophysiology, genetics, and 
15 
 
clinical phenotypes in MND in order to discover new treatment approaches (Kiernan, 
Vucic et al. 2011).  
In Australia, it is estimated that 2 people per day are diagnosed with MND.  On 
any one day, approximately 1,900 people have the disease.  In 2011, 790 people in 
Australia died from MND (MND Australia 2014).  The MND Association of Western 
Australia (MNDAWA) estimates that there are 100-120 people living with MND in 
Western Australia (WA), with 40 to 50 people dying from the disease each year.  These 
numbers will increase as the population in WA increases and ages.  At any one time, 
MNDAWA manages approximately 145 clients, including people with MND and 
families who are supported during bereavement (WA Department of Health 2008a). 
 2.1.1  Types of MND  
MND is an overarching term for a group of disorders that affect motor neurones. 
There are four main groups which principally vary based on the location of the primary 
motor neurones affected. 
• ALS – This form of MND has a spinal onset and involves both upper and 
lower motor neurones with weakness occurring in one or more limbs.  
People commonly present with weakness in the hands or feet, including 
tripping or grasping difficulties (Mitchell and Borasio 2007).  ALS is the 
most common form of MND (Talbot, Turner et al. 2010). 
• Progressive bulbar palsy – This form of MND has a bulbar onset and 
affects primarily the upper motor neurones.  People commonly present 
with speech and swallowing issues, including slurred speech, choking, 
and difficulty chewing (Mitchell and Borasio 2007).  A few will present 
with respiratory insufficiency, including breathlessness, poor sleep and 
morning headache (Kent 2012).  Progressive bulbar palsy affects 
approximately 20-25% of those diagnosed with MND, and it has the 
shortest survival (McDermott and Shaw 2008, Kent 2012).   
• Progressive muscular atrophy – This form of MND primarily affects the 
lower motor neurones.  People commonly present with weakness in the 
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legs.  People with this presentation typically survive longer, from five to 
ten years from symptom onset (Kent 2012). 
• Primary lateral sclerosis – This form of MND only affects the upper 
motor neurones. It is the least common form, affecting 3-5% of people 
with MND, and typically progresses more slowly than ALS (Kiernan, 
Vucic et al. 2011). 
Though each group may present and progress differently, there is significant 
overlap of symptoms among the different types.  Eventually, these different groups may 
develop symptoms in all areas of the body (Oliver and Aoun 2013).   
2.1.2  Physical Symptoms  
Direct symptoms resulting from the degeneration of motor neurones include  
muscle weakness and atrophy, twitching, muscle cramps, speech difficulty (dysarthria), 
shortness of breath (dyspnea), difficulty swallowing (dysphagia), and uncontrolled 
crying or laughter (emotional lability/pseudobulbar affect) (Oliver and Borasio 2004, 
Mitchell and Borasio 2007).  Indirect symptoms include pain, drooling (sialorrhea), 
thick mucus secretions, constipation, sleep problems, and psychological disturbances 
(Mitchell and Borasio 2007).  There is also an association between frontotemporal 
dementia (FTD) and MND (Lomen-Hoerth, Murphy et al. 2003, Kiernan, Vucic et al. 
2011), and some level of cognitive decline is encountered in approximately 50% of 
people with MND (Merrilees, Klapper et al. 2010).   
2.1.3  Management  
Intervention for MND centers on managing symptoms and the provision of 
palliative care as there are limited options for treatment and no cure (Miller, Jackson et 
al. 2009).  Care goals include maintaining independence and physical function for as 
long as possible, managing physical symptoms, facilitating communication about end of 
life issues, and providing psychosocial support for people with MND and their family 
(Kristjanson, Toye et al. 2003, Oliver and Borasio 2004, Mitsumoto, Bromberg et al. 
2005, Kent 2012).  It is recommended that people with MND receive coordinated and 
comprehensive care at a multidisciplinary clinic from a team which may include a 
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neurologist, gastroenterologist, rehabilitation specialist, physiotherapist, occupational 
therapist, respiratory therapist, speech therapist, dietician, social worker, research 
coordinator, mental health professional, neuropsychologist, nurse case manager, and 
palliative care physician (Miller, Rosenberg et al. 1999, Mitsumoto and Rabkin 2007, 
Andersen, Abrahams et al. 2012).  Multidisciplinary care received through specialized 
MND clinics improves quality of life and lengthens survival (Van den Berg, Kalmijn et 
al. 2005, Miller, Jackson et al. 2009).  Attendance at clinics also reduces hospital 
admissions (Andersen, Borasio et al. 2005).  Good communication between health care 
providers is essential, and the care received at multidisciplinary clinics is typically 
coordinated with care received from general practitioners and community-based services 
(Andersen, Borasio et al. 2005, Kent 2012). 
Depending on disease progression, most people with MND will confront 
numerous decisions regarding medical interventions to manage their increasing 
impairment and decline in function.  Such interventions include: the use of mobility aids 
such as walkers, wheelchairs, and hoists; the insertion of a gastronomy tube or 
percutaneous endoscopic gastronomy (PEG) to aid nutrition; the use of assisted 
ventilation to aid breathing when respiratory muscles weaken; and the use of 
augmentative and alternative communication (AAC) devices to supplement or replace 
loss of speech.  Because muscle weakness in the lower limbs can result in falls and 
impaired walking, people with MND may require a wheelchair for safe mobility (Kent 
2012), modifications to their homes, and/or other mobility aids.  People with MND who 
have impaired swallowing may desire a PEG tube to aid eating and drinking, which is 
the standard procedure (Leigh, S Abrahams et al. 2003).  Insertion of a PEG can prolong 
life, as malnutrition and weight loss are associated with shortened survival (McDermott 
and Shaw 2008). Weakness of respiratory muscles can cause numerous problems, 
including dyspnoea, anxiety, decreased clearance of saliva and respiratory infections 
(Kent 2012).  Non-invasive ventilation (NIV), which is ventilation that supports 
breathing through a mask rather than through a breathing tube, improves symptoms 
caused by respiratory insufficiency, improves quality of life, and increases survival 
(Miller, Jackson et al. 2009).  In addition, people with MND may encounter speech 
impairment or lose the ability to speak altogether.  In bulbar presentation, this can occur 
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quite early in the disease trajectory.  Speech therapy and the transition to AAC can help 
maintain the ability to communicate (Brownlee and Bruening 2012). 
 2.1.3.1 Local context 
In Australia, a General Practitioner (GP) is usually the primary health 
professional and the first point of contact for a person with MND.  Most states and 
regions, with the exception of Tasmania, the Australian Capital Territory (ACT), and the 
Northern Territory, have multidisciplinary clinics located in major metropolitan 
hospitals.  In Tasmania, a regional advisor performs assessments and makes appropriate 
referrals for the care of people with MND.   The ACT is served by the MND Association 
and three multidisciplinary clinics in adjacent New South Wales.  The Northern 
Territory does not have a multidisciplinary clinic nor a motor neurone disease 
association, and people with MND in that state are referred to the MND Association in 
New South Wales for advice and assistance (MND Care Net 2014). 
In WA, the geographical area focused on in this study, there are two specialised 
hospital-based multidisciplinary MND clinics in the Perth metropolitan region that 
provide care to people with MND.  There is also a satellite clinic in Bunbury, two hours 
south of Perth.  People with MND are typically scheduled to attend the clinic every three 
months.   In WA, about 20% will choose a form of feeding support like a PEG and about 
20% of people with MND receive NIV and (WA Department of Health 2008a).   People 
in WA use assisted ventilation more frequently than those in Europe (10%) but less 
frequently than those in Japan (46%) (Borasio, Gelinas et al. 1998, Leigh, S Abrahams 
et al. 2003).   
People with MND also typically visit their GP and receive social support, care 
advice and advocacy from the MNDAWA.  For people under the age of 65, the Multiple 
Sclerosis Society of WA provides in-home care and respite for people diagnosed with 
rapidly degenerative neurological conditions, including MND, through the Neurological 
Conditions Coordinated Care Program (NCCCP) (Bahn and Giles 2012).  People over 
the age of 65 can access in-home or residential care through government aged-care 
packages.  To access these services, a member of the aged care assessment team 
(ACAT) within the Department of Health performs an assessment and makes a referral 
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for the appropriate level of service.  Services range from supportive services, such as 
personal care, meals and nursing visits to help a person stay at home, to 24-hour high-
level care in a residential facility.  Additionally, community palliative care is available at 
the end-stage by referral from a physician.  Despite these services, there is a lack of 
coordination between services for people with MND, as well as gaps in respiratory 
specialist support and allied health support, including social work, counseling, and 
psychological care (WA Department of Health 2008a). 
Formal psychosocial care can be accessed through a GP, who can provide a 
referral for mental health services provided by GPs, psychologists, psychiatrists, and 
eligible social workers.  The Better Access to Mental Health program provides Medicare 
rebates for a maximum of 10 individual and 10 group sessions per year (Department of 
Health 2012).   NCCCP and community palliative care both employ counselors, who can 
provide services on request.  MNDAWA Care Advisors also provide informal 
psychosocial support (WA Department of Health 2008a).   
Service delivery in WA is complicated by its large geographical size and 
population dispersion.  WA is Australia’s biggest state, accounting for 33% of the 
Australian continent and covering an area of 2,525,500 km2.   WA is bigger in size than 
Western Europe and four times the size of Texas.  Meanwhile, WA’s population of 2.5 
million represents a population density of only .8 people per square kilometre and 
accounts for only 11% of the national total.  In comparison, the population density of the 
US is 32 people per square kilometre, whereas the whole of Australia is 8 people per 
square kilometre.  Approximately 80% of WA’s population lives in the Perth 
metropolitan area; however, 500,000 people reside in rural and remote areas where 
accessing services can be difficult (Australian Bureau of Statistics 2013).  Figures from 
WA by region from 2001 through 2006 reveal that 19% of people with MND were 
treated by WA County Health Service in rural areas, with 81% treated in the Perth 
metropolitan area (WA Department of Health 2008a).  People in rural areas are served 
by their GPs and are unlikely to receive MND specialist input into their disease 
management.  The lack of neurologist specialist care and allied supports in rural and 
regional areas presents a dilemma in the equity of care for people with MND and their 
families for which there is no easy answer (Smith 2007, WA Department of Health 
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2008a).    
2.1.4 Key symptoms and management points along the MND care 
trajectory related to psychosocial distress in people with MND 
The following symptoms and management points in MND care during the 
disease course are related to psychosocial distress and should be considered in the 
provision of psychosocial care for people with MND and their families.  (The 
psychosocial needs of people with MND will be discussed in more detail in Chapter 3). 
 2.1.4.1   Diagnosis 
Diagnosis of MND in the early stages of the disease is difficult.  The average 
delay from onset of symptoms to diagnosis is 14 months (Leigh, S Abrahams et al. 
2003), this is in part due to their being no definitive diagnostic test.  Diagnostic criteria 
(called the El Escorial Diagnostic Criteria) require the following to be present: signs in 
more than 1 of 4 body regions; evidence of both upper and lower motor neurone 
degeneration; and progressive spread (Mitchell and Borasio 2007, Mitsumoto and 
Rabkin 2007).  In addition, because MND is a rare disease, most GPs will see only one 
or two cases in their careers which contributes to the difficulty of formulating the 
diagnosis (McDermott and Shaw 2008).  An accurate and early diagnosis is important 
because delay may cause anxiety and impair a person’s social and professional life 
(Andersen, Borasio et al. 2005).  Uncertainty about the diagnosis can cause fear, 
confusion and worry, and these feelings are amplified when experienced over a long 
period of time, resulting in psychological distress (O'Brien, Whitehead et al. 2011a, 
Mistry and Simpson 2013). 
When a diagnosis is made, it is experienced as a shocking and devastating 
experience for people with MND and their family members, and some will need 
psychological support to help them cope (Borasio, Sloan et al. 1998, WA Department of 
Health 2008a, Andersen, Abrahams et al. 2012, Mistry and Simpson 2013).  Many will 
undergo a period of reactive depression and may benefit from psychological intervention 
(Mitchell and Borasio 2007).  The way the diagnosis is communicated can have a 
profound effect on people with MND and their family members (O'Brien, Whitehead et 
al. 2011a, Andersen, Abrahams et al. 2012), yet surveys have shown that people with 
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MND and their family members perceive that the diagnosis is communicated in a less 
than satisfactory manner 50% of the time (Borasio, Sloan et al. 1998, McCluskey, 
Casarett et al. 2004). When the diagnosis is communicated poorly, it can leave people 
with MND feeling hopeless and abandoned, and negatively impact their relationship 
with their physician (Andersen, Borasio et al. 2005, O'Brien, Whitehead et al. 2011a).  
Insensitive delivery of the diagnosis can also affect psychological adjustment to loss and 
grief (Ackerman and Oliver 1997, Borasio, Sloan et al. 1998).   At the time of diagnosis, 
clinical management guidelines highlight the need to provide assurance of ongoing 
support by a multidisciplinary team (Andersen, Borasio et al. 2005, Andersen, Abrahams 
et al. 2012), including psychological support and counseling (Leigh, S Abrahams et al. 
2003).  Nonetheless, research findings suggest people with MND do not receive 
sufficient emotional support at the time of diagnosis (O'Brien, Whitehead et al. 2011a). 
  2.1.4.2  Loss of speech  
Verbal communication is impaired in 70-80% of people with MND during the 
course of the disease (Leigh, S Abrahams et al. 2003, Oliver and Borasio 2004).  In 
people with bulbar onset, problems with speech are an early symptom which usually 
progresses to speech loss within months (Leigh, S Abrahams et al. 2003).  Speech loss 
and impairment can adversely affect the quality of life of people with MND and their 
family members (Murphy 2004) because communication is fundamental to social 
closeness and participation in life (Miller, Rosenberg et al. 1999).  To limit impairment, 
early involvement of a speech therapist is recommended to allow time to plan and adapt 
to AAC strategies and aids (Oliver and Borasio 2004).  AAC aids and devices include 
unaided (gestures, signs, facial expressions) low-tech (white board, or letter or picture 
boards), and high tech aids (computer-based systems) (Brownlee and Bruening 2012).  
AAC can improve quality of life for people with MND by maintaining function, offering 
a greater sense of independence, providing the means to assist with medical decision 
making, improving relationships, and providing opportunities for social support and 
personal growth (Brownlee and Palovcak 2007, Joubert 2013).  The overall goal in this 
area is for health care providers is to provide supports to optimise meaningful 
interpersonal communication (Andersen, Abrahams et al. 2012).   
In WA, there are speech therapists associated with the MND multidisciplinary 
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clinics, and referral can be made to AAC specialists at the Communications and 
Assistive Technology Service, Department of Medical Engineering and Physics, Royal 
Perth Hospital, who have knowledge of the full range of AAC aids.  With these 
resources, people with MND are able to select technologies depending on their needs, 
abilities and financial resources, ranging from low tech white boards to various methods 
of computerized type-to-speech technology, including tablet computers and 
Lightwriters, which are small and portable type-input voice-output devices.   
  2.1.4.3  Emotional lability  
Emotional lability, also called pseudobulbar affect, is experienced by up to 50% 
of people with MND (Mitchell and Borasio 2007).  A person experiencing emotional 
lability will display an affect triggered by an emotion that is discordant to the situation, 
such as mood-incongruent, inappropriate, or uncontrolled crying or laughing (Elman, 
Houghton et al. 2007).  For example, a nostalgic memory which may evoke a sigh in 
most people can evoke a prolonged crying episode in someone experiencing emotional 
lability.  It is not a mood disorder or mental illness  (Elman, Houghton et al. 2007, 
Mitchell and Borasio 2007), rather it is caused by the neurodegenerative disease 
affecting the brain, and a person experiencing this symptom has little control (Andersen, 
Abrahams et al. 2012).  It can be very disturbing to the person with MND and others in 
social situations (Mitchell and Borasio 2007), and in severe cases may be disabling, 
primarily due to the stigma attached to losing emotional control (Moore, Gresham et al. 
1997).  There are drug treatments (Miller, Jackson et al. 2009, Kent 2012), but only 15% 
of  people with MND request these drugs (Meininger 2005) despite recommendations 
that emotional lability receive as much attention as other physical symptoms in MND 
(Goldstein, Atkins et al. 2006).  People with MND and their families can find this 
symptom distressing but are often unaware it is a symptom of MND (Elman, Houghton 
et al. 2007).  Emotional lability in the person with MND is a predictor of psychological 
distress in MND family carers (Goldstein, Atkins et al. 2006), thus treatment may 
benefit both the person with MND and their family carer.  Emotional lability has the 
potential to cause distress and interfere with psychotherapy where triggering emotions 
may be evoked, especially in people with MND who are unaware of this symptom. 
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2.1.4.4  Cognitive and neurobehavioral decline 
For many years, people diagnosed with MND were told their brain remained 
untouched while their body deteriorated (Kent 2012).  Today, it is understood that there 
is an overlap between MND and frontotemporal lobe degeneration which may lead to 
frontotemporal dementia (FTD) (Phukan, Pender et al. 2007).  Impaired frontal lobe 
function has been reported in up to 50% of people with MND (Merrilees, Klapper et al. 
2010, Raaphorst, De Visser et al. 2010).   Approximately 15% of people with MND will 
meet the criteria for FTD (Ringholz, Appel et al. 2005, Miller, Jackson et al. 2009, 
Merrilees, Klapper et al. 2010) with 11% of that total meeting the criteria for the 
behavioural variant of FTD, characterised by apathy, disinhibition, irritability and lack 
of empathy (Lillo, Mioshi et al. 2011).  FTD and cognitive-behavioral decline are more 
common in people with bulbar presentation (Achi and Rudnicki 2012), and in some, 
FTD is the presenting symptom of MND (Elamin, Phukan et al. 2011).  To date, there 
are no empirically tested treatments available for cognitive or behavioral impairment in 
MND (Miller, Jackson et al. 2009). 
FTD manifests symptoms in three areas: language, behavior and/or personality, 
which may overlap and exist on a continuum (Achi and Rudnicki 2012).  In some people 
with MND, cognitive impairment results in speech and language dysfunction (Leigh, S 
Abrahams et al. 2003, Giordana, Ferrero et al. 2011).  Other people will experience a 
change in behaviour: apathy, executive dysfunction and disinhibition are the most 
commonly cited neurobehavioral symptoms of people with MND (Chio, Vignola et al. 
2010, Merrilees, Klapper et al. 2010, Lillo, Mioshi et al. 2011).   People with MND who 
develop FTD may exhibit severe symptoms including aggression, irritability, 
impulsivity, loss of insight, self-centeredness, lack of empathy, food cravings, and 
obsessive-compulsive behaviors (Merrilees, Klapper et al. 2010).   
A comprehensive neuropsychological assessment is recommended according to 
MND management guidelines (Phukan, Pender et al. 2007, Miller, Jackson et al. 2009) 
but is not feasible for most clinics who have inadequate resources (Achi and Rudnicki 
2012).  Common dementia screenings like the Mini-Mental State Examination are 
insensitive to cognitive and behavioral impairment in people with MND (Andersen, 
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Abrahams et al. 2012).  Short screening tests specifically for people with MND have 
been developed, such as the Addenbrooke's Cognitive Examination Revised (ACE-R) 
(Mioshi, Dawson et al. 2006) and the ALS Cognitive Behavioral Screen (Woolley, York 
et al. 2010) but are not yet in widespread use (Bede, Oliver et al. 2011).  In WA, 
neuropsychological assessments are very rarely completed and cognitive screening 
measures are not used (A. Kermode, personal communication, 1 Oct. 2011).   
Cognitive-behavioral symptoms can have a significant impact on people with 
MND and their families, and negatively affect quality of life, including relationships, 
social supports, and adherence with treatment (Bede, Oliver et al. 2011, Lillo, Mioshi et 
al. 2011).  Practice guidelines suggest that healthcare professionals become 
knowledgeable about cognitive behavioral impairment in MND and pursue training in 
the management of this symptom (Andersen, Abrahams et al. 2012).  Potentially, 
concepts learned from the management of dementia can be applied to people with MND 
who have impaired frontal lobe function.   
2.1.4.5  End of life care 
The current suggested clinical approach for MND advocates that palliative care 
should begin at the time of diagnosis rather than in the final weeks of life (Leigh, S 
Abrahams et al. 2003, Mitsumoto, Bromberg et al. 2005, Andersen, Borasio et al. 2007, 
Andersen, Abrahams et al. 2012), but there are no accepted international standards for 
when palliative care should be initiated (Bede, Oliver et al. 2011).  Late referral of 
people with MND to palliative care services is common (Bede, Oliver et al. 2011).  In 
the US, for example, strict criteria by Medicare for access to palliative care services 
results in many people with MND dying without adequate access to end of life care 
(Elman, Houghton et al. 2007).  In a European survey of specialist MND care providers 
it was reported that the available medical care for people with MND was insufficient in 
the terminal phase in 33% of cases from Northern Europe and 61% of cases from 
Southern Europe (Borasio, Shaw et al. 2001).   In separate research with service users in 
the UK and Australia, people with MND and their families reported they found it 
difficult to access palliative care services (Ray and Street 2011, O'Brien, Whitehead et 
al. 2011b).   
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In the Australian state of Victoria, the Department of Health commissioned a 
study called the MND Pathway Project citing a need to assist people with MND access 
palliative care services as well as a need to assist palliative care services manage and 
support people with MND (Victorian Government Department of Human Services 
2008).  An interim report determined that palliative care of people with MND could not 
be integrated into existing frameworks, that palliative care workers were not confident in 
their knowledge about MND, and people with MND lacked understanding about 
palliative care services (Victorian Government Department of Human Services 2008).  
Between 2000 and 2002, less than 10% of people in WA who died of non-malignant 
diseases accessed palliative care services, compared with 66% of people who died of 
cancer (McNamara, Rosenwax et al. 2006).  This research demonstrates a clear need for 
increased provision of palliative care services for people with MND.   
Palliative care offers important services at the end of life that are not a primary 
focus of MND multidisciplinary care.  These services include terminal phase pain and 
symptom management, the provision of practical and emotional supports for MND 
caregivers such as respite care and counseling, preparation of advance directives, 
assistance with end of life decision making, and the provision of information about death 
(Bede, Oliver et al. 2011).  It is argued that without these services, many of the needs of 
people with MND and their family carers will not be adequately met.  Palliative care, 
which provides support for psychosocial and existential distress, is especially important 
for people with MND as research indicates feelings of hopelessness and being a burden 
on family can lead to requests for a hastened death or suicide (Ganzini, Johnston et al. 
1998, Ganzini, Silveira et al. 2002).   
2.2  Family caregiving in MND 
Generally, end of life caregiving by families is demanding and associated with 
psychological distress (Leblanc, London et al. 1997, Pinquart and Sorenson 2003, Aoun, 
Kristjanson et al. 2005).  In MND, the demands are greater than most other diseases, and 
the burden of the disease falls heavily on family carers (Hecht, Graesel et al. 2003).  
MND family carers experience exceptional strain due to the rapid and progressive nature 
of the disease, coupled with the incapacitating effects of MND (Chio, Gauthier et al. 
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2005).  In many ways, care for a person with MND is similar to family caregiving in 
other terminal disease populations.  However, there are also unique features in MND 
family caregiving due to the disease trajectory of MND (Oliver and Turner 2010), the 
particular challenges faced by MND family carers, and the lack of available supports to 
MND family carers (Grande, Stajduhar et al. 2009).  Family carers of terminally ill 
people in general have numerous unmet psychosocial needs (Hudson and Payne 2011, 
Harding, List et al. 2012), and this is mirrored in MND.  MND practice guidelines state 
that the provision of psychosocial care for MND family carers is a vital area for research 
(Mitsumoto, Bromberg et al. 2005), and there are calls to develop psychosocial 
interventions for MND family carers (Aoun, Bentley et al. 2013). 
Australian statistics indicate that most of the daily care for people with MND is 
provided by family carers throughout the course of illness (Love, Street et al. 2005).  
MND family carers encounter significant life changes that include both daily changes 
and long term adjustments (Hughes, Sinha et al. 2005).  They provide an enormous 
amount of care which grows over time as people with MND require increasing 
assistance with nearly all aspects of daily living (Chio, Gauthier et al. 2005).  Time spent 
caring for people with MND is related to overall disability and ranges from 5 hours per 
day for those with mild disability to 15 hours per day for those with severe impairment 
(Chio, Gauthier et al. 2006).  A progressive increase occurs in time spent on bathing, 
dressing, toileting, administering medications, and feeding, corresponding with level of 
disability (Chio, Gauthier et al. 2006).  MND family carers also face anxieties about 
illness progression, the well-being of family (Bromberg and Forshew 2002, Trail, 
Nelson et al. 2004); changes in family roles (Lackey and Gates 2001, Hughes, Sinha et 
al. 2005); loss of a reciprocal relationship (Ray and Street 2006b); and being judged and 
blamed by other family members for care decisions (Martin and Turnbull 2001).   
People with MND in WA will meet an average of 82 different health care 
providers during the course of the disease (WA Department of Health 2008a), further 
increasing the burden on carers who manage visits and coordinate appointments with 
other family commitments.  The time demands on Australian MND family carers and 
the lack of respite care results in feelings that the carer’s life is on hold and completely 
occupied with their caring role (Kristjanson, Toye et al. 2003).  Family carers in rural 
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areas are further disadvantaged due to the lack of supports such as in-home care and 
respite care (Bahn and Giles 2012). 
MNDAWA provides psychosocial support to carers through carer training 
sessions and a Carer Support Program, which includes monthly educational meetings 
and peer support.  In addition to their other roles, MND care advisors offer informal 
counseling and psychosocial care to MND family carers, and they also provide 
bereavement support for up to six months after death; however, the small number of care 
advisors employed by MNDAWA limits their availability (WA Department of Health 
2008a).  There is a lack of equitable access for people with MND to palliative care 
services in WA (WA Department of Health 2008a, WA Department of Health 2008b), 
and as a result many family carers miss out on the psychosocial and supportive care 
provided by palliative care at the end of life.   
2.2.1 Key symptoms and management points along the MND care 
trajectory related to psychosocial distress in MND family carers 
The following symptoms and management points in MND care are related to 
psychosocial distress for MND family carers and should be considered in the provision 
of psychosocial care for people with MND and their families.   (The psychosocial needs 
of MND family carers will be discussed in more detail in Chapter 3). 
  2.2.1.1 Cognitive and neurobehavioral decline 
Cognitive and behavioral changes associated with MND can have a profound 
impact on family carers, sharply increasing depression and burden and negatively 
affecting their quality of life (Chio, Vignola et al. 2010, Merrilees, Klapper et al. 2010). 
Some family carers observe these changes, while the person with MND may lack insight 
and be unaware (Woolley, Moore et al. 2010).  Other family carers fail to recognize 
symptoms that develop slowly, and some use denial, where they negate and dismiss 
observable symptoms, in order to cope (Woolley, Moore et al. 2010).  Determining the 
full impact of FTD in people with MND on their family carers is not yet known and 
requires further investigation (Lillo, Mioshi et al. 2011).  Recommended screening 
methods and procedures are in development (Mioshi, Dawson et al. 2006, Woolley, 
York et al. 2010), but robust and validated interventions to support carers are lacking.    
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  2.2.1.2 Assisted ventilation 
Respiratory muscle weakness increases over time, and people with MND begin 
to experience breathlessness (Mustfa, Walsh et al. 2006).  Breathlessness and subsequent 
assisted ventilation can cause family carers to feel helpless and ill-prepared to cope, 
causing anxiety, depression, and distress (Gysels and Higginson 2009).  Assisted 
ventilation increases survival time for people with MND, which leads to an extended 
period of caregiving (Mustfa, Walsh et al. 2006, Rabkin, Albert et al. 2006).  When a 
person with MND is ventilator-dependent, family carers often feel excessively burdened 
and report feelings of resentment, frustration and unhappiness (Gelinas, O'Connor et al. 
1998).  Continuous ventilator use can also result in a person with MND losing the ability 
to communicate (Kent 2012), and sexuality is negatively affected (Kaub-Wittemer, 
Steinbuchel et al. 2003), all of which can add to the stress and burden on MND carers.   
NIV, which involves positive-pressure ventilation through a face mask which is 
often used only at night (McDermott and Shaw 2008), is the preferred therapy for 
respiratory insufficiency (Andersen, Abrahams et al. 2012).  The impact of NIV itself on 
caregiver burden is minimal (Baxter, Baird et al. 2013); however, it can create stressful 
and complex issues at the end of life with decisions around whether and when it should 
be withdrawn (Oliver and Turner 2010).  Long term mechanical ventilation (LTMV), 
where breathing is performed continuously through an intubation tube, is used less 
frequently and is not recommended due to its high cost and the substantial emotional and 
social impacts on both people with MND and their caregivers (Andersen, Abrahams et 
al. 2012).   LTMV often results in ‘locked-in syndrome’ where the person with MND 
becomes completely paralyzed and unable to communicate (Leigh, S Abrahams et al. 
2003).   LTMV can inadvertently result when people with MND present to an 
emergency room in respiratory failure (Eng 2006).  These patients are rarely able to 
wean off the ventilator without causing death, creating a situation where both options, 
including continuing to live dependent on a ventilator or withdrawal of the ventilator and 
subsequent respiratory failure and death, are highly distressful (Leigh, S Abrahams et al. 
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2003, Eng 2006).  Several studies have shown that caregiving for people with MND 
using LTMV increases burden and decreases quality of life for the family carer (Kaub-
Wittemer, Steinbuchel et al. 2003, Akiyama, Kayama et al. 2006, Rabkin, Albert et al. 
2006).  The use of LTMV varies between countries (Andersen, Abrahams et al. 2012).  
It is often used in Japan, sometimes used in the US, and rarely used in the UK and 
Australia (Borasio, Gelinas et al. 1998).   
  2.2.1.3 End of life caregiving  
 MND family carers gradually lose the ability to interact with their loved ones at 
the end of life, causing them to feel powerless and struggle with meaning (Akiyama, 
Kayama et al. 2006).  Important components of the relationship deteriorate, such as sex 
life and marital communication, which present additional psychosocial and emotional 
challenges for spouse carers (Wasner, Bold et al. 2004, O'Connor, McCabe et al. 2008, 
Atkins, Brown et al. 2010).  As people with MND lose function, family carers 
experience increased symptoms of somatic depression, including reduced quality of 
sleep and appetite (Pagnini, Rossi et al. 2010).  Conflict can be created when people 
with MND and their family have different beliefs or attitudes about care (Bolmsjo and 
Hermeren 2003).  People with MND may refuse life-sustaining treatments, such as 
insertion of a PEG tube or use of assisted ventilation (Kaub-Wittemer, Steinbuchel et al. 
2003), or they may have an interest in hastening death, which can be upsetting for family 
carers (Rabkin, Wagner et al. 2000).   
  2.2.1.4 Bereavement 
Caregiving ends at death but MND continues to affect families.  During 
bereavement, MND family carers experience lasting emotional effects, including 
sadness, anger, fear, frustration, depression, and, for some, hopelessness (Hebert, 
Lacomis et al. 2005).  MND practice guidelines suggest spiritual and bereavement care 
be provided to family members as a way of preventing complicated bereavement 
(Mitchell and Borasio 2007).  However, in a Canadian study where 27 bereaved MND 
family carers were surveyed, 37% of caregivers reported that they were coping poorly or 
very poorly sometimes years after death, and 68% reported a need for ongoing support 
(Martin and Turnbull 2001).  A Western Australian study revealed that MND family 
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carers may be more vulnerable to prolonged grief and suggests that those who had 
delayed access to palliative care services have the at highest risk (Aoun, Connors et al. 
2012).  While there is recognition of the value of grief and bereavement support for 
MND family carers in the literature, this support is often reported to be inadequate by 
both MND family carers and MND specialist health care providers (Hebert, Lacomis et 
al. 2005, Aoun, Connors et al. 2012).   
2.3 Summary 
 MND is a relatively rare neurodegenerative disease with no cure.  People with 
MND gradually lose function of all voluntary muscles and become paralyzed.  Most 
people with MND die from respiratory failure.  Treatment centers on managing 
symptoms and providing palliative care, with goals of maintaining function and quality 
of life for as long as possible, and providing psychosocial support to the person with 
MND and his/her family.  During the course of the disease, several symptoms and 
management points are related to psychosocial distress and the provision of psychosocial 
care.  These include diagnosis, speech loss, emotional lability, cognitive and 
neurobehavioral decline, and end of life care.  Optimal care is provided by MND 
multidisciplinary clinics working together with GPs, palliative care, and community-
based services.   
 MND family carers experience significant strain during the caring experience.  
They provide long hours of care and face numerous anxieties.  Management points in the 
care trajectory of a person with MND that relate to psychosocial distress in MND 
caregivers are cognitive and neurobehavioral decline, the use of assisted ventilation, end 
of life caregiving, and bereavement. 
 There are 100-120 people living with MND in WA, and 40-50 die each year.  
Multidisciplinary care is provided at two hospital-based MND clinics in the Perth 
metropolitan area and a satellite clinic in Bunbury.  People with MND are typically 
scheduled to attend the clinic every three months.  People with MND also typically visit 
their GP and receive social support, care and advocacy from MNDAWA.  For people 
under the age of 65, the Multiple Sclerosis Society manages a program called NCCCP to 
provide in-home and respite care for people with MND, including home visits from a 
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neurological nurse.  People over the age of 65 can apply for in-home care available to 
older people, although this does not include the specialist services of a neurological 
nurse.  Community palliative care may be available upon referral from a physician, and 
research has shown people with MND have difficulty accessing these services in WA.  
WA covers a vast area of 2,525,000 km2 and its size is a challenge for service 
provision.  About 19% of people with MND in WA live in rural areas, where a lack of 
neurologist specialist care and allied supports is common.  The current situation presents 
an inequity in care available to people with MND and their families who live in rural 
and remote areas.   
Neuropsychological assessments are extremely rare in MND care in WA.  
Because FTD may not be adequately screened for and treated in WA, MND family 
carers and health care providers may not be aware of cognitive and neurobehavioral 
decline, and there are missed opportunities to provide support in this important area.  
Psychosocial care can be accessed by referral from a GP.  NCCCP and community 
palliative care employ counselors and social workers who can provide psychosocial 
support to people with MND and their families.  MNDAWA Care Advisors also provide 
informal psychosocial support, which extends into bereavement for family carers.   
Overall, people with MND and their family carers are presented with numerous stresses 
and challenges over the course of the disease and their psychosocial needs are largely 
unmet.   
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CHAPTER THREE 
3.  Literature Review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fans, for the past two weeks you have been reading about a bad break I 
got. Yet today I consider myself the luckiest man on the face of the earth. 
I have been in ballparks for seventeen years and have never received 
anything but kindness and encouragement from you fans. 
Look at these grand men. Which of you wouldn't consider it the highlight 
of his career to associate with them for even one day? 
Sure, I'm lucky. Who wouldn't consider it an honor to have known Jacob 
Ruppert?  Also the builder of baseball's greatest empire, Ed Barrow?  To 
have spent the next nine years with that wonderful little fellow Miller 
Huggins?  Then to have spent the next nine years with that outstanding 
leader, that smart student of psychology, the best manager in baseball 
today, Joe McCarthy! 
Sure, I'm lucky. When the New York Giants, a team you would give your 
right arm to beat, and vice versa, sends you a gift -- that's something! 
Chapter Three presents a review of the literature 
and it is divided into three sections.  The first 
section examines the psychosocial needs and 
stressors of people with MND.  The second section 
examines the psychosocial needs and stressors of 
MND family carers.  Together, these two sections 
present evidence that maintaining quality of life for 
people with MND and their family carers is a 
primary treatment goal.  Previous research has 
shown that quality of life for people with MND 
and their family carers is dependent on 
psychosocial and existential issues, rather than 
physical decline.  Despite this, no psychosocial 
interventions have been developed to treat distress 
and improve quality of life.  The third section 
provides a comprehensive review of the literature 
on dignity therapy, a palliative care psychosocial 
intervention designed to alleviate existential 
distress, enhance quality of life, and increase 
meaning, purpose and dignity at the end of life. 
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When everybody down to the groundskeepers and those boys in white 
coats remember you with trophies -- that's something. 
When you have a wonderful mother-in-law who takes sides with you in 
squabbles against her own daughter -- that's something. When you have a 
father and mother who work all their lives so that you can have an 
education and build your body -- it's a blessing! When you have a wife 
who has been a tower of strength and shown more courage than you 
dreamed existed-- that's the finest I know. 
So I close in saying that I might have had a tough break, but I have an 
awful lot to live for! (Gehrig 1939 para. 3). 
 
Lou Gehrig was a celebrated first baseman for the New York Yankees baseball team.  
He gave the above farewell speech to 60,000 fans at Yankee Stadium on 4 July 1939, 
confirming his diagnosis of MND/ALS, which came to be known thereafter as Lou 
Gehrig’s disease in the US.  He died less than two years later at age 37.  This well-
known speech highlights the importance of meaning, hope, and relationships in coping 
with MND. 
 
3.1 Introduction 
 MND presents numerous psychosocial stressors and challenges for a person 
diagnosed with the disease and their family.  The literature presented in this chapter 
articulates these challenges and includes findings from empirical research on issues 
relating to quality of life.  Understanding quality of life is necessary in order to address 
the total pain (Saunders 1964) of people with MND and their families and carry out 
Dame Cicely Saunders’ grounding philosophy that says palliative care should help 
people with life limiting illness live fully until death (Saunders 1976).  Through the 
literature review, characteristics of interventions that may benefit people with MND and 
their family carers are revealed, which lays the groundwork for understanding why 
dignity therapy may prove beneficial.  
 This section also reviews the literature on dignity therapy.  Dignity therapy is 
based on research that produced a theoretical model of dignity in the terminally ill.  
Using this model, dignity therapy was created, trialed and tested in a palliative care 
34 
 
population where almost all participants had cancer.  After the pilot testing showed 
promising benefits for both people with terminal disease and their families, an IRCT 
with people with end-stage cancer was performed demonstrating similar benefits.  
Dozens of studies have followed exploring dignity therapy in more detail, including 
effectiveness studies, feasibility studies with different groups, cultural studies, case 
studies, studies exploring the themes found in dignity therapy documents, clinical 
perspectives, and implementation studies.  A review of the resulting published literature 
will aid in understanding the possible benefits and limitations of dignity therapy for 
people who have MND.  
3.2 Psychosocial Needs of People with MND  
 3.2.1 Quality of life 
 The WHO defines quality of life (QOL) as “individuals’ perceptions of their 
position in life in the context of the culture and value systems in which they live and in 
relation to their goals, expectations, standards and concerns”  (World Health 
Organization 1997).  More simply, QOL can be described as the degree of similarity 
between a person’s hopes and expectations and their current reality (Calman 1984).  It 
encompasses bio-psycho-social-spiritual issues encountered during illness, including 
biological aspects (symptoms), psychological aspects (thoughts and emotions), social 
aspects (relationships, resources and supports), and spiritual aspects (religious and 
existential concerns) (Pagnini, Rossi et al. 2010).   In MND, because there is no curative 
treatment, care is focused on maintaining QOL.  While there appears to be a determined 
community of researchers examining QOL and the psychosocial aspects of MND, the 
research published in this area represents only about 8% of the total articles published 
relating to the illness (Pagnini, Simmons et al. 2012).  The majority of published 
research continues to be conducted in the biological realm, typically on identifying 
causes and ameliorating physical symptoms. 
 Despite this focus, research has shown that QOL in people with MND is more 
likely to be related to psychosocial and spiritual conditions of life such as social support, 
hopelessness, meaning and purpose, and sense of burden, rather than biological aspects 
and physical condition (Ganzini, Johnston et al. 1999).  In a prospective study with 96 
35 
 
participants, Simmons et al. (2000) found psychosocial and existential concerns were 
significantly correlated to QOL in people with MND,  whereas physical impairment was 
not.  Clarke (2001) confirmed these results and acknowledged the significant 
relationship between QOL and psychosocial wellbeing, particularly in people with MND 
with the greatest physical disability.  A recent retrospective study of 72 people with 
MND further validated that QOL in people with MND is independent of physical 
function and that QOL does not decline as physical function declines (Cupp, Simmons et 
al. 2011).   
 Research has further determined that QOL in people with MND is related to 
several psychosocial, existential and psychological stressors.  For example, Gibbons et 
al. (2013) conducted a quantitative study with 147 participants in the UK and found the 
psychosocial variables related to QOL in people with MND are depression and social 
withdrawal.  Several QOL studies have shown that people with MND view social and 
spiritual areas as the most important components of QOL (Chio, Gauthier et al. 2004, 
Neudert, Wasner et al. 2004, Foley, O'Mahony et al. 2007, Roach and Averill 2009).   In 
a quantitative study with 80 participants in Italy, Chio and colleagues (2004) found QOL 
was related to supportive and spiritual factors, while a German study with 51 
participants found family and friends have the strongest effect on QOL (Neudert, 
Wasner et al. 2004).  In an Irish qualitative study with five purposively selected 
participants, all participants placed importance on their faith in helping to maintain QOL 
(Foley, O'Mahony et al. 2007).  Thus, psychosocial and spiritual health emerges as the 
most important factor affecting QOL.  In addition, emotional wellbeing is associated 
with longer survival in people with MND based on a longitudinal study with 144 
participants in the US (McDonald, Wiedenfeld et al. 1994).  Nonetheless, the physical 
aspects of MND continue to receive the most attention in MND research and care 
(Worthington 1996, McLeod and Clarke 2007, Pagnini, Simmons et al. 2012).  
Considering the importance of maintaining QOL to overall treatment goals in MND, 
there is insufficient research on the psychosocial impacts of MND on quality of life 
(Epton, Harris et al. 2009) and a lack of direction on providing psychological, 
psychosocial and spiritual care (Pagnini 2012, Pagnini, Simmons et al. 2012).  Below are 
research findings on some of the key psychosocial factors related to QOL in people with 
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MND. 
 3.2.2 Hope 
 Hope and hopelessness are important psychological factors related to QOL in 
MND.   As a result of interviews exploring the meaning of hope in 30 dying people, 
Kaye Herth defined hope as an inner power directed toward enrichment of being (Herth 
1990).  Dr. Jerome Groopman defines hope as the ability to see a path to the future 
(Groopman 2004).   People with MND know nothing can be done to change their fate 
because MND has no cure.  As such, a diagnosis of MND threatens hope, forcing 
families to rework their life goals, dreams and expectations (McLeod and Clarke 2007, 
Mitsumoto and Rabkin 2007).  In research exploring hopelessness in 136 people with 
MND, 32% of people with MND were reported to feel moderately to severely hopeless 
(Plahuta, McCulloch et al. 2002).  Feeling a loss of control and loss of purpose in life are 
predictors of hopelessness in people with MND (Plahuta, McCulloch et al. 2002), and 
hopelessness is positively correlated with suffering and negatively correlated with QOL 
(Ganzini, Johnston et al. 1999).  Like QOL, hopelessness is not correlated with physical 
function or decline (Plahuta, McCulloch et al. 2002, Fanos, Gelinas et al. 2008).  Rather, 
it is related to social support, spiritual beliefs, the ability to adapt, living in the moment, 
and self-transcendence (Fanos, Gelinas et al. 2008). 
 Hopelessness is often considered a component of depression, but people with 
MND do not suffer from significantly high rates of depression (Neudert, Wasner et al. 
2004, Averill, Kasarskis et al. 2007) .  A study comparing depression in people with 
MND and terminal cancer found similar rates of depression in the two groups, although 
people with MND scored higher on hopelessness and suicidal ideation (Clarke, McLeod 
et al. 2005).   As such, it is the hopelessness facet of depression that appears to differ in 
people with MND.  A 2005 prospective study with 53 participants found that people 
with MND who displayed hopelessness, loss of meaning, and existential suffering 
developed a syndrome they termed “end of life despair” and were at increased risk of 
suicide (Albert 2005 p. 73).   
In people with terminal illness, hopelessness is a stronger predictor of suicidal 
ideation and intent than depression (Chochinov, Wilson et al. 1998).  Research shows 
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that people with MND have an elevated interest in hastened death compared to other 
disease groups.  In Oregon, where physician-assisted suicide (PAS) is legal, 0.4% of 
cancer deaths were by PAS, while 5% of people with MND chose PAS  (Ganzini, 
Silveira et al. 2002).  Those who considered hastening death scored higher on a 
hopelessness scale than those people with MND who did not (Ganzini, Johnston et al. 
1998), and hopelessness is the strongest predictor of assisted suicide in people with 
MND (Albert 2005).  People with MND are also at an increased risk for suicide.  A 
population-based cohort study examining 6,642 people with MND in Sweden between 
1965 and 2004 demonstrated a 6-fold increased risk of suicide among persons with 
MND over the general population.  When the study compared people with MND to other 
terminal illnesses, the MND population had the greatest risk of suicide.  Suicide risk was 
highest in the first year after diagnosis, and higher for people diagnosed at a younger 
age.  These findings are indicative of the  psychological distress and hopelessness 
experienced by people with MND, not only at the end of life but also from the earliest 
stages of the disease (Fang, Valdimarsdottir et al. 2008).  
While depression can be treated pharmacologically, hopelessness requires a non-
pharmacological approach to help people with MND see a path to the future, maintain 
hope, and find meaning in life (Mitchell and Borasio 2007, Simmons 2013).  Research 
exploring hope in people with MND found self-transcendence, a connection to one’s 
past and future generations, reminiscence, relationships, spirituality, and living in the 
moment led to improved hopefulness (Fanos, Gelinas et al. 2008).  Though intervention 
studies are lacking, psychological interventions addressing these areas are a promising 
method for decreasing hopelessness among people with MND (Plahuta, McCulloch et al. 
2002).  It is recommended that psychologists, counselors, spiritual care workers, and 
other MND health professionals understand hopelessness in order to optimize treatment 
and psychosocial care (Simmons 2013). 
3.2.3 Spirituality and meaning 
When faced with a life-limiting condition, people often ask questions about the 
meaning of life (Breitbart, Gibson et al. 2004).  Viktor Frankl, one of the founders of 
existential psychotherapy, stated, “We must never forget that we may also find meaning 
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in life even when confronted with a hopeless situation, when facing a fate that cannot be 
changed" (Frankl 2006 at 112).  Spirituality has both a religious dimension, relating to a 
person’s relationship with a higher power, and an existential dimension, relating to 
meaning in life and connection to the world (Dal Bello-Haas, Andrews-Hinders et al. 
2000).  Psycho-oncology research has shown that spiritual and existential needs are high 
in cancer patients (Moadel, Morgan et al. 1999).  A significant relationship between 
meaning in life and wellbeing has been reported in people facing death (Fegg, Kogler et 
al. 2010), and a feeling there is meaning in life appears to safeguard against depression 
and hopelessness in people with advanced cancer (Breitbart, Rosenfeld et al. 2000).   
Spirituality offers a source of meaning and comfort as death approaches and, for many, 
meaning is directly related to spirituality (Fegg, Kramer et al. 2008).   
Several studies have documented the importance of religion, faith, spirituality 
and meaning in preserving QOL in people with MND.  A quantitative study with 60 
people with MND examining the relationship between spiritual wellbeing and QOL 
determined that people with higher spirituality had better QOL (Dal Bello-Haas, 
Andrews-Hinders et al. 2000).  In a longitudinal study with 49 people with MND, a 
significant relationship developed over time between religiousness and improved QOL 
(Walsh, Bremer et al. 2003).  People with MND who possess higher levels of spirituality 
are more hopeful and have fewer concerns about death (Murphy, Albert et al. 2000).  
Those who attend worship services and pray regularly report these practices help them to 
cope with MND (Murphy, Albert et al. 2000).  In a qualitative study, people with MND 
placed the most importance in faith in helping them to accept their illness and see value 
in their remaining days (Foley, O'Mahony et al. 2007).   People with MND who have 
higher levels of spirituality are less likely to consider assisted suicide (Ganzini, Johnston 
et al. 1998), and those who find meaning in life despite advancing illness report a 
strengthened will to live (Ozanne, Graneheim et al. 2013).  Religious faith appears to 
have a protective effect against depression (Rabkin, Wagner et al. 2000), and people 
with MND describe spirituality as a significant source of strength in coping with the 
disease and improving QOL (Pagnini, Rossi et al. 2010).   
Despite findings such as these, there is no research evaluating the effects of 
spiritually-based practices or counseling in people with MND (Pagnini, Lunetta et al. 
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2011).   Several interventions, including dignity therapy (see below), have been 
developed to enhance meaning at the end of life, primarily in cancer patients (Breitbart, 
Gibson et al. 2004, Chochinov, Kristjanson et al. 2011), but they have not been tested 
for people with MND. 
3.2.4 Dignity, social support and relationships 
Empirical research on the meaning of dignity to people who are terminally ill has 
shown that dignity has much to do with social interactions (Chochinov, Hack et al. 
2002b).  Privacy violations, lack of social support, callous and uncompassionate care, 
and feeling a burden to others are reported to be perceived as assaults on dignity 
(Chochinov, Hack et al. 2002a).  How a patient sees themselves and is seen by others 
also affects dignity; the ability to maintain pride, retain autonomy and control, and 
preserve identity in the face of physical deterioration are important (Chochinov, Hack et 
al. 2002a).  Conserving dignity, where people with MND describe the importance of 
being respected, valued, and seen independently of their illness, is a common theme in 
interviews assessing QOL with people with MND (Bolmsjo 2001, Foley, O'Mahony et 
al. 2007, Foley, Timonen et al. 2012).  Protecting self-esteem, maintaining control, and 
preserving self-image are other important dignity related themes (King, Duke et al. 
2009, Ray, Brown et al. 2012).  Like hopelessness, loss of dignity is related to wishes for 
a hastened death in people with terminal illness (Van der Maas, Van Delden et al. 1991, 
Ganzini, Nelson et al. 2000) and people with MND may request PAS due to dignity 
related concerns such as feelings of being a burden, loss of autonomy, and loss of 
dignity (Bascom and Tolle 2002, Mitsumoto and Rabkin 2007). 
The importance of good quality family relationships and support affect feelings 
of dignity and psychosocial health in people with MND (Foley, O'Mahony et al. 2007, 
Ray, Brown et al. 2012).  As a person with MND becomes more physically impaired, the 
factors which contribute to QOL shift from those that are dependent on physical 
function, like exercise, hobbies and work, to those that are not, such as social, spiritual 
and existential factors (Cupp, Simmons et al. 2011).  In research on QOL measures, 
support of family and friends has the strongest impact on the QOL of people with MND 
(Neudert, Wasner et al. 2004), and Fegg (2010) found people with MND list family, 
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partners and friends as the greatest sources of meaning in life.   
Family carers are among the most important resources for coping in people with 
MND, and thus problems or conflicts in the relationship are detrimental to QOL (Fegg, 
Kogler et al. 2010).  Feeling a burden on family members, reduced socialization and a 
perceived lack of social support are frequently cited as psychosocial stressors that affect 
dignity in people with MND (Ganzini, Johnston et al. 1999, Simmons, Bremer et al. 
2000).  Moreover, people with MND who have lost the ability to speak encounter higher 
levels of psychosocial distress due to their social isolation and the impact of the loss on 
family relationships (Goldstein, Adamson et al. 1998, Ray, Brown et al. 2012).  The use 
of AAC methods can preserve communication between people with MND and their 
families and social groups and decrease psychosocial distress (Pagnini 2013).  Dignity 
therapy and other interventions that preserve and enhance dignity, self-worth,  and 
accomplishments may be useful to alleviate psychosocial distress in people with MND 
(Clarke, McLeod et al. 2005) 
3.2.5 Discussion  
The psychological impacts of MND are severe and the impacts on QOL can be 
significant.  Despite progressive physical deterioration and increasing impairment, 
psychological health and QOL in people with MND is primarily dependent on spiritual, 
existential, relationship and support factors (Simmons, Bremer et al. 2000, Robbins, 
Simmons et al. 2001).  Researchers examining QOL and psychological distress often 
conclude that people with MND would experience significant benefits from existential, 
psychological and psychosocial interventions (Pagnini 2012).  Numerous studies 
mention the need for MND health care providers to consider the psychological, 
psychosocial and spiritual support systems of people with MND, rather than focus 
primarily on physical disability (Plahuta, McCulloch et al. 2002, Foley, O'Mahony et al. 
2007, McLeod and Clarke 2007).  The development of interventions that address hope, 
meaning, and existential and psychosocial distress in people with MND has often been 
suggested in the literature (Trail, Nelson et al. 2004, Foley, O'Mahony et al. 2007, Fegg, 
Kogler et al. 2010).  Interventions which engage the family are also important, as 
research indicates that partner and family relationships have high importance in people 
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with MND, and family problems or conflict are detrimental to the QOL of people with 
MND (Fegg, Kogler et al. 2010). 
 While it is suggested that psychologists have a significant role to play “in every 
step” of MND (Pagnini, Rossi et al. 2010 p. 1), there is a lack of research and guidance 
in regard to providing psychosocial and psychological care (McLeod and Clarke 2007, 
Pagnini 2012) and there are few psychological interventions developed or tested to treat 
psychosocial and spiritual distress in people with MND (Pagnini 2012).  A recent 
randomized controlled trial of an expressive disclosure intervention, where people with 
MND wrote or spoke about their deepest thoughts and feelings related to MND over a 
period of days, found the intervention increased psychological wellbeing in people with 
MND who previously had difficulty expressing emotions (Averill, Kasarkis et al. 2013).  
A mindfulness meditation training intervention to reduce distress has been specifically 
created for people with MND and a randomized controlled trial is currently underway 
(Pagnini, Di Credico et al. 2014).  Nonetheless, people with MND remain largely 
unaided in finding coping strategies and accessing support to help sustain psychological 
wellbeing and QOL as the disease progresses.  This has resulted in numerous calls to 
develop and research psychological interventions (Plahuta, McCulloch et al. 2002, 
Pagnini, Simmons et al. 2012, Whitehead, O'Brien et al. 2012).  To guide future 
intervention research, previous studies have determined that hopelessness, spirituality 
and meaning, and social support are among the most important psychosocial factors 
affecting quality of life in people with MND (McLeod and Clarke 2007).  Because of its 
ability to bolster hope, dignity, spirituality and meaning, dignity therapy has been 
mentioned as a specific intervention that shows promise at alleviating end of life distress 
in people with MND (Clarke, McLeod et al. 2005, Fanos, Gelinas et al. 2008).   
3.3 Psychosocial Needs of MND Family Carers 
3.3.1 Quality of life  
Palliative care recognizes that addressing the needs of family carers is a primary 
objective (World Health Organization 2014).  This is especially important for MND 
family carers, as they provide the majority of care and support to people with MND 
(Love, Street et al. 2005) , and they play an important role in clinical decision making 
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(Mitsumoto, Bromberg et al. 2005, Hogden, Greenfield et al. 2013).  Research 
addressing QOL in MND family carers has documented the negative influence of MND 
on caregiver QOL (Jenkinson, Fitzpatrick et al. 2000, Miyashita, Narita et al. 2011, 
Aoun, Bentley et al. 2013).  While QOL in people with MND remains constant with 
time, the QOL of MND family carers declines over time (Roach and Averill 2009).  
QOL in MND family carers appears unrelated to the severity of MND, patient QOL, or 
the level of care (Rabkin, Wagner et al. 2000, Lo Coco, Lo Coco et al. 2005, Murphy, 
Felgoise et al. 2009).  Factors that contribute to decreased QOL include tension, 
infrequent outings, decreased time for oneself, and the presence of anxiety and 
depression (Krivickas, Shockley et al. 1997, Calvo, Moglia et al. 2011, Simmons 2013).  
Trail and colleagues (2004) found the greatest stressor of MND family carers was 
existential distress, including loss of faith and worries about the future.  Increased QOL 
in MND family carers is related to religiousness (Calvo, Moglia et al. 2011) and 
spirituality (Lo Coco, Lo Coco et al. 2005), and MND family carers rate family and 
social support as one of the most important areas contributing to their QOL (Lo Coco, 
Lo Coco et al. 2005).   
Interventions aimed at psychosocial factors are key to maintaining QOL in MND 
family carers (Simmons 2013); however, research and development of psychosocial 
interventions for MND family carers are lacking (Aoun, Bentley et al. 2013).  Research 
findings also suggest the support currently offered to MND family carers by health care 
providers focuses on practical rather than emotional adjustments (Brown 2003, 
Oyebode, Smith et al. 2013), which may add to social isolation and inhibit meaning-
making processes (Oyebode, Smith et al. 2013).  Below are some of the significant 
psychosocial factors related to QOL in MND family carers.   
3.3.2 Anxiety and depression 
Depression and anxiety are the most common sources of psychological distress 
in MND family carers (Aoun, Bentley et al. 2013).   The rapid deterioration typical in 
MND results in increased distress over time, including an increase in depression 
(Goldstein, Atkins et al. 2006, Gauthier, Vignola et al. 2007).  Factors related to 
depression include the ongoing losses that occur as illness progresses (Ray and Street 
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2006b), the increase in carer burden (Gauthier, Vignola et al. 2007), and the rise in 
caregiving intensity (Miyashita, Narita et al. 2009).  However, a longitudinal study on 
depression in MND family carers found that psychological distress, rather than clinical 
depression, is a more accurate description of the depressed mood encountered in MND 
family carers (Rabkin, Albert et al. 2009).   Though some MND family carers in this 
study had scores on the Beck Depression Inventory-II (Beck, Steer et al. 1996) 
indicating they were depressed, comments in qualitative interviews suggest that feelings 
resulting from the caregiving experience, including sadness, feeling under pressure, 
lacking time for oneself, isolation, and exhaustion, were the cause of depressed mood 
(Rabkin, Albert et al. 2009).   
MND family carers have been found to be more depressed than people with 
MND receiving care (Trail, Nelson et al. 2003).  A study of people with MND/family 
carer couples found that while QOL and depression levels were steady in people with 
MND over a nine-month period, MND family carers experienced a significant increase 
in caregiver burden and depression (Gauthier, Vignola et al. 2007).  Caregiver 
depression may be related to depression in the person with MND (Rabkin, Wagner et al. 
2000, Chio, Gauthier et al. 2005), and research suggests that a reason for this is that the 
consequences of MND influences both the person with MND and their family carer to a 
similar extent (Olsson Ozanne, Strang et al. 2010).  The quality of the relationship 
between people with MND and their family carers was found to be the most important 
factor in determining whether an MND family carer developed depression (Rabkin, 
Albert et al. 2009).   
Depression in MND family carers may also be influenced by gender, culture or 
ethnicity.  A study of Japanese MND family carers reported extremely high rates of 
depression (61%) (Miyashita, Narita et al. 2009), while two studies of American MND 
family carers reported low rates (19% and 23%), even when patients were severely 
disabled (Rabkin, Wagner et al. 2000, Rabkin, Albert et al. 2009).  There are indications 
that MND family carers who are women experience higher levels of psychological 
distress than men though the reasons for this are unclear (Goldstein, Adamson et al. 
2000, Hecht, Graesel et al. 2003, Chio, Gauthier et al. 2005, Atkins, Brown et al. 2010, 
Chio, Vignola et al. 2010).  
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Only two published studies have assessed anxiety in MND family carers.  
Goldstein and colleagues (1998) reported 42% of MND family carers had scores 
suggesting the presence of anxiety, while Vignola (2008) reported prevalence rates from 
71 to79%.  Risk factors associated with anxiety are longer marriages or shorter duration 
of symptoms (Goldstein, Adamson et al. 1998).  While it has been asserted that anxiety 
may be associated with the level of disability of the person with MND (Jenkinson, 
Fitzpatrick et al. 2000, Bolmsjo and Hermeren 2003), or may arise from uncertainty 
about disease progression (Ray and Street 2006b), these studies did not investigate these 
links.  In qualitative interviews, MND family carers report a wide range of anxieties 
about the final stage of the disease and death including; fear and uncertainty about the 
future, worries about losing control and decision making abilities, and anxiety over how 
they and their children (including adult children) will cope with loss and bereavement 
(Whitehead, O'Brien et al. 2012).  In an Italian study with 40 MND family carers, 
anxiety, depression and caregiver burden were positively related to each (Pagnini, Rossi 
et al. 2010). 
3.3.3 Caregiver burden 
For MND family carers, caregiver burden increases over time as physical 
function of people with MND declines (Goldstein, Atkins et al. 2006, Gauthier, Vignola 
et al. 2007, Pagnini, Rossi et al. 2010, Aoun, Bentley et al. 2013).   MND family carers 
do not have adequate time for self-care and to attend to their own needs (Rabkin, Albert 
et al. 2009).  They commonly express concerns about their health (Pagnini, Rossi et al. 
2010), and report they suffer from exhaustion and fatigue (Rabkin, Wagner et al. 2000, 
Ray and Street 2006a, Ray and Street 2006b, Gauthier, Vignola et al. 2007, Rabkin, 
Albert et al. 2009, O'Brien, Whitehead et al. 2011b, O'Brien, Whitehead et al. 2012), as 
well as insomnia and interrupted sleep (van Teijingen, Friend et al. 2001, Dawson and 
Kristjanson 2003, Ray and Street 2006a).  The lack of time for oneself is reported by 
some researchers as being a principal reason for caregiver burden (Chio, Gauthier et al. 
2005, Gauthier, Vignola et al. 2007, Miyashita, Narita et al. 2009, Pagnini, Rossi et al. 
2010).   
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In a longitudinal study, Gauthier (2007) found burden in MND family carers 
increased over time, but QOL remained stable.  As such, QOL appears dependent on 
factors other than the physical decline of the care recipient (Lo Coco, Lo Coco et al. 
2005).   This is identical to the findings on QOL in people with MND, where QOL is not 
related to physical decline but instead related primarily to psychosocial factors 
(Simmons, Bremer et al. 2000).  However, symptoms of cognitive and neurobehavioral 
decline (Lillo, Mioshi et al. 2012) and reliance on assisted ventilation both have a 
significant impact on increasing burden and diminishing QOL in MND family carers 
(Aoun, Bentley et al. 2013).   A recent Australian postal survey of 140 MND family 
carers identified abnormal behavior in people with MND, including impulsivity and 
disinhibition, as the strongest predictor of high caregiver burden (Lillo, Mioshi et al. 
2012).  The increase in caregiver burden and decrease in QOL over time is likely due to 
increased caring hours, increased anxieties, and decreased social support that can result 
from cognitive and behavioral impairment, constant mechanical ventilation, or other 
factors (Aoun, Bentley et al. 2013) rather than physical decline in and of itself. 
Positive social support mitigates burden in MND family carers  (Lo Coco, Lo 
Coco et al. 2005, Love, Street et al. 2005, O'Connor, McCabe et al. 2008, Atkins, Brown 
et al. 2010, Pagnini, Rossi et al. 2010).  Satisfaction with social support levels weakens 
the negative effects of MND on perceived burden and QOL (O'Connor, McCabe et al. 
2008, Atkins, Brown et al. 2010).  However, MND family carers, particularly those 
providing care over an extended time, encounter difficulties seeking and maintaining 
social support (Chio, Gauthier et al. 2005, Love, Street et al. 2005, Ray and Street 
2006a).  MND family carers tend to have reduced social contacts, decreased social 
networks and poor quality social interactions due to caregiving responsibilities (Trail, 
Nelson et al. 2003, Love, Street et al. 2005, Ray and Street 2005), which contribute to 
social isolation and perceived burden (Love, Street et al. 2005).  When social supports 
are reduced, MND family carers have an increased reliance on professional services; 
however, research has shown that adequate professional supports are lacking and MND 
family carers are dissatisfied with the lack of available services (O'Brien, Whitehead et 
al. 2012) which indicates a gap in care. 
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3.3.4 Hope 
Few studies have evaluated the impact of hope and hopelessness on family carers 
in a palliative care setting (Williams, Duggleby et al. 2013).  However, in the studies 
that have been conducted, hope has been identified as a psychosocial resource that helps 
family carers of the terminally ill to cope with the difficulty of the caregiving experience 
(Herth 1993, Dawson and Kristjanson 2003, Duggleby, Holtslander et al. 2010).  Hope 
impacts on a family carer’s ability to cope with stressful, life-threatening situations 
(McClement and Chochinov 2008) and higher hope levels are associated with family 
carers feeling prepared to take on the tasks and demands of the caregiver role 
(Henriksson and Arestedt 2013).  
Family carers of the terminally ill define hope as “a dynamic inner power that 
enables transcendence of the present situation and fosters a positive new awareness” 
(Herth 1993 p. 538).  In a meta-synthesis of 14 qualitative studies on hope in family 
carers of people with chronic conditions, Duggleby and colleagues (2010) defined hope 
as “transitional dynamic possibilities within uncertainty” by conceptually integrating the 
synthesized themes found in the studies (p. 154).  In a longitudinal study with 25 family 
carers of the terminally ill where interviews occurred at three time points, from two 
weeks after hospice admission to two weeks before death, hope changed over time from 
specific hopes to more general hopes, such as hope for a close relationship with the 
family member or for a peaceful death (Herth 1993).  Findings from a recent study of 
hope in caregivers of advanced cancer patients found hope was related to social support, 
spirituality, living in the moment, acceptance, and optimism (Williams, Duggleby et al. 
2013).  Hope is important to family carers regardless of age, relationship or setting 
(Duggleby, Holtslander et al. 2010), although younger family carers are at risk for both 
lower levels of hope and higher levels of distress (Lohne, Miaskowski et al. 2012).   
In contrast, in qualitative interviews with 9 bereaved family carers in Finland, a 
lack of hope, where there is little to look forward to in the remaining days of their family 
member, was defined as a feature of poor palliative care (Miettinin, Alaviuhkola et al. 
2001).  In a study of 10 Canadian family carers of people receiving palliative care, 
“eroding hope” was a main concern, which resulted from bad days, negative messages, 
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and poor experiences in the health care system (Holtslander, Duggleby et al. 2005).  
Family carers dealt with eroding hope by living in the moment, acceptance, staying 
positive, and maintaining a fighting spirit (Holtslander, Duggleby et al. 2005).  Studies 
have shown family carers of the terminally ill score lower levels of hope overall than the 
patients themselves (Herth 1993, Benzein and Berg 2005).  Increasing hope may help 
decrease depression and caregiver distress (Lohne, Miaskowski et al. 2012).  To increase 
hope in family carers of advanced cancer patients, a journaling program, focusing on 
what gives a carer hope each day, are currently being developed and tested (Williams, 
Duggleby et al. 2013). 
While studies have evaluated the influence of hope in family carers of the 
terminally ill, none have studied its impact on MND family carers.  However, studies 
with MND family carers have highlighted hopelessness as an important factor related to 
psychological distress.  MND family carers said having something to look forward to 
was crucial to their ability to go on (Rabkin, Albert et al. 2009).  In a qualitative study 
with 16 bereaved MND family carers, 11 family carers, including all 6 who met the 
criteria for prolonged grief disorder, expressed profound feelings of hopelessness during 
their caregiving experience (Aoun, Connors et al. 2012).  Research by Chio and 
colleagues (2005) concluded that caregiver burden may be alleviated in MND family 
carers by supporting a sense of hope.   These findings suggest that interventions that 
assist family carers to increase hope and decrease hopelessness may help to reduce 
depression and alleviate distress.  
 3.3.5  Discussion 
Research has shown a high degree concordance between psychological distress 
in MND family carers and the psychological distress of people with MND, specifically 
in the areas of depression, anxiety and quality of life (Rabkin, Wagner et al. 2000, Chio, 
Gauthier et al. 2005).  The QOL, distress and burden experienced by MND family carers 
appears to be directly related to the existential wellbeing and spirituality of the care 
recipient (Pagnini, Lunetta et al. 2011).  In a longitudinal study where people with MND 
and their family carers rated the wellbeing of both themselves and their counterpart, the 
psychological wellbeing of people with MND and their family carers retained a close 
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correlation over time that was not affected by disease progression or increased disability 
(Olsson, Markhede et al. 2010).  Similarly, Atkins et al (2010) studied marital 
relationships in MND and found the quality of the marital relationship was related to 
psychological and emotional factors rather than symptoms of the disease.  Findings from 
palliative care research shows that hope within family members has a reciprocal role in 
maintaining hope in terminally ill patients (Herth 1990, Herth 1993).  These findings 
indicate the importance of treating psychosocial distress in MND family carers as it may 
also positively affect the person with MND, and also in the reverse (Rabkin, Wagner et 
al. 2000).    
 While research continues to document the burden and distress experienced by 
MND family carers and the concordance of distress between people with MND and their 
family carers, this evidence has not translated into improved care through access to 
psychological or psychosocial supports (Aoun, Bentley et al. 2013).  Interviews with 
MND family carers have found that they desire psychological and psychosocial support, 
but are often unable to access these services (O'Brien, Whitehead et al. 2012).  This 
disparity between desired supports and the availability of supports is a source of carer 
distress (O'Brien, Whitehead et al. 2012).  These studies highlight a gap in care, and 
there are no intervention studies to date that have developed or assessed direct 
psychosocial supports for MND family carers (Aoun, Bentley et al. 2013) despite 
suggestions in the literature (Benzein and Berg 2005, Pagnini 2012).  However, 
recommendations for future interventions are suggested in many of the studies.   
Interventions designed to enhance communication between people with MND 
and their family carers have the potential to improve the psychological wellbeing of both 
parties (Gauthier, Vignola et al. 2007).  Counseling interventions, care information 
courses and support groups have the potential to reduce the burden of MND family 
carers (Hecht, Graesel et al. 2003).  The development of spiritually-based interventions 
have been indicated by several studies to potentially improve MND family carers’ QOL 
(Davey, Wiles et al. 2004, Trail, Nelson et al. 2004, Lo Coco, Lo Coco et al. 2005, 
Murphy, Felgoise et al. 2009, Calvo, Moglia et al. 2011).  Interventions that improve 
existential wellbeing in people with MND may also improve the psychological 
wellbeing of their family carers (Pagnini, Rossi et al. 2010).  Dignity therapy 
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(Chochinov, Hack et al. 2005), which focuses on maintaining hope and a sense of 
meaning in the patient, may also increase hope and meaning in the family carer.  
Caregiver burden may be decreased by an intervention like dignity therapy, as burden is 
decreased in those who find meaning in their caregiving experience (Chio, Gauthier et 
al. 2005).   
3.4 Dignity therapy 
 3.4.1 History and empirical foundation   
Professor Harvey Max Chochinov is a Canadian psychiatrist and researcher 
working in the field of palliative care.  Influenced by Dame Cicely Saunders’ concept of 
total pain (Chochinov 2012), he has become a strong advocate for person-centered care 
at the end of life.  In the 1990s, Chochinov and colleagues studied why some people 
with terminal illness sought a hastened death and found a strong association between a 
desire for hastened death and hopelessness and depression (Chochinov, Wilson et al. 
1995, Chochinov, Wilson et al. 1998).   Loss of dignity was a common source of distress 
for those with terminal illness and was identified as a primary reason why patients lost 
the will to live (Van der Maas, Van Delden et al. 1991, Ganzini, Nelson et al. 2000, 
Chochinov, Hack et al. 2002b), but “dignity” was a vague term subject to multiple 
meanings (Chochinov, Hack et al. 2002a).  Chochinov then sought to understand the 
meaning of dignity from the perspective of a dying person through qualitative interviews 
with 50 terminally ill patients.  Through this research, Chochinov developed an 
empirical model of dignity in the terminally ill where he identified three major 
categories with themes and subthemes, shown in Table 3-1 (Chochinov, Hack et al. 
2002a).  Chochinov validated his dignity model in a subsequent quantitative study where 
211 advanced cancer patients were asked to rate the extent to which their personal 
dignity was related to the 22 individual items derived from the themes and subthemes in 
Figure 3-1.  In this study, all but 1 of the 22 items (thinking about how life would end) 
were endorsed by over half of the participants  (Chochinov, Kristjanson et al. 2006).  
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Table 3-1.  Major dignity categories, themes and subthemes, with example 
statements in italics 
Illness Related 
Concerns 
Dignity Conserving Repertoire Social Dignity Inventory 
 
Level of Independence 
Cognitive Acuity 
    “Can I think clearly?” 
 
Functional Capacity 
    “Can I function  
      physically?” 
 
Symptom Distress 
Physical Distress 
    “Am I experiencing 
      physical pain?” 
 
Psychological distress 
   “What will happen 
     with my medical  
    condition?” 
   “How will I die?” 
 
Dignity Conserving Perspectives 
Continuity of self 
    “Am I still the same person?” 
Role Preservation 
    “Can I still play important 
      roles?” 
Generativity/legacy 
    “Am I leaving something 
     behind? 
Maintenance of pride 
    “Can I still take pride in  
      myself? 
Hopefulness 
    “Do I still have hope?” 
Autonomy/control 
    “Do I feel in control?” 
Acceptance 
    “Am I at peace with what is  
     happening?” 
Resilience/fighting spirit 
    “Do I have the will to go  
     on?” 
Dignity Conserving Practices 
Living “in the moment” 
    “Am I able to live each day as  
     it comes? 
Maintaining normalcy 
   “Am I able to have some 
   normality to my days? 
Seeking spiritual comfort 
    “Can I find comfort in my 
     spiritual beliefs?” 
Privacy boundaries 
  “Are my privacy  
    boundaries being  
    violated?” 
 
Social support 
  “Am I supported by my  
    family and friends?” 
 
Care tenor 
   “Am I being treated by my 
    health professionals with  
    respect and kindness? 
 
Burden to others 
   “Am I a burden to  
    others?” 
 
Aftermath  concerns 
   “What will happen to 
those I love after I die?” 
 
 
 
 Chochinov used his empirical model of dignity in the terminally ill to pursue 
research in two directions: 1) the development of “dignity-conserving care,” a model for 
palliative care providers designed to improve the health care experience by preserving 
the dignity of those nearing death (Chochinov, Hack et al. 2002a, Chochinov 2007); and 
2) the development of dignity therapy, a brief psychotherapeutic intervention to bolster 
dignity and alleviate distress at the end of life (Chochinov, Hack et al. 2005). Through 
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his research, Chochinov found that as a person moves closer to death, feelings of 
hopelessness, being a burden to others, and a loss of dignity are important psychological 
stressors that often lead to existential suffering and depression (Chochinov 2006).  As a 
psychiatrist, Chochinov sought to explore the use of psychotherapy to alleviate these 
stressors.  Before developing dignity therapy, Chochinov and colleagues evaluated other 
psychotherapeutic interventions already in use, including group therapy, cognitive 
behavioral therapy, logotherapy, and life review.  They concluded that none of these 
were ideal as they did not specifically address the types of dignity-related issues that 
confront the dying (Chochinov, Hack et al. 2004). Moreover, they found psychotherapy 
was not widely embraced in palliative medicine, and there was a lack of research and 
efficacy studies supporting the use of different modalities in palliative care populations 
(Chochinov, Hack et al. 2004). 
Chochinov’s empirically based model of dignity at the end of life provided the 
framework for the development of dignity therapy and informs the tone, structure and 
content of the therapy.  Dignity therapy touches on seven specific dignity-related themes 
from Chochinov’s empirical model of dignity, shown in Figure 3-1 (Chochinov, Hack et 
al. 2005).  How dignity therapy specifically addresses the seven dignity concerns is 
shown in Table 3-2 (Chochinov, Hack et al. 2005). 
 
Figure 3-1. Dignity concerns supported by dignity therapy  
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Table 3-2.  Dignity concerns and how dignity therapy addresses the concern  
DIGNITY CONCERN HOW DIGNITY THERAPY ADDRESSES THE CONCERN 
Generativity Interview sessions between the therapist and client are tape-
recorded and transcribed, with an edited transcript returned to 
the client who may share it with and bequeath it to family 
and/or friends. 
Continuity of self Clients are invited to share memories that are foundational to 
their identity and sense of self. 
Role preservation Clients are invited to share previous or current roles that 
contribute to their core self. 
Maintenance of 
pride 
Clients have the opportunity to speak about their 
accomplishments and other sources of pride. 
Hopefulness Clients are engaged in a therapeutic process intended to 
increase hope through discovery meaning and purpose. 
Aftermath 
concerns 
Clients are given the opportunity to help prepare their family 
for a future without them. 
Care tenor A dignity therapist is empathic, nonjudgmental, encouraging 
and respectful, and through the therapy experience sees the 
client as a whole person rather than as a dying patient. 
 
 
 3.4.2 The intervention   
Dignity Therapy was  designed to decrease suffering, enhance quality of life, 
create spiritual peace, strengthen relationships, and increase a sense of meaning, purpose 
and dignity at the end of life (Chochinov, Hack et al. 2005).   In dignity therapy, a 
therapist invites a person with life-limiting illness to discuss aspects of their life they 
want remembered and share important messages using the dignity therapy question 
protocol (Chochinov, Hack et al. 2005, Chochinov 2012).  The protocol is composed of 
several questions as follows: 
• Tell me a little about your life history; particularly the parts that you either 
remember most or think are the most important?  When did you feel most alive? 
• Are there specific things that you would want your family to know about you, and 
are there particular things you would want them to remember? 
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• What are the most important roles you have played in life (family roles, vocational 
roles, community service roles, etc.)?  Why were they so important to you, and what 
do you think you accomplished in those roles? 
• What are your most important accomplishments, and what do you feel most proud 
of? 
• Are there particular things you feel still need to be said to your loved ones or things 
that you would want to take time to say once again? 
• What are your hopes and dreams for your loved ones? 
• What have you learned about life that you would want to pass along to others?  What 
advice or words of guidance would you wish to pass along to your son, daughter, 
husband, wife, parents, other(s)? 
• Are there words or instructions that you would like to offer your family to help 
prepare them for the future? 
• In creating this permanent record are there other thing you would like included? 
The sessions are recorded, transcribed and carefully edited together with the 
participant.  A final document, which Chochinov calls a ‘generativity document’ 
(Chochinov, Hack et al. 2005, Chochinov 2012), is returned to the participant, which 
they can share or bequeath to family members and friends.  In using the term 
‘generativity,” Chochinov borrows from Erik Erikson’s theory of psychosocial 
development (Chochinov and McKeen 2011) where Erikson described 8 developmental 
tasks appropriate to all individuals, spanning from birth to death (Erikson 1950).  In the 
seventh stage, the task of ‘generativity’ encompasses giving back to society and helping 
to guide future generations.  Thus, the ‘generativity document’ resulting from dignity 
therapy is a means to document a person’s legacy for future generations.  Below is a 
step-by-step summary of the dignity therapy process (Chochinov and McKeen 2011, 
Chochinov 2012): 
Initial meeting:  In the first session, the therapist explains how dignity therapy 
works, introduces the dignity therapy questions, identifies potential recipients of the 
generativity document, and answers any questions.  At the conclusion of this meeting, 
the time and setting for the interview are discussed and arranged. 
The interview: A guided recorded conversation takes place between the therapist 
and participant using the dignity therapy questions in order to address important issues 
54 
 
the participant would like to document, such as personal history, meaningful roles and 
accomplishments, lessons learned, and hopes or wishes for their family. 
Editing:  A verbatim transcript of the recorded interview is created.  The 
therapist who performed the interview performs an initial edit of the transcript outside 
the presence of the participant changing the verbatim interview into a more prose-like 
document.  The purpose of this initial editing process is to clean up the transcript, clarify 
what is said, correct time sequences and find a suitable ending.  After the manuscript has 
been shaped and polished, another meeting takes place where the therapist reads the 
document to the participant.  Together they make any final edits to the document.  The 
participant may choose to add or delete material until they feel the document reflects 
what they truly want to say. 
Finalizing the document and concluding the therapy:  The therapist finalizes the 
document and presents copies to the participant, who can share them as they wish.  The 
document is printed and bound in a way that will preserve the document and which 
reflects its importance.  For example, Chochinov’s practice is to print the document on 
“bond grade, beige paper, and to place it in blue, lightweight binder” (Chochinov 2012  
p. 98) 
Dignity therapy invites participants to talk about the parts of their life that they 
found most meaningful.  It also allows them to talk about issues related to grief, offer 
comfort to their loved ones, and provide advice and instructions for the future.  The 
process creates a tangible legacy, the dignity therapy generativity document, and 
provides the opportunity for the participant to leave behind a permanent record of his or 
her life (Chochinov, Hack et al. 2005, Chochinov 2006). 
 3.4.3 Previous research   
Dignity therapy was pilot tested by Chochinov and colleagues with 100 
participants, 97 of whom had end-stage cancer.  This one group, pre/post-test study 
found that dignity therapy was acceptable to participants, who reported numerous 
benefits from the therapy, and it showed a promising ability to alleviate distress at the 
end of life (Chochinov, Hack et al. 2005).   Sixty family members completed a feedback 
questionnaire several months after the death of the participant.  Ninety-five percent of 
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family members reported that dignity therapy had helped the deceased before death, and 
78% reported that the document helped them in bereavement (McClement, Chochinov et 
al. 2007).  Thus, dignity therapy showed a promising potential to reduce distress in 
family members of the terminally ill, as well as to mitigate their bereavement 
experience.   
 Subsequently, the National Institutes of Health funded an IRCT.   In that study, 
326 participants (95% of whom had cancer) were randomized into three arms – dignity 
therapy, client-centered care, and standard palliative care.  There were no significant 
differences reported on outcome measures of distress between the three groups post-
intervention.  However, the study demonstrated greater self-reported benefits in the 
dignity therapy group similar to those found in the pilot study.  As a result, dignity 
therapy was recommended for clinical use with patients nearing death (Chochinov, 
Kristjanson et al. 2011).  
While it may be considered somewhat unusual for a psychotherapy that did not 
demonstrate significant differences on the outcome measures to be recommended for 
clinical use, Chochinov made a convincing case for why his study failed to show 
improvements on the outcomes but was still beneficial to patients (Chochinov, 
Kristjanson et al. 2011).  Specifically, the study population reported low baseline levels 
of distress prior to the intervention and therefore floor effects prevented improvements 
in the outcomes (Chochinov, Kristjanson et al. 2011).  Chochinov cited a 2010 meta-
analysis which concluded that distress prior to an intervention is critical when 
researching psychosocial interventions in people with cancer (Schneider, Moyer et al. 
2010).  Chochinov also pointed to a recent published review paper which found there are 
no quality of life measures responsive to change in palliative care populations (Albers, 
Echteld et al. 2010).  Finally, while palliative care is intended to address the spiritual and 
psychosocial needs of patients and their total pain, Chochinov noted there are extremely 
few psychotherapeutic options for use at the end of life to address these concerns.  
Consequently, he argued that dignity therapy’s ‘something,’ which are the numerous 
benefits reported by study participants facing death, is better than nothing, and that the 
findings were sufficient to support dignity therapy’s continued clinical use (Chochinov, 
Kristjanson et al. 2011).  In an environment where it is recognized that palliative care 
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research is exceptionally challenging (McWhinney, Bass et al. 1994, Grande and Todd 
2000), Chochinov’s argument was embraced and dignity therapy was widely endorsed 
(Ferrell 2005, Nekolaichuk 2011, Akechi 2012, Hack 2012, Kumar, Morse et al. 2012).  
Soon after publication of the results of the IRCT, Chochinov published an instructional 
manual for the clinical application of dignity therapy (Chochinov 2012) and routine 
clinical practice of dignity therapy was initiated in hospice environments in several 
countries, including the U.S. and Australia (Squires 2014, Zahn 2014). 
 3.4.4 Recent developments  
Twenty-three additional studies have been published in recent years evaluating 
various aspects of dignity therapy, from its use with different cultural groups, different 
disease populations, the cost of implementing the therapy, the experiences and 
perspectives of staff delivering the therapy, and the themes found in dignity therapy 
documents.  This research is summarized below and in Appendix A. 
  3.4.4.1   Feasibility studies with different study populations   
Two studies evaluated the feasibility of providing dignity therapy to elderly 
people in residential care, expanding dignity therapy from a palliative care intervention 
used in the final months of life to general use with people receiving care in the final 
years of life.  Similar to the results of the IRCT, a phase II randomized controlled 
feasibility study of dignity therapy performed with 60 older people in care homes in the 
UK found no significant differences in the outcome measures, but the dignity therapy 
group reported more benefits than the control group in a feedback questionnaire.  The 
results suggest dignity therapy may be beneficial to this non-palliative care population, 
though it may take longer to perform (Hall, Goddard et al. 2012).  In a second feasibility 
study with 23 elderly people in long-term care in Canada, dignity therapy was tested 
with two groups: 1) those who were cognitively intact and who completed the therapy 
themselves, and 2) those who suffered from dementia and completed the therapy through 
a family member proxy.  In this study, the participants, proxies, and health care 
providers reported benefits in a feedback questionnaire.  The findings suggest that 
dignity therapy can be successfully performed through a proxy with people who have 
cognitive impairment which is a substantial modification of the original intervention, 
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and demonstrated that it may provide benefits to the elderly in aged care settings.  The 
authors also suggest that the dignity therapy document can assist health care providers in 
aged care settings to treat all residents with dignity, thus improving care (Chochinov, 
Cann et al. 2012). 
A feasibility study of dignity therapy delivered to 8 people using 
videoconferencing was undertaken to evaluate whether dignity therapy could be 
delivered to people dying at home, including those in rural and remote locations.  The 
small study, conducted over a decade ago when videoconferencing from home was less 
common, found that telemedicine appeared to be a feasible way to deliver dignity 
therapy.  The intervention was delivered in a timely fashion with few technical issues, 
and participants reported high satisfaction with dignity therapy in a feedback survey.  
This study noted, however, that therapists commonly complained about the amount of 
time needed to edit the transcripts into a final document (Passik, Kirsh et al. 2004). 
  3.4.4.2   Effectiveness of dignity therapy  
Several studies have examined the effectiveness of dignity therapy to validate 
and expand on the findings of the dignity therapy IRCT.  A Danish study found similar 
benefits were reported on a feedback survey as were reported in the IRCT.  The 
pre/post-test evaluation performed a culturally modified form of dignity therapy with 80 
people with advanced cancer who were admitted to inpatient and outpatient palliative 
care.  In addition to the feedback survey, they measured six outcomes at the conclusion 
of the intervention with mixed results: QOL decreased and depression increased while 
the participants’ sense of dignity and sense of being a burden improved (Houmann, 
Chochinov et al. 2014).  The authors also reported that participants with children 
appeared to experience an increased benefit, which supports dignity therapy’s ability to 
address generativity concerns and the legacy they are leaving to future generations.  
In a qualitative study, interviews were performed with people with advanced 
cancer in both the intervention and control group with the aim of critically examining 
the perceptions and benefits encountered during participation in dignity therapy 
research.  Interviews were completed with those who remained in a dignity therapy 
study at one week (N=29) and four weeks (N=20) after the document was completed.  
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Participants from both the intervention and control groups indicated that they received a 
benefit from their contact with the researchers. There was also support for four of the 
seven dignity concerns from the model of dignity in both groups, including ‘continuity 
of self,’ ‘maintenance of pride,’ ‘care tenor,’ and ‘hopefulness.’  The only difference 
between the groups was the dignity therapy group supported the concept of 
‘generativity’ concerns.  Moreover, the researchers did not find support for ‘role 
preservation’ and ‘aftermath concerns’ in either group.  The findings of this study 
suggest that advanced cancer patients find similar benefits through participating in 
research as they do from dignity therapy, although dignity therapy may offer an 
additional benefit by addressing generativity concerns (Hall, Goddard et al. 2013b).  
However, the study did not find support for two of Chochinov’s seven dignity concerns 
from the 22-item dignity model which form the theoretical basis for dignity therapy.   
In order to examine whether social or cultural factors affected the outcomes of 
dignity therapy, a small phase II randomized controlled trial of dignity therapy with 45 
advanced cancer patients was performed in the UK.  The results showed improvement 
on one outcome, hope, which was higher in the intervention group receiving dignity 
therapy (though hopefulness was not assessed in the IRCT).  The intervention group also 
reported more benefits in a feedback survey than the control group, which is consistent 
with the findings of the IRCT (Hall, Goddard et al. 2011).   As a result of this study, 
hopefulness emerged as an important outcome measure in dignity therapy research.  A 
second study soon followed which also found improvements in hope through dignity 
therapy: an RCT in Iran with 70 people with chronic renal failure found that the hope 
levels in the dignity therapy group increased significantly one month post-therapy.  This 
research also suggests that dignity therapy may be beneficial to people with chronic 
illness (Vaghee, Javadi et al. 2012). 
To address the hypothesis put forth in the findings of the IRCT that floor effects 
resulting from low baseline levels of distress prevented improvements on the outcome 
measures, a Portuguese RCT sought to limit the study population to terminally ill 
patients with high baseline levels of anxiety and depression. Preliminary results from 
this study with 60 participants, 95% of whom had cancer, found that dignity therapy 
reduces anxiety and depression at 4 and 15 days post-intervention, although these effects 
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were not sustained at 30 days post-intervention (Juliao, Oliveira et al. 2012).  This 
research suggests that dignity therapy may be effective in the short-term in reducing 
anxiety and depression in patients with elevated anxiety and depression scores.  On the 
other hand, a small study with 10 participants with advanced cancer found distressed 
participants were more likely to drop out and not complete the therapy, indicating that 
dignity therapy may not be ideal for distressed populations.  In a feedback questionnaire, 
three of the four participants who completed dignity therapy reported that dignity 
therapy had been helpful and made their life more meaningful (Johns 2013), which is 
consistent with the findings of the IRCT and other dignity therapy research. 
  3.4.4.3  Effectiveness of dignity therapy in aged care settings 
Following the two studies which found dignity therapy to be feasible for the 
elderly in residential care, qualitative research was conducted to explore the benefits 
experienced by this group as a result of dignity therapy.  Interviews were conducted with 
both the control and intervention groups.  Both groups indicated they received a benefit 
by taking part in the study and through interactions with researchers.  Interviews 
revealed that aged care residents gave little thought to the dignity concerns of 
‘generativity,’ ‘aftermath concerns,’ ‘role preservation,’ and ‘continuity of self.’  This 
study also reported that the benefits of dignity therapy were countered by problems and 
concerns, as some aged care participants felt the document was not a thorough enough 
biography and others were concerned how their documents would be received.  Though 
all participants passed a brief cognitive screen, the Blessed Orientation Memory 
Concentration test (Katzman, Brown et al. 1983), the researchers found cognitive 
impairment was a factor with minor and major memory lapses affecting the therapy and 
resultant documents.  The findings of this study suggest that dignity therapy may be 
beneficial to a small minority of aged care residents, but that it should not be offered as 
usual care (Hall, Goddard et al. 2013a, Hall, Goddard et al. 2013b). 
  3.4.4.4   The impact of dignity therapy on families 
To explore further the results reported in the pilot study where dignity therapy 
showed a benefit to family members during bereavement (McClement, Chochinov et al. 
2007), three studies looked at the impact of dignity therapy on family members.  In one 
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study, interviews were conducted with 14 family members of older people in care homes 
in the UK in order to explore the family members’ views and experiences of dignity 
therapy performed with their relative.  The findings were primarily positive and family 
members reported the documents helped them learn new details about their relatives, 
communication with their relatives was enhanced as a result of reading the documents, 
and many felt the documents had the potential to provide comfort during bereavement.  
On the other hand, some family members also voiced worries and concerns over the 
content of the documents and the strain placed on their relatives as a result of the therapy 
process (Goddard, Speck et al. 2013).  In a second study, six family members of 
advanced cancer patients in the US who received dignity therapy completed a feedback 
survey.  All reported that reading the transcript was meaningful to them and that it 
increased the sense of purpose, dignity and meaning for their relative (Johns 2013).  
However, in a third qualitative study with nine family members of advanced cancer 
patients, two-thirds described negative experiences as a result of their relative’s 
participation in dignity therapy, including concerns about the content of the generativity 
document, worries about who received and did not receive the document, and fears over 
its impact on family relationships, although family members remained positive about the 
overall impact of dignity therapy on the participant, themselves and other family 
members (Hall, Goddard et al. 2013b).  The findings of these studies indicate that family 
members primarily experience dignity therapy as positive, but the potential exists to 
create problems and disturbances for family members through the creation of the dignity 
therapy generativity document. 
  3.4.4.5  Dignity therapy with different cultural groups 
The creator of dignity therapy and the theoretical model of dignity at the end of 
life upon which dignity therapy is grounded, Professor Harvey Max Chochinov, is based 
in Canada, and the pilot study and IRCT took place at three international sites: 
Winnipeg, Canada, New York City, USA, and Perth, Australia (Chochinov, Hack et al. 
2005, Chochinov, Kristjanson et al. 2011).  As such, dignity therapy is a distinctly 
Western intervention.  Two studies have examined whether dignity therapy can be 
performed with different cultural groups.  A study in Denmark assessed whether the 
dignity therapy interview questions were acceptable to the Danish cultural group.  This 
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study found dignity therapy was acceptable with some revisions to the question protocol, 
for example, reducing emphasis on self-praise, pride in oneself and accomplishments, as 
these were not culturally accepted.  The results of this study suggest that dignity 
therapists must be culturally sensitive and modifications to the question protocol may be 
necessary for different cultural groups (Houmann, Rydahl-Hansen et al. 2010). 
A study in Japan was abandoned when they were unable to recruit eligible 
advanced cancer patients with less than six months to live to receive dignity therapy and 
received an 86% refusal rate.  The reasons given for refusal suggest cultural differences 
between Western and Japanese attitudes about the end of life.  Aversion to death 
awareness is more common in Japan and dignity therapy was found to be too 
confronting for many (Akechi, Akazawa et al. 2012).  In a second Japanese study, only 
subjects expected to benefit from dignity therapy were approached.  Eleven patients 
were recruited and completed dignity therapy.  The findings from feedback 
questionnaires reported satisfaction figures that were not as high as those found in 
Western studies.  As a result, the authors suggest that dignity therapy should not be 
offered routinely in Japan due to cultural differences, but it may benefit some Japanese 
patients who wish to leave a legacy (Akechi, Akazawa et al. 2012).  These finding 
suggest that research surrounding the acceptability of dignity therapy be conducted 
before dignity therapy is adopted for use with non-Western cultural groups. 
  3.4.4.6   Case studies 
Case studies have the ability to provide detail, explore a new area, and develop 
theoretical insights (Walshe, Caress et al. 2004).  Several authors have published case 
studies to provide depth and pose new questions for future dignity therapy research.  A 
paper that presented case studies of three distressed people with advanced cancer who 
completed dignity therapy found these participants felt dignity therapy helped them and 
would help their families at 1 and 4 weeks post-intervention.  However, the cases 
highlighted the complexities of delivering a psychotherapy to distressed people with 
advanced illness who are struggling with issues dignity therapy is not designed to 
address, such as physical pain or social problems.  In addition to experiencing difficulty 
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delivering the therapy in these cases, the dignity related problems of these participants 
returned when their condition deteriorated (Hall, Goddard et al. 2013c). 
A New York psychiatrist presented two novel cases of dignity therapy with 
people suffering from mental illness.  In the first, a woman with severe depression who 
struggled with feelings of hopelessness and loss of meaning was given dignity therapy.  
The subject reported that it helped her “find hope” and improved her mood  (Avery and 
Baez 2012).  In the second case, a man with severe mental illness awaiting transfer to a 
state hospital for psychiatric hospitalization underwent a modified dignity therapy 
process where he wrote out answers to the dignity therapy questions and then the 
psychiatrist created a generativity document from the writings.  The participant reported 
dignity therapy “restored hope” and helped him communicate with family members.  
Also, the participant’s children stated that they understood their father better as a result 
of dignity therapy (Avery and Savitz 2011).  In both studies, the authors argue that 
people with chronic or severe mental illness have much in common with people who are 
facing death, including loss of dignity, hopelessness, loss of purpose and meaning, and 
low QOL.  They suggest future research to adapt dignity therapy to be used with people 
who have a major mental illness (Avery and Savitz 2011, Avery and Baez 2012). 
  3.4.4.7   Themes in dignity therapy documents 
To understand dignity therapy better, researchers have inquired into the content 
of generativity documents, and four studies examined the themes found in dignity 
therapy transcripts.  Fifty documents from the IRCT were analyzed to discover the most 
common ‘values’ expressed in dignity therapy; these were family, pleasure, caring, 
sense of accomplishment, true friendship, and rich experience (Hack, McClement et al. 
2010).  In a study where 23 dignity therapy transcripts were examined, the final 
transcripts were qualitatively analyzed to discover the most commonly discussed areas.  
In rank order, they were autobiographical information, love, lessons learned, important 
roles, accomplishments, character traits, unfinished business, hopes, catalysts, 
overcoming challenges, and guidance for others (Montross, Winters et al. 2011).  In both 
studies, the values and themes expressed by participants bear a relation to the questions 
posed in the dignity therapy question protocol.   
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Twelve final dignity therapy transcripts were qualitatively analyzed to examine 
the narrative types and themes.  The study found patients’ stories fell into three narrative 
types: 1) evaluation narratives where patient’s reflected on their early life before illness 
occurred; 2) transition narratives, where patients discussed the transition from the past to 
their current condition; and 3) legacy narratives, where patients reflected on stories and 
messages they wished to leave their loved ones.  An overarching theme of overcoming 
adversity was discovered in evaluation narratives, and common subthemes included 
heritage, maturation and social lives.  In transition narratives, themes included illness-
related concerns and personal growth through the illness experience.  In legacy 
narratives, themes included newfound perspectives as a result of facing death, messages 
to family to appreciate life before it was too late, and advice on how family should move 
forward with their lives (Tait, Schryer et al. 2011).   In a second paper analyzing the 
same transcripts, the authors found participants used ‘eulogistic strategies,’ to create 
discursive order out of their life events, moving readers from the past, through the 
present, and to a future where they are deceased (Schryer, McDougall et al. 2012). 
  3.4.4.8   Implementation studies 
Three studies have sought to provide information about the pragmatic aspects of 
delivering dignity therapy in a clinical setting, including referral processes, transcription 
costs, and clinical time required for service provision.  In one study in a hospice setting 
performed in the US, 20 people completed dignity therapy.  The mean number of 
sessions was 4 and the mean total clinical session time per participant was 6.3 hours.  
(This does not include the editing time which was done solely by the clinician and which 
was not tracked).  On average, patients addressed five questions from the dignity therapy 
question protocol.  The mean finished document was 8 pages in length and 2,993 words 
long, the cost of transcription ranged from $27 to $144 with a mean of $56 per transcript 
(Montross, Winters et al. 2011).   
A second study was performed examining the implementation of dignity therapy 
into clinical practice at a cancer center in the US.   Ten people entered the study, three 
declined to complete the editing process and three died before the documents could be 
completed.  Of the four that were finished, the mean document was 11 pages in length 
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and 5,878 words long, which, for reasons unknown, is almost double the length of those 
in the Montross study cited above.  Therapists spent 3 to 4 hours editing the document 
and the average interview lasted 66 minutes.  There was no information provided on 
total sessions, total therapist time involved, or duration of the therapy (Johns 2013).   
A third study with 27 people in an aged care setting reported the mean total hours 
taken to deliver the therapy was 15.04 hours per participant.  The mean hours of client 
contact time amounted to 3.48 hours (just over half of the 6.3 hours reported client 
contact time in the Montross study cited above).  The mean hours needed to edit the 
documents was 8.69 (more than double the 3 to 4 hours reported in the Johns study 
above).  The authors report that the increased editing time was due to disjointed stories 
and memory issues of the participants, which may also account for the reduced client 
contact time.  The mean duration of the therapy was 31.81 days from initial interview to 
handing over the document.  This study did not report on the length of the document 
(Hall, Goddard et al. 2012).  From the research conducted thus far, it is difficult to assess 
the time and resources required to implement a dignity therapy program into practice.  
None of the studies provided comprehensive data and there are major differences across 
the data presented.  
  3.4.4.9   Clinical perspectives 
Four studies explored the impacts of dignity therapy on staff and clinicians.  
Feedback was sought from 18 hospice staff members who referred people for dignity 
therapy on the value of dignity therapy as a clinical service.  Overall, staff felt dignity 
therapy was worthwhile, helpful, had some ability to reduce pain and suffering, and that 
it would help family members.  Staff reported that dignity therapy was a positive 
experience for patients and also helped increase their connections to patients (Montross, 
Meier et al. 2013).  Similar findings emerged from a survey of 7 health care providers in 
an aged care setting (Chochinov, Cann et al. 2012). 
Thirty-six undergraduate students in a social work class performed dignity 
therapy with hospice patients and were interviewed about the impact that administering 
dignity therapy had on them.  Three themes emerged; “greater appreciation for life,” 
“connection to my own family,” and “service and legacy.”  The study found that the 
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experience was a resounding success and a meaningful experience (Davis Berman 
2014).  In another study, twelve medical residents performed dignity therapy in a study 
that aimed to examine residents’ experiences of delivering dignity therapy, residents’ 
reflections on patients’ life stories, and residents’ reflections on the dignity therapy 
intervention in the context of their broader medical education.  The study found that 
residents felt conversations with dying patients, particularly the skill of soliciting the 
patients’ life story, was poorly taught in medical school, and that a hidden message 
existed in their training that learning a patient’s story is not a valued domain of the 
physician (Tait and Hodges 2013).  It is noteworthy that in all of these studies, clinicians 
reported a benefit to themselves from dignity therapy, often as both a personally 
meaningful experience for themselves, as well as a method of enhancing care.   
 3.4.5  Discussion 
While there were no differences on the outcomes measuring distress between the 
three study arms in the dignity therapy IRCT, the dignity therapy group reported more 
benefits and higher satisfaction with the therapy on a feedback questionnaire than the 
other groups.  Therefore, the primary method relied on to evaluate the benefits of dignity 
therapy and recommend it for clinical practice is self-report questionnaires, where high 
numbers of participants reported that dignity therapy was helpful to them, improved 
their sense of dignity, purpose and meaning, and where almost all participants reported 
dignity therapy to be a satisfactory experience (Chochinov, Kristjanson et al. 2011). 
Similar results on the feedback questionnaire were reported in the previous pilot study 
(Chochinov, Hack et al. 2005), and several studies have gone on to use the same or a 
very similar feedback questionnaire in their research, reporting similar results (Passik, 
Kirsh et al. 2004, Hall, Goddard et al. 2011, Chochinov, Cann et al. 2012, Hall, Goddard 
et al. 2012, Houmann, Chochinov et al. 2014).  In addition, some dignity therapy studies 
examining potential benefits to family members have used a similar questionnaire with 
consistent results (McClement, Chochinov et al. 2007, Chochinov, Cann et al. 2012, 
Johns 2013).  Findings based on these self-report measures are arguably the most 
important and have formed the empirical base for the effectiveness of dignity therapy. 
Some would argue that findings based on self-report are inherently unreliable (Nisbett 
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and Wilson 1977) but there is also a case to be made that self-report measures are as 
valid as other outcomes (Haeffel and Howard 2010). 
Subsequent studies have attempted to strengthen these findings by using a variety 
of outcome measures to examine whether dignity therapy diminishes psychological 
distress.  From this research, the most promising instrument appears to be the Herth 
Hope Index (HHI) (Herth 1990, Buckley and Herth 2004) assessing hopefulness as 
studies in the UK and Iran have both reported increased hope using this measure after 
dignity therapy (Hall, Goddard et al. 2011, Vaghee, Javadi et al. 2012).  Another 
promising instrument is the Hospital Anxiety and Depression Scale (HADS) (Zigmond 
and Snaith 1983) as a result of a Portuguese study showing short-term improvements in 
anxiety and depression using this measure in cancer patients who had high levels of 
distress at baseline (Juliao, Oliveira et al. 2012).  No other outcome measure used to date 
has been able to provide evidence of improved QOL or decreased psychological distress 
as a result of dignity therapy. 
In their IRCT, Chochinov and colleagues suggested that low baseline levels of 
distress caused floor effects which prevented significant changes in the outcome 
measures (Chochinov, Kristjanson et al. 2011).  The Portuguese study, which screened 
for high distress in participants and then showed reductions in anxiety and depression, 
provides support for this assertion (Juliao, Oliveira et al. 2012).  However, a US study 
found people who were highly distressed had high dropout rates and were thus unable to 
benefit from dignity therapy (Johns 2013), and a UK case study examining the 
experiences of three distressed cancer patients concluded the complexities of delivering 
dignity therapy to distressed people may pose a substantial barrier (Hall, Goddard et al. 
2013c).  Thus, while dignity therapy may have the ability to decrease distress in 
distressed patients, it may not be feasible to perform dignity therapy with people 
experiencing substantial distress.  Further research in this area is warranted.   
Dignity therapy is based on an Chochinov’s theoretical model of dignity in the 
terminally ill (Chochinov, Hack et al. 2002a), and it is designed to respond to the dignity 
concerns of role preservation, maintaining hope, maintenance of pride, continuity of self, 
generativity, care tenor, and aftermath concerns (Chochinov, Hack et al. 2005).  Two 
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studies in the UK evaluated whether dignity therapy responded to the seven dignity 
related concerns it was designed to address (Hall, Goddard et al. 2013a, Hall, Goddard et 
al. 2013b).  In the first study, through qualitative interviews with cancer patients in both 
the control and intervention groups, the researchers found that participants from both 
groups felt an increase in hopefulness, care tenor, maintenance of pride, and continuity 
of self as a result of participating in the research.  Neither group reported improvements 
in aftermath concerns or role preservation, while the dignity therapy group alone 
experienced generativity benefits (Hall, Goddard et al. 2013b).  The findings in a Danish 
study that people with children experienced more benefits from dignity therapy supports 
the idea that dignity therapy alleviates generativity concerns (Houmann, Chochinov et 
al. 2014).   
Similar interviews assessing dignity related concerns were conducted with 
people in aged care in both the control and intervention groups.  In this study, both 
groups reported that they received benefits from participating in research, but the study 
found no benefits relating to the seven areas in the theoretical model of dignity that 
dignity therapy is meant to address (Hall, Goddard et al. 2013a). These findings suggest 
that dignity therapy is most effective at addressing generativity concerns in people with 
terminal illness, and that person-centered contact, be it through an intervention or 
contact with researchers, provides numerous dignity-related benefits in and of itself 
(Chochinov 2007).  
Initial steps have been taken to determine if dignity therapy can be used outside 
of palliative care settings.  Three studies examined the application of dignity therapy 
with elderly people residing in aged care settings, which is a deviation from the 
palliative care population but also a group that faces the end of life and suffers from 
dignity-related distress (Chochinov, Cann et al. 2012, Hall, Goddard et al. 2012, Hall, 
Goddard et al. 2013a).  Two of the studies reported more benefits (via the feedback 
questionnaire) in the intervention group than in the control group (Chochinov, Cann et 
al. 2012, Hall, Goddard et al. 2012), although the remaining study concluded that the 
excessive time needed to deliver the therapy, the negative experiences by family 
members, and the cognitive issues of residents indicate that dignity therapy may not be 
appropriate in this clinical setting (Hall, Goddard et al. 2013a).   
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Several studies have looked at other deviations from the dignity therapy 
intervention protocol (Chochinov 2012).  The feasibility of conducting dignity therapy 
in aged care settings with people who suffer from dementia through a family member 
proxy was assessed.  In this study, the researchers suggest dignity therapy conducted in 
this manner is an acceptable deviation offering benefits to all involved parties including 
the resident, family and staff (Chochinov, Cann et al. 2012).  Novel applications of 
dignity therapy in people with chronic illness (Vaghee, Javadi et al. 2012), people with 
mental illness (Avery and Baez 2012) (Avery and Savitz 2011), and people in their 
homes using videoconferencing (Passik, Kirsh et al. 2004) appear to offer benefits but 
require further study.   Dignity therapy may need to be modified to be performed with 
non-Western cultural groups.  A Danish study found the question protocol required 
revision (Houmann, Rydahl-Hansen et al. 2010), and a Japanese study found dignity 
therapy is culturally incompatible (Akechi, Akazawa et al. 2012).   
Research evaluating the impact of dignity therapy on family members 
substantiates initial findings that dignity therapy conducted with patients can be 
beneficial to family (McClement, Chochinov et al. 2007).   However, in one study with 
family members of advanced cancer patients, two-thirds of family members also 
described negative experiences from dignity therapy (Hall, Goddard et al. 2013b), and 
family members of aged care residents also voiced worries and concerns about the 
therapy (Goddard, Speck et al. 2013) .  These findings are very different from the 
findings of the IRCT, where Chochinov and colleagues (2011) reported “a few occasions 
family members were dissatisfied with the generativity document” (p. 761).  Negative 
experiences were also reported in some aged care participants who felt the dignity 
therapy document created problems (Hall, Goddard et al. 2013a), which is different to 
Chochinov et al.’s pilot study and IRCT where no instances of dissatisfaction or distress 
were reported  by dignity therapy participants (Chochinov, Hack et al. 2005, Chochinov, 
Kristjanson et al. 2011).  Further research is warranted, including longitudinal studies, to 
investigate potential negative experiences and distress caused to both participants and 
family members as a result of the dignity therapy intervention and generativity 
document. 
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Four studies have examined the themes contained in dignity therapy transcripts 
(Hack, McClement et al. 2010, Montross, Winters et al. 2011, Tait, Schryer et al. 2011, 
Schryer, McDougall et al. 2012), although the approach in each of these studies was 
different making comparison difficult.  One study assessed common values (Hack, 
McClement et al. 2010), two addressed common themes (Montross, Winters et al. 2011, 
Tait, Schryer et al. 2011), and another evaluated narrative types found in the documents 
(Schryer, McDougall et al. 2012).  The findings of these studies suggests the material 
discussed in the documents is consistent with the questions asked in the dignity therapy 
question framework, including autobiographical information, important roles, family and 
relationships and accomplishments.   Legacy messages, such as guidance and advice to 
family members, were also important themes.  In two studies, a theme emerged that was 
not apparent in the question protocol, which was overcoming challenges and adversity 
(Montross, Winters et al. 2011, Tait, Schryer et al. 2011). 
Finally, several studies addressed the practical realities of delivering dignity 
therapy.  Overall, dignity therapy clinicians reported that delivering the therapy was a 
meaningful and worthwhile experience that increased their connection to patients 
(Montross, Meier et al. 2013, Tait and Hodges 2013, Davis Berman 2014).  Health care 
providers of involved participants also reported positive impacts from the intervention, 
including increased knowledge about a patient as a result of reading their document 
(Chochinov, Cann et al. 2012, Montross, Meier et al. 2013).  Three studies looked at 
pragmatic aspects of delivering the therapy, including time taken, costs expended and 
length of documents, but the findings are limited by incomplete information reported in 
these studies (Montross, Winters et al. 2011, Hall, Goddard et al. 2012, Johns 2013).  
Two studies noted that the time required to edit documents may be excessive and 
problematic for clinical implementation (Passik, Kirsh et al. 2004, Hall, Goddard et al. 
2012), and one noted that travel time, cancelled appointments, and delays were common 
issues that compounded the substantial time commitment required by clinicians to 
complete the intervention (Hall, Goddard et al. 2012).  Future studies that report 
comprehensively on the time and resources required to deliver dignity therapy are 
needed, especially in light of findings that person-centered contact alone appears to offer 
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many of the same benefits as dignity therapy (Hall, Goddard et al. 2013a, Hall, Goddard 
et al. 2013b).   
3.5 Summary 
MND presents numerous psychosocial and existential challenges for people 
diagnosed with the disease and their family carers throughout the disease trajectory. 
Research into significant psychosocial stressors on people with MND has shown that 
hopelessness, spirituality, and dignity are important areas of potential distress requiring 
attention and intervention.  In MND family carers, anxiety and depression, caregiver 
burden, and hopelessness are important factors.   In addition, the level of distress in 
either the person with MND or their family carer impacts on the level of distress of the 
other party.  This shows that alleviating distress in one may have a beneficial impact for 
both.  The impact of these challenges and stressors are more significant than the physical 
challenges encountered in MND on QOL.  Because MND has no cure, maintaining QOL 
for people with MND and their caregivers is a primary treatment goal.  However, despite 
the importance of psychosocial and existential distress on QOL, the vast majority of 
MND research is dedicated to the biological arena including the treatment of physical 
symptoms.   Despite numerous calls in the literature, only one psychological, 
psychosocial, existential or spiritual intervention can be found in the literature to provide 
support or treat distress in people with MND or their family carers.   
Dignity therapy was developed to alleviate psychosocial and existential distress 
at the end of life.  It was designed to decrease suffering, enhance QOL, create spiritual 
peace, strengthen relationships, and increase a sense of meaning, purpose and dignity at 
the end of life through the creation of a legacy document.  Approximately two dozen 
studies on various aspects of dignity therapy have built an empirical understanding of its 
benefits, but the effectiveness of dignity therapy has been difficult to fully document.   
Nonetheless, some studies have shown increases in hope and decreases in anxiety and 
depression as a result of dignity therapy, along with reports of increased meaning and 
decreased burden.   Dignity therapy has proven feasible, but it may take longer to 
complete for people in aged care than for people with advanced cancer. 
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One of the most positive indicators of benefits derived from dignity therapy is 
that it has proven highly acceptable in all research settings, and participants and family 
carers report numerous benefits in self-report feedback questionnaires.  Clinicians and 
health care professionals also report benefits from the therapy.  On the other hand, 
although initial studies did not document negative experiences from the therapy, recent 
research highlights some problems with certain groups, including family carers hurt by 
some aspect of the document and aged care residents who do not feel the document is 
complete or worry about how it will be perceived.  There has also been some challenge 
to the empirical basis for dignity therapy in findings that do not support the seven 
dignity related concerns among people receiving dignity therapy that dignity therapy is 
meant to address. 
Nonetheless, dignity therapy is a promising psychosocial intervention to alleviate 
distress and enhance the end of life of people with MND and their family carers, but its 
feasibility, acceptability and potential effectiveness must be assessed.   The experience 
of MND differs substantially from the experience of cancer, and cancer patients and 
family carers are the participants in most dignity therapy research, including the IRCT.  
Levels of distress differ in these two groups, as well as physical symptoms which may 
impact on the therapy.  By exploring the use of dignity therapy with people who have 
MND, the three challenges confronting palliative care are being addressed, including 
researching a psychosocial intervention, performing research which impacts on the care 
and supports provided to family carers, and researching a palliative care intervention that 
impacts on a disease group other than cancer.   This research supports the Dame Cicely 
Saunders grounding philosophy of palliative care to address the total pain encountered 
by people with MND and their family carers during their illness, and to help them live 
fully until death. 
  
72 
 
CHAPTER FOUR 
4.  Methodology 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
She said she is preparing me, because the results point to motor neurone 
disease.  I was shocked but too numb to react.  I don’t want to think about it. 
…The occupational therapist came to assess our problems.  She suggests we 
get a stair lift or a proper lift.  What a bore.  I felt depressed about what the 
future holds for me, and so sorry for poor Joss having this burden of my 
weakness, and all the expense of adapting the house for my illness. ...The 
therapist came.  She was so depressing – she wanted wheelchairs and 
handrails and lifts.  I found her forcefulness oppressive, and I want to 
escape.  Joss and I can muddle on together – it’s much better. …We had brill 
for supper.  At the end of the meal I suddenly felt very tearful and could not 
stop weeping.  My speech is getting slower and my right hand weaker.  I am 
so frustrated and desperate. (Ackland and Ackland 2009 pp. 211-214) 
 
Selected lines from a few pages of Rosemary Ackland’s diary about being diagnosed 
with MND and the beginning of her MND journey.  Rosemary’s husband is British actor 
Joss Ackland, who published Rosemary’s diary after her death from MND in 2002. 
 
 
 
Chapter Four consists of a published study 
protocol paper outlining the methodology of the 
study.  The paper is entitled, “Is dignity therapy 
feasible to enhance the end of life experience of 
people with motor neurone disease and their 
family carers.”  It was published in the open 
access, peer-reviewed journal BMC Palliative 
Care.  The design is a cross-sectional one group 
pre/post-test design.  Outcomes for participants 
included hopefulness, spirituality/meaning and 
dignity.  Outcomes for family carers included 
caregiver burden, hopefulness and 
anxiety/depression.  Acceptability with both 
groups was to be determined through a feedback 
questionnaire, which was the same measure used 
in the IRCT.   
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Abstract
Background: Development of interventions that address psychosocial and existential distress in people with
motor neurone disease (MND) or that alleviate caregiver burden in MND family carers have often been suggested
in the research literature. Dignity therapy, which was developed to reduce psychosocial and existential distress
at the end of life, has been shown to benefit people dying of cancer and their families. These results may not be
transferable to people with MND. The objectives of this study are to assess the feasibility, acceptability and potential
effectiveness of dignity therapy to enhance the end of life experience for people with motor neurone disease
and their family carers.
Methods/design: This is a cross-sectional study utilizing a single treatment group and a pre/post test design.
The study population will comprise fifty people diagnosed with MND and their nominated family carers. Primarily
quantitative outcomes will be gathered through measures assessed at baseline and at approximately one week
after the intervention. Outcomes for participants include hopefulness, spirituality and dignity. Outcomes for family
carers include perceived caregiver burden, hopefulness and anxiety/depression. Feedback and satisfaction with
the intervention will be gathered through a questionnaire.
Discussion: This detailed research will explore if dignity therapy has the potential to enhance the end of life
experience for people with MND and their family carers, and fill a gap for professionals who are called on to
address the spiritual, existential and psychosocial needs of their MND patients and families.
Trial registration: ACTRN Trial Number: ACTRN12611000410954
Keywords: Motor neurone disease, Amyotrophic lateral sclerosis, Palliative care, Existential distress, Family carers,
Dignity therapy
Background
As a result of elevated interest in hastened death at the
end of life by people with motor neurone disease
(MND), also known as amyotrophic lateral sclerosis
(ALS), numerous studies have examined factors that
affect quality of life, psychological health, and end-of-life
distress in this population. Findings indicate that quality
of life in MND-diagnosed individuals is independent of
physical decline [1,2]; that interest in hastened death
is correlated with hopelessness [3,4]; and that MND
patients with higher levels of spirituality and sense of
meaning experience less end of life distress [5,6]. This
research has resulted in a call to develop psychosocial
interventions for use with the MND population that
will bolster hopefulness, spirituality, and meaning [7,8];
however, very little work has been done to develop and
implement such interventions.
MND is a family disease, and family carers carry an
exceptional burden by providing a high level of care,
often for the duration of the illness. Family carers of
people with MND are more depressed than people with
MND overall [9]. As time goes on and dependency
increases, family carers exhibit increasing levels of dis-
tress symptoms [10,11]. Studies on the quality of life in
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MND family carers suggests that perceived caregiver
burden can be alleviated by finding positive meaning
[12,13] and by supporting a sense of hope [14].
Dignity therapy, a brief psychotherapeutic intervention
based on empirical research into the concept of dignity
at the end of life [15], has proven successful at increas-
ing hope, sense of meaning and will to live in a palliative
care population, where most patients had cancer diagno-
ses. Dignity therapy offers people with terminal illness
the opportunity to create a generativity document. In a
recorded interview guided by a counsellor or health care
professional, the participant is invited to recount aspects
of their life they want remembered, find meaning and
purpose to their life, and express final words or advice.
The interview is transcribed and edited, and a final dig-
nity therapy transcript is returned to the participant to
share with others as they wish.
A pilot study of dignity therapy produced positive
results for participants and family members. A heigh-
tened sense of dignity was reported in 76% of partici-
pants, an increased sense of purpose was reported by
68%, an increased sense of meaning was reported by
67%, and 47% reported an increased will to live [16].
A recent randomised controlled trial reported similar
outcomes [17]. In the pilot study, family members were
also positive about the intervention, with 95% reporting
they would recommend dignity therapy, 78% reporting
that it helped them during their time of grief, and 77%
believing the document would be a continuing source
of comfort [18].
Nonetheless, because these studies both utilized a pri-
marily cancer population, the results are not transferable
to people with MND. Ability to communicate, cognitive
acuity, stage of illness, baseline levels of distress and
demographic features are some of the factors that may
vary in this population and make implementation of dig-
nity therapy difficult. The delivery of the intervention
may require modification, i.e. to be performed at an earl-
ier stage in the disease process or by utilizing assisted
communication methods. Therefore, feasibility testing of
dignity therapy with the MND population is warranted
[19,20].
Moreover, while the previous dignity therapy study
focused on the intervention’s positive influence on the
bereavement experience of family members, it did not
look at how the intervention may affect the carer during
the caring experience.
Aims and objectives
The aims of this study are to assess the feasibility,
acceptability and potential effectiveness of dignity ther-
apy to enhance the end of life experience for people with
MND and their family carers. The specific objectives
are to:
a) Determine whether dignity therapy is likely to
increase hope, meaning and dignity in people
with MND.
b)Determine whether dignity therapy is likely to
increase hope, and decrease anxiety, depression,
and perceived burden in family carers of people
with MND.
c) Determine whether dignity therapy is acceptable
to people with MND and their family carers.
d)Determine whether it is feasible to provide dignity
therapy to people with MND.
e) Pilot methods for a future randomized controlled
trial.
Methods
Study design
This is a cross-sectional study utilizing a single treat-
ment group and a repeated measures pre/post test
design. A control group is not being utilized due to
1) the small MND population available in Western Aus-
tralia 2) access issues to people with MND, and 3) the
fact that dignity therapy (nor any other psychosocial
intervention) has yet to be tried with this palliative care
population and the feasibility of dignity therapy needs to
be tested before proceeding to an RCT. The study design
has been modelled to reduce bias and increase validity
where possible. For example, the short duration of the
intervention coupled with utilizing a single post-testing
point one week after the intervention will minimize con-
founding variables.
Ethical approval
This study has been approved by the Curtin University
Human Research Ethics Committee (19/2011).
Participants
The sample will comprise 50 adults diagnosed with
MND who are registered with the MND Association of
Western Australia. A second group will consist of up to
50 family carers of the participants.
People with MND
Inclusion criteria Persons with a diagnosis of MND
aged 18 and over who are able to communicate in Eng-
lish are included in the study. As this is a feasibility
study, participants who are unable to communicate ver-
bally may participate if they are able to utilize an assisted
communication method. Communication issues will be
explored and reported in the findings. There is no selec-
tion criteria based on stage of the disease as MND is a
fatal disease with no hope of remission making an end-
of-life intervention appropriate at any time after diagno-
sis. Participants will not be screened for existential or
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psychosocial distress; however, these will be assessed
at baseline.
Exclusion criteria Participants who are unable to provide
informed consent, either due to cognitive issues or illness
severity will be excluded. Cognitive impairment will be
screened using the ALS-Cognitive Behavioral Screen [36].
If the participant receives a score of less than ten, the par-
ticipant and family carer will be excluded from the study.
Family carers
A family carer of each participant will be invited to take
part in the study, comprising a second research popula-
tion of up to 50 family carers. A family carer is defined
as the person indicated by the participant as the primary
family carer. The family carer must be at least 18 years
of age, able to provide informed consent and able to
communicate in English. If the family carer does not
wish to participate, then the person with MND remains
eligible to take part in the study.
The intervention and study procedures
The intervention will be administered by the researcher, a
counselling psychologist undertaking a PhD by research
at Curtin University in Western Australia. The researcher
has been trained in dignity therapy at an intensive work-
shop by Professor Harvey Chochinov, who developed the
intervention and who performed the empirical studies
upon which the intervention is based.
Recruitment will be undertaken through the MND Asso-
ciation of Western Australia (MNDAWA). MNDAWA will
liaise directly with participants to protect the identity of
MND-diagnosed individuals. Letters will be sent out to all
members of MNDAWA and potential participants are
identified when they telephone the researcher or return a
copy of the letter expressing their interest. The researcher
will first speak with the person with MND or family carer
to elaborate further on the nature of the study and answer
any questions. If the participant wishes to proceed, a
meeting will be scheduled. If time permits, information
sheets and consent forms will be mailed in advance of
the meeting to provide time to consider the study and
discuss their participation with family and health care
providers. All meetings will occur at a time of the parti-
cipant’s choosing and in their care environment. Since
the participant’s condition can fluctuate, the timing of
the contacts can be flexible and meetings rescheduled.
The researcher will make detailed notes of these experi-
ences in order to include information about timing issues
in the findings.
At the initial meeting, the researcher will review the
participant and family carer information and consent
forms with the participant/family carer dyad, check for
understanding and answer any outstanding questions.
Written consent will be obtained and MND participants
will be tested for cognitive impairment that is significant
enough to exclude them from the study. If the participant
and family carer remain in the study, socio-demographic
and health questionnaires and baseline measures will be
collected from each. An appointment for the first dignity
therapy session will be made, ideally within two to three
days. The researcher will provide the participant a copy of
the dignity therapy question framework so that they may
begin reflecting on their responses.
Dignity therapy question protocol
Tell me a little about your life history; particularly the
parts that you either remember most or think are the
most important? When did you feel most alive?
Are there specific things that you would want your
family to know about you, and are there particular
things you would want them to remember?
What are the most important roles you have played in
life (family roles, vocational roles, community service
roles, etc.)? Why were they so important to you, and
what do you think you accomplished in those roles?
What are your most important accomplishments, and
what do you feel most proud of?
Are there particular things you feel still need to be said
to your loved ones or things that you would want to
take time to say once again?
What are your hopes and dreams for your loved ones?
What have you learned about life that you would want
to pass along to others? What advice or words of
guidance would you wish to pass along to your son,
daughter, husband, wife, parents, other(s)?
Are there words or perhaps even instructions that you
would like to offer your family to help prepare them for
the future?
In creating this permanent record are there other thing
you would like included?
[16] at p. 5522.
The next meeting is the primary dignity therapy ses-
sion, where participants are invited to address and rec-
ord themes, thoughts and feelings about themselves and
their lives that they would like remembered. The ques-
tion framework is flexible, and provides a guide for the
researcher to shape the interview by following the parti-
cipant’s cues. If the participant desires, a family carer
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may be present during the interview to provide emo-
tional support and help facilitate the interview. If partici-
pants require a second or third interview session due to
communication issues, fatigue, or the breadth of infor-
mation they would like to share, these will be scheduled
as soon as possible.
After recording has finished, a verbatim transcript
will be prepared (usually within 24–48 hours). The
researcher will shape the interview into a narrative using
the learned dignity therapy editing method, which omits
non-starters and irrelevant sections (such as interrup-
tions) and tags content that needs to be clarified or
perhaps omitted due to the harm it could inflict on reci-
pients. Another appointment will be made with the par-
ticipant as soon as practicable to read through and edit
the transcript. In this session, the participant will be
invited to make corrections, clarifications or additions as
desired. In the final dignity therapy session, the final
bound transcript is given to the participant. The partici-
pants may have as many copies of the document as they
wish and share them with whoever they choose.
Post-testing will occur with both the participant and fam-
ily carer one week after the final dignity therapy document
has been returned. To reduce response bias, post-testing
questionnaires will be sent out and returned via mail. A re-
search officer (not related to the project) from the Western
Australian Centre for Cancer and Palliative care will per-
form the post-testing if assistance is needed to complete
the questionnaires. A single point of post-testing soon after
completion of the sessions is planned in order to reduce
moderating variables. Further, the possible immediate im-
pact of the intervention is being examined for the purposes
of this feasibility study and not the longevity of the out-
comes, which can be assessed in future studies. A study
design flow chart is shown in Figure 1.
Measures and outcomes
The measures chosen have been validated and are quick
and easy to administer and use, in order to decrease the
burden on the study population. Brief versions of the
outcome measures have been selected where available.
Primary outcome measure for people with MND
The primary outcome measure is the participant’s sense
of hopefulness. This will be assessed utilizing the Herth
Hope Index [21,22], a validated instrument developed
for use with the terminally ill. Distressed MND patients
score higher on hopelessness than distressed cancer
patients at the end of life [23], and interest in hastened
death or suicidal ideation in the MND population has
been shown to correlate with hopelessness [3,24], which
indicates that the level of hopefulness a key factor of
psychological distress in this disease population.
Secondary outcome measures for people with MND
Secondary outcome measures used to assess potential
effectiveness include, 1) dignity, which will be measured
with the Patient Dignity Inventory (PDI) [25], a validated
measure which evolved directly from the empirical
studies into dignity concerns in the terminally ill, and;
2) spiritual well-being, which will be measured with the
Functional Assessment of Chronic Illness Therapy-
Spiritual Well-Being Scale (FACIT-sp-12) [26], a vali-
dated measure showing strong internal reliability. To
assess the acceptability of dignity therapy, a modified
version of the dignity therapy Patient Feedback Ques-
tionnaire [17] is being utilized to collect information on
the views, experiences and opinions of the participants
about the intervention. To assess the feasibility of the
intervention, data will be collected about the time taken
to organize and conduct the dignity therapy sessions,
any special accommodations made in the delivery of the
intervention, deviations from the dignity therapy proto-
col, and reasons for non-completion. The researcher will
also record, through the use of a journal, observations
and experiences of delivering the intervention, including
positive and negative participant responses.
Primary outcome measure for family carers
The primary outcome is the family carer’s sense of per-
ceived burden, which will be measured through the Zarit
Burden Inventory [27]. Research of caregiver burden
in MND family carers has documented the consider-
able burden attached to caring for persons with MND
[28,29]. Caregiver burden increases as patient function
declines [30-32]. Studies indicate that MND caregiver bur-
den can be alleviated by finding positive meaning [12,13]
and by supporting a sense of hope [14]. It can be inferred
that dignity therapy may impact hope and meaning, thereby
alleviating caregiver burden. In the alternative, whether this
intervention increases burden is a factor that also must
be considered when evaluating its overall impact.
Secondary outcome measures for family carers
Secondary outcome measures used to assess the poten-
tial impact of dignity therapy on family carers includes
1) hopefulness, utilizing the Herth Hope Index [21]. The
HHI has been used successfully in studies with family
caregivers of terminally ill patients [33], and 2) anxiety
and depression, which will be measured with the Hos-
pital Anxiety and Depression Scale [34], an instrument
often used with family caregivers showing strong reli-
ability and validity. To assess the acceptability of dignity
therapy to family carers, a modified version of the dig-
nity therapy Family Feedback Questionnaire [17] is being
utilized to collect information on the views, experiences
and opinions of the family carers about the intervention.
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Demographic and health status
Demographic and health status information collected
from persons with MND will include disease specific
health-related quality of life utilizing the Amyotrophic
Lateral Sclerosis Assessment Questionnaire-5 [35], cogni-
tive behavioural functioning from the carer’s perspective
utilizing the ALS Cognitive Behavioral Screen [36], age,
gender, and health history.
Demographic and health status information collected
from family carers will include the level of disability of
the care recipient utilizing the Amyotrophic Lateral
Sclerosis Functional Rating Scale-R [37,38], cognitive be-
havioural functioning from the carer’s perspective utiliz-
ing the ALS Cognitive Behavioral Screen [36], age, gender,
relationship to the person with MND, caring hours per
day, employment status, and health history.
Analysis
For summarizing purposes, descriptive statistics will
be obtained for demographic variables. To assess the
possible impact of the intervention on the psychosocial
and existential concerns of the participant and family
carer, pre and post intervention comparisons for each
outcome variable will be carried out using Wilcoxon’s
signed rank-sum tests, given that the main outcome
variable measured will not be normally distributed [16].
Spearman’s rank correlation coefficient will be calculated
to assess the possible correlation between variables of
interest. It is anticipated that there will be a post-
intervention improvement on all psychosocial measures
for both the participant and family carer after the dignity
therapy intervention. Open-ended responses in feedback
questionnaires will be coded and analysed using
MNDAWA contacts researcher with contact information for 
MND participant who has expressed an interest in the study
Continued Initial Session: 
Family Carer Demographic and Health 
Questionnaire
ALSFRS-R
Herth Hope Index
Zarit Burden Interview
Hospital Anxiety and Depression Scale
Continued Initial Session:
Patient Demographic and Health Questionnaire
ALSAQ-5 health assessment
Herth Hope Index
FACIT-sp
Patient Dignity Inventory
Dignity therapy session(s) 
(1-2 days later)
Review and Editing of Dignity therapy transcript 
(2-3 days later)
One week post-intervention
Patient Feedback Questionnaire
ALSAQ-5 health assessment 
Herth Hope Index
FACIT-sp
Patient Dignity Inventory
One week post-intervention
Family Carer Feedback Questionnaire
ALSFRS-R
Herth Hope Index
Zarit Burden Interview
Hospital Anxiety and Depression Scale
MND Participant
Initial Session:
Explain study and obtain consent
ALS-CBS
Family Carer
Initial Session:
Explain study and obtain consent, ALS-CBS
If family carer does not wish to participate, MND  
participant can proceed.
Return and ReviewDignity therapyTranscript
(2-3 days later)
Score of >10 on ALS-CBS, MND participant 
and family carer excluded from study 
Figure 1 Study Design Flow Chart.
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descriptive statistics. The IBM SPSS version 20 statistical
software package will be used for all analyses. A p value
less than 0.05 is considered to be statistically significant.
Discussion
Several studies, as well as MND practice guidelines, sug-
gest the need to develop and utilize interventions that
will support hopefulness, a sense of meaning, and dig-
nity in order to alleviate psychosocial and existential dis-
tress in persons with MND [7,8]. Despite this, very little
has been done to develop or implement such interven-
tions. In fact, an extensive literature search completed
for this study revealed there were no psychosocial inter-
ventions specifically designed or tailored to alleviate
existential distress and improve the quality of life of per-
sons with MND. This research will begin to fill this gap,
providing a possible solution to a concern about this
specific population, as well as continue to advance the
overall focus of alleviating psychosocial distress at the
end of life, an area of palliative care which has been
widely acknowledged as being in need of improvement.
This study will determine if dignity therapy is likely to
be effective in enhancing the end of life experience for
both people with MND and their family carers, if it is
acceptable to people with MND and their family carers,
and if it is feasible to offer the intervention to this popu-
lation. It will explore what allowances or modifications
might need to be made to deliver the intervention
to people who are sometimes unable to communicate
verbally. It will provide a preliminary examination of
how cognitive or neurobehavioral issues encountered in
persons with MND might affect the intervention, includ-
ing the completion and sharing of a generativity docu-
ment that reflects a true sense of the person with MND.
Finally, if the intervention is unsuccessful, this study will
determine what factors contributed to a negative out-
come, as well as any unexpected consequences to per-
sons with MND or their families.
This research has implications for psychological and
health care professionals who work with people with
motor neurone disease and other neurological disorders,
as well as those who work in palliative care settings.
Both are often called on to address the spiritual, existen-
tial and psychosocial needs in their patients. If dignity
therapy proves to be effective, it could be a relatively
brief and easy to administer intervention that could be
made available to people with MND. This study has the
potential to provide a precise intervention to ameliorate
psychosocial and existential distress, as well as improve
the quality of care provided to people with MND and
their family carers.
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CHAPTER FIVE 
5.  Study findings relating to people with MND 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
I’m a different self now.  I’m different in my attitudes.  I’m different 
appreciating my body, which I didn’t do fully before.  I’m different in terms 
of trying to grapple with the big questions, the ultimate questions, the ones 
that won’t go away. 
And which are the important questions? 
As I see it, they have to do with love, responsibility, spirituality, awareness.  
And if I were healthy today, those would still be my issues.  They should 
have been all along. (Albom 1997  p. 175) 
 
A conversation between Morrie Schwartz, a retired professor and a man with MND, and 
Mitch Albom, his former student and journalist.  Albom wrote the memoir “Tuesdays 
with Morrie” about 14 weekly meetings/interviews he had with Schwartz in the final 
months of his life.  The book became a bestseller and was made into a movie starring 
Jack Lemmon as Morrie.   
 
 
 
 
Chapter Five consists of a published manuscript of 
the study findings relevant to people with MND.  
The paper is entitled, “Feasibility, acceptability, 
and potential effectiveness of dignity therapy for 
people with motor neurone disease.”  This paper 
was published in the open access, peer-reviewed 
interdisciplinary journal PLoS One.  The results of 
the study on 29 people with MND showed no 
significant changes on the outcome measures on 
the group level, but there were increases in hope 
on the individual level.  Dignity therapy was 
acceptable and the results of the feedback 
questionnaire were similar to the results found in 
the IRCT.  Dignity therapy is feasible if the 
therapist can overtime time and communication 
difficulties. 
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there were changes in hopefulness on the individual level. The results of the feedback questionnaire indicates dignity
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Introduction
Motor neurone disease (MND), also known as amyotrophic
lateral sclerosis, is an uncommon neurodegenerative disease that is
progressive and always fatal. There is no cure and few options exist
for treatment. While a few die within six months, others live ten
years or more. On average, people live two to three years after
diagnosis before eventually succumbing to paralysis and death,
most often from respiratory failure [1,2].
Despite the considerable physical and emotional suffering
involved, there is little focus on addressing the psychological
needs of people with MND. Quality of life is generally high [3–5],
but people with MND often experience significant psychological
distress including anxiety and hopelessness [6]. Psychological
distress in MND is associated with decreased quality of life and
decreased survival rates [7,8]. Hopelessness is correlated with
interest in hastened death [3,9,10]. Among those with terminal
diagnoses, people with MND report the highest levels of interest in
hastened death [11] and they also have the greatest risk of suicide
[12]. These effects are mitigated in people who report higher levels
of spirituality and sense of meaning [13,14]. Such findings have led
to calls for psychological interventions to bolster hopefulness,
spirituality, and meaning in people with MND [1,15]; however,
intervention studies are lacking.
One promising intervention is dignity therapy; a brief psycho-
therapeutic intervention based on an empirical understanding of
dignity at the end of life [16]. Dignity therapy offers people facing
death the opportunity to create a document about their life [17].
In a recorded life reflection interview, a person with terminal
disease is afforded the opportunity to discuss significant memories,
meaningful events and important accomplishments, as well as
leave messages for loved ones. In previous studies, dignity therapy
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has been shown to alleviate existential distress in a palliative care
population where most people had malignant conditions [18,19].
With a key aim to bolster hope and meaning, dignity therapy has
the potential to alleviate psychological distress in people with
MND [15]. However, because most of the people in previous
dignity therapy research had terminal cancer, the findings of its
effectiveness are not transferable to people with MND. Diagnosis,
ability to communicate, cognitive acuity, stage of illness, baseline
levels of distress and demographic features are factors that
differentiate people with MND from people with end-stage cancer.
Finally, delivery of dignity therapy to people with MND may
require modification, for example, to be performed at an earlier
time or via assisted communication methods.
Aims and objectives
The aim of this study was to assess the feasibility, acceptability,
and potential effectiveness of dignity therapy to enhance the end of
life experience for people with MND. The specific objectives were
to determine whether:
a) dignity therapy increases hope, meaning, and dignity in
people with MND;
b) dignity therapy is acceptable to people with MND; and
c) it is feasible to provide dignity therapy to people with MND.
Methods
Study design
This cross-sectional study utilized a one-group pre-test-post-test
design. A control group was not utilized due to 1) the small MND
population, 2) access issues to people with MND, 3) ethical
concerns over making a potentially useful intervention unavailable
to a control group, and 4) the need to test the feasibility of dignity
therapy with people with MND [20,21]. Further details can be
found in our protocol [22].
Ethical approval
This study was approved by the Curtin University Human
Research Ethics Committee (19/2011).
Setting
Participants were primarily enrolled as a result of outreach from
the Motor Neurone Disease Association of Western Australia
(MNDAWA). MNDAWA sent recruitment letters to people who
had been diagnosed with MND and referred to their services by a
general practitioner or neurologist. In the last six months of the
study, we used social networking, a press release, and information
on the university web site to assist in reaching the recruitment goal.
One participant in Queensland participated via video-conferenc-
ing. Twenty-two participants reported living in an urban/
metropolitan area and seven in rural areas. Twenty-seven
participants were living at home at the time of the intervention,
one in an aged-care facility and one a hospital.
Participants
Individuals diagnosed with MND, over 18 years old, who could
communicate in English and provide informed consent (based on
the ALS-Cognitive Behavioural Screen (ALS-CBS) [23] where a
cut-off score of 10 was used or the Blessed Orientation Memory
Concentration (BOMC) test [24] where a cut-off score of 9 was
used) were eligible for the study. Participants were provided with
information sheets and written consent was obtained. Enrolment
occurred between June 2011 and July 2013. People were excluded
if they were too ill to complete the requirements of the protocol.
There were no selection criteria based on distress levels, disease
stage or proximity to death.
The intervention
The intervention was administered by a researcher trained in
dignity therapy by Harvey Max Chochinov who developed the
therapy [18,19]. The therapy interviews were audio-recorded and
transcribed verbatim by a transcriptionist. The researcher shaped
the transcribed interviews using the prescribed editing process [17]
and then returned to edit and complete the transcripts with the
participants. The document was read aloud to each participant at
the conclusion of the intervention. To mitigate response bias, post-
testing took place via mail or through a visit from a second
researcher. The researcher engaged in regular supervision sessions
from Prof. Chochinov. To optimize adherence to the dignity
therapy protocol, three recordings, transcripts, and completed
documents (10%) were reviewed by three experienced researchers
(two trained in dignity therapy) and deemed to be adherent.
Measures and Outcomes
Effectiveness. Outcome data to measure potential effective-
ness were collected from participants at baseline and one week
after completion of dignity therapy. The primary outcome
measure was the participant’s sense of hopefulness assessed
with the Herth Hope Index [25,26], a reliable (a=0.97) validated
instrument developed for use with the terminally ill, with a score
ranging from 12–48 and where higher scores indicate more
hopefulness. Secondary outcomes were: 1) Dignity, measured by
the Patient Dignity Inventory (PDI) [27]. The PDI has a scale of
25–125 (higher scores indicate greater distress). It is a reliable
(a=0.93) validated measure which evolved directly from the
empirical studies into dignity concerns in the terminally ill. [27] 2)
Spiritual well-being, measured by the Spiritual Well-Being
subscale of the Functional Assessment of Chronic Illness Therapy
scale (FACIT-sp-12) [28]. The FACIT-sp-12 has a scale of 0–48
with higher scores indicating greater spiritual wellbeing, and it is a
reliable (a=0.87) and valid measure [28].
Acceptability. The Participant Feedback Questionnaire used
in the international randomised controlled trial of dignity therapy
(IRCT) [19] was modified by adding three items on hopefulness
and family support, and was used to collect the participants’
experiences and opinions of the intervention. The questionnaire
contained 25 questions answered with a 5-point Likert scale and
space for brief explanation.
Feasibility. Data were collected about the time taken to
conduct the therapy sessions, any special accommodations made
in the delivery of the intervention, deviations from the dignity
therapy protocol, reasons for non-completion, and reasons for
attrition.
Demographic and health status. Disease specific health-
related quality of life was measured with the Amyotrophic Lateral
Sclerosis Assessment Questionnaire-5 (ALSAQ-5) where scores
range from 0–20 (higher scores indicating more impairment) [29],
and cognitive behavioural functioning was assessed with the ALS –
CBS [23]. Level of impairment of the person with MND and
change in physical function over time was collected from the
family carer using the Amyotrophic Lateral Sclerosis Functional
Rating Scale-R (ALS-FRS) where scores range from 0–48 (lower
scores indicating more impairment) [30,31]. Demographic data on
age, gender, education level, marital status, and health history
were also collected.
Dignity Therapy for People with MND
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Analysis
Data were analysed with generalised linear mixed models
(GLMM) as implemented through SPSS’s (Version 20) GENLIN-
MIXED procedure. Model parameters were estimated with robust
standard errors in order to accommodate potential violations of
the model assumptions. Participant was treated as a random effect
and Time (pre-test, post-test) was treated as a fixed effect. Age,
gender, time since diagnosis, marital status, level of education, and
number of days from pre-test to post-test were also treated as fixed
effects and analysed individually as potential moderators of the
intervention effect. In order to optimise the likelihood of
convergence, a separate GLMM analysis was run for each of the
three outcome measures. The GLMM maximum likelihood
procedure is a full information estimation procedure that uses all
the data present at each assessment point. All of the pre-test data
and all of the post-test data are incorporated into the analysis,
which reduces sampling bias associated with participant attrition.
GPower (Version 3.1) indicated that 29 participants would be
sufficient to capture ‘moderate to large’ (f= .28) pre-post changes
on the outcome variables. A reliable change (RC) score for each
participant [32] was computed to investigate the presence of
reliable pre-post change at the individual rather than group level.
The RC score is the degree to which the person changes on the
outcome variable divided by the standard error of difference
between the pre- and post-test scores. When the absolute value of
the RC score is greater than 1.96, (Wise [33] has argued that this
value can be reduced in some situations), it is likely that the post-
test score reflects a real or reliable change. Descriptive statistics were
used to summarize demographic variables and feedback responses.
Results
Response rate
MNDAWA distributed recruitment letters to all 147 members
diagnosed with MND on three occasions between May 2011 and
May 2013. Thirty-five people responded (response rate 24%) and
29 of these people completed the study (completion rate 78%).
Those who did not complete include three people who changed
their mind before entering the study, two who changed their mind
after entering the study, two who died before completion and one
who was excluded due to cognitive impairment. While all 29
completed dignity therapy, one did not complete any post-test
measures due to illness, one completed the feedback questionnaire
but not the outcome measures, and three additional participants
did not complete the PDI fully.
Demographic information
Participants, 20 men and 9 women, ranged from 32 to 81 years
of age with almost half between the ages of 60 and 69. Twenty-
four were married or partnered. Thirteen reached secondary
education; 16 achieved university or postgraduate education. (See
Table 1 for more demographic information on the study
population).
Baseline levels of impairment and distress
The sample group was moderately impaired (ALS-FRS mean
= 32.61, SD =9.76). Scores on the ALSAQ-5 indicate the sample
had moderate health-related quality of life (mean = 9.31, SD
=3.96). The group was hopeful, had low dignity-related distress,
but appeared to be facing some struggles with their spiritual
wellbeing (see Table 2 Pre-test scores). The mean total score for
spiritual wellbeing was 30.7 (SD =10.43) which was lower than in
people with cancer (mean = 38.5, SD=8.1) [28].
Effectiveness
Descriptive statistics for the outcome variables are reported in
Table 2. There were no significant pre-test post-test changes for
hopefulness (F [1,54] = 2.79, p= .101, d= .46), dignity (F [1,54]
= 0.45, p= .504, d= .20), or spirituality (F [1,54] = 0.01, p= .936,
d= .05). Potential moderators of the intervention effect (age,
gender, time since diagnosis, marital status, level of education, and
number of days from pre-test to post-test) were individually
entered in the regression model in order to determine whether
significant pre-test-post-test changes would be observed at certain
values of the moderator. There was no significant Moderator x
Time interactions for any outcomes (all ps ..1).
A reliable change (RC) score for each participant [32]. The
results indicate that some individuals showed an improvement in
hopefulness, while a quarter showed deterioration (see Table 3).
Interestingly, all of the study participants who had an increase in
hopefulness reported they were both religious and spiritual, while
43% of the group whose hopefulness declined reported they were
neither religious nor spiritual. Additionally, 50% of the group with
improved hopefulness had been diagnosed with MND for four
years of more, while 85% of the group that declined had been
diagnosed for two years or less.
Acceptability
The participants found dignity therapy to be satisfactory
(92.8%), helpful to them (89.2%), helpful to their family (85.2%),
and would recommend dignity therapy to others with MND
(84%). They reported the strongest positive improvements in the
dignity-related areas of looking after unfinished business (67.9%),
continuity of self (67.9%) acceptance (64.2%), and role preserva-
tion (60.8%). There were lesser improvements in feeling like a
burden (28.6%), increased will to live (33.3%), lessened sadness or
depression (35.7%), and sense of control (35.7%). Seventy percent
reported they felt closer to the people who meant the most to them
after dignity therapy, and 63% felt dignity therapy would result in
better appreciation in them from their families.
The results of the feedback questionnaire are very similar to the
results of the dignity therapy arm in the IRCT which showed that
dignity therapy outperformed standard care in a palliative care
population where 96% suffered from end-stage cancer [19] (see
Table 4). In both studies, people undergoing dignity therapy
reported the psychotherapy was helpful to them, improved their
quality of life and increased meaning. These findings demonstrate
that people with MND experience similar benefits from dignity
therapy as reported in previous research with people with cancer
[19] (see Table 4).
Feasibility
Dignity therapy for the sample took from three to seven sessions,
consistent with the standard protocol [17,34]. The majority of
participants (69%) finished the therapy in four sessions (mean
= 4.14). Four participants (13.8%) completed in the standard of
two weeks [19]. The time to completion ranged from 7 to 152
days, with about half completing by 25 days (mean = 42, SD=36).
Reasons for extended completion times included (often in
combination) the participants’ speech impairment, travel, hospital
or respite care admissions, family and employment obligations,
and desire for more time to work on the document [35].
Participants’ use of various assisted communication methods
meant that dignity therapy was successfully completed with six
people who, due to MND, had lost the ability to speak. An
additional three people had moderate speech impairment and
these participants had the three longest completion times (87, 134,
Dignity Therapy for People with MND
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Table 1. Demographic characteristics of study group.
Gender
Male 20
Female 9
Age
30–39 1
40–49 1
50–59 4
60–69 15
70–79 6
80–89 2
Marital Status
Married 24
Widowed 3
Divorced/separated 1
Never married 1
Residence area
Urban/metropolitan 22
Rural 7
Residence type
Home 27
Hospital 1
Aged-care facility 1
Presently living with
Spouse 23
Alone 4
Other 2
Highest level of education attained
Secondary/high school 13
University/technical 13
Postgraduate 3
Current employment status
None 22
Full-time 2
Part-time 3
On leave 2
Time since diagnosis
Less than one year 8
One to two years 9
Two to three years 4
Three to four years 0
More than four years 8
Time since initial symptoms
Less than one year 2
One to two years 10
Two to three years 5
Three to four years 3
More than four years 9
Prior history of depression (before MND diagnosis)
Yes 6
No 23
Have you been prescribed medication to help you cope?
Dignity Therapy for People with MND
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and 152 days). One participant with moderate speech impairment
completed the intervention using videoconferencing and email.
Discussion
This is the first study to explore the feasibility of dignity therapy
with people with MND and, to our knowledge, the first study of a
targeted psychotherapeutic intervention for this population. We
expected to detect measureable post-intervention increases in
hope, dignity and spirituality at the group level but this did not
occur. This may be due to a number of reasons, including the
difficulties with demonstrating psychosocial change at the end of
life with self-report measures [36], the result of evidence which
suggests the benefits of psychosocial interventions at the end of life
can most readily be shown in patients who have elevated levels of
distress [37], and/or that the outcome measures chosen were not
sensitive to the impacts that occurred. Very small pre-post effects
were present for dignity and spirituality, and the effect for
hopelessness was small to moderate. However, without a control
group, we were unable to ascertain whether the intervention had a
prevention effect against expected declines in hope, dignity, and
spirituality over time as a person with MND deteriorates and
approaches death. At the individual level, tentative findings are
that dignity therapy may be effective at increasing hopefulness in
people who are more spiritual and also in some with advanced
disease, as reported in previous research [38].
Nonetheless, the positive results on the feedback survey indicate
most people with MND believe dignity therapy to be beneficial.
The intervention was found to be overwhelmingly positive.
Feedback indicated dignity therapy helped enhance the end of
life by supporting the unique identity of the person, helping with
acceptance, allaying aftermath concerns, finding meaning and
purpose, and improving family relationships which mirrors the
previous findings of the pilot study and international randomised
controlled trial of dignity therapy performed with people with end-
stage cancer [18,19]. Moreoever, people with MND believe
dignity therapy will be of help to their family members after death
indicating a potential benefit to family members during bereave-
ment as found in other studies [39,40]
Feasibility
Dignity therapy with people with MND is feasible if the
therapist can overcome time and communication difficulties, as it
takes longer to administer with people who have MND than those
with cancer. Therapist time was increased in order to travel to
participants in their homes to deliver the intervention (previously
completed in palliative care settings [19,34]) and was compounded
for participants in rural areas. Ninety-three percent of participants
were in the community rather than an in inpatient or care facility.
As such, we were less in control of the schedule. Additionally, for
people with speech impairment, dignity therapy was prohibitively
difficult and time consuming to perform. Adapted methods appear
Table 1. Cont.
Gender
Anti-depressant 7
Anti-anxiety 2
Sleeping medication 1
Anti-anxiety & sleeping medication 1
No 18
Do you consider yourself to be a religious person?
Yes 8
Somewhat 10
No 11
Do you consider yourself to be a spiritual person?
Yes 10
Somewhat 14
No 5
Cognitive screening scores
No impairment 19
Suspected mild to moderate impairment 10
doi:10.1371/journal.pone.0096888.t001
Table 2. Mean Pre-test Post-Test Scores on Measures for Hopefulness, Dignity, and Spirituality.
Outcome Pre-test N Post-test N
Hopefulness (HHI) 38.76 (5.10) 29 36.61 (6.80) 27
Dignity (PDI) 48.59 (15.45) 29 47.59 (12.91) 24
Spirituality (FACIT-sp-12) 30.72 (10.43) 29 30.92 (9.88) 27
doi:10.1371/journal.pone.0096888.t002
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to present viable solutions to these issues, such as some of the
therapy being conducted via email or utilizing videoconferencing.
Unique aspects common to MND, including speech impairment
and mild to moderate cognitive impairment, did not detract from
the benefits of the therapy. These results indicate that dignity
therapy is feasible and acceptable, and it offers potential benefits
for people with MND.
Strengths and limitations
The strengths of this feasibility study were the high response
rate, high completion rate, a group representative of people with
MND in demographic and health status characteristics, the use of
MND-specific cognitive and health status measures, and the
measure used to assess acceptability being nearly identical to the
one used in the dignity therapy international randomised
controlled trial, which allows for comparison. The limitations
include inadequate power to discover small effects, mild to
moderate levels of distress at baseline, the lack of a control group,
and the use of outcome measures not developed or validated for
use with people who have MND. The study group may not be
representative of the MND population as a whole as those who
selected to participate may have been more likely to think dignity
therapy would be beneficial.
Table 3. Percentage (Number) of Participants Showing Reliable Improvement, Deterioration, and No Change for Hopefulness,
Dignity, and Spirituality.
Outcome Improved Deteriorated No change N
Hopefulness (HHI) 14.8 (4) 25.9 (7) 59.3 (16) 27
Dignity (PDI) 0 0 100 (24) 24
Spirituality (FACIT-sp-12) 0 0 100 (27) 27
doi:10.1371/journal.pone.0096888.t003
Table 4. Results of the Participant Feedback Questionnaire Compared to Dignity Therapy and Standard Care in the IRCT [19].
People w/MND
(n =28)
Dignity therapy IRCT
(n=108)
Standard palliative care
IRCT (n=111)
DT has been helpful to me 4.18 (0.72) 4.23 (0.64) 3.50 (1.01)
DT has been as helpful as any other aspect of my health care 3.50 (0.88) 3.63 (1.04) 3.27 (1.04)
DT has improved my quality of life 3.39 (0.79) 3.54 (0.95) 2.96 (0.96)
DT has given me a sense of looking after unfinished business 3.68 (0.61) 3.35 (1.01) 2.86 (1.60)
DT has improved my spiritual wellbeing 3.36 (0.68) 3.27 (1.09) 3.00 (1.11)
DT has lessened my sadness or depression 3.04 (0.96) 3.11 (1.02) 2.57 (0.92)
DT has lessened my sense of feeling a burden to others 2.96 (0.92) 2.81 (0.98) 2.58 (0.95)
DT has made me feel more worthwhile or valued 3.50 (0.79) 3.38 (0.93) 3.35 (1.00)
DT has made me feel like I am still me 3.71 (0.85) 3.81 (0.85) 3.59 (0.92)
DT has given me a greater sense of having control over my life 3.18 (0.77) 3.02 (1.02) 3.16 (1.00)
DT has helped me to accept the way things are 3.54 (0.92) 3.39 (1.062) 3.31 (1.01)
DT has made me feel more respected and understood by others 3.33 (0.98) 3.16 (0.90) 3.04 (0.98)
DT has made me feel that I am still able to carry out important
tasks or fill an important role
3.61 (0.99) 3.62 (0.97) 3.48 (1.00)
I have found DT to be satisfactory 4.21 (0.69) 4.26 (0.63) 3.80 (0.74)
DT has made me feel that my life currently is more meaningful 3.54 (0.69) 3.55 (1.05) 3.19 (1.70)
DT has given me a heightened sense of purpose 3.32 (0.82) 3.49 (1.04) 3.20 (0.98)
DT has given me a heightened sense of dignity 3.36 (0.87) 3.52 (1.04) 3.09 (1.02)
DT has made me feel more hopeful 3.00 (0.86) N/R N/R
DT has lessened my suffering 3.25 (0.75) 2.86 (1.04) 2.70 (1.02)
DT has increased my will to live 2.96 (0.98) 2.94 (1.11) 2.76 (1.04)
DT has helped me feel closer to people who mean the most to
me
3.63 (0.97) N/R N/R
DT has or will be of help to my family 4.00 (0.78) 3.93 (0.80) 3.20 (1.00)
DT could change the way my family sees or appreciates me 3.48 (1.05) 3.58 (1.01) 2.85 (1.00)
I would recommend DT to other patients and family dealing
with motor neurone disease
4.04 (0.98) N/R N/R
Note: Data are mean (SD). Score 1 is strongly disagree, 2 disagree, 3 neither agree nor disagree, 4 agree, 5 strongly agree. N/R = not reported.
doi:10.1371/journal.pone.0096888.t004
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Implications for future research
This feasibility study sets the stage for a phase II randomised
controlled trial. Potential effectiveness should be further explored
through research with people with MND with elevated distress.
Research into conducting the intervention via email and through
videoconferencing is also indicated. There has been one small
study with eight participants showing dignity therapy can be
delivered using videoconferencing [41] but a larger study is
warranted. Future studies should include hope as an outcome as
well as explore the possible relationship between a person’s
spirituality and changes to hopefulness through dignity therapy.
Conclusions
Dignity therapy for people with MND is feasible and the unique
features of MND, including speech impairment and mild to
moderate cognitive impairment can be managed, but the
intervention is likely to take a greater length of time to complete
compared to previous studies, especially with those individuals
experiencing speech impairment who do not utilize assisted
communication. Dignity therapy is acceptable to people with
MND, who report numerous benefits. Further research is
warranted to explore its ability to diminish distress.
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CHAPTER SIX 
6.  Study findings relating to MND family carers 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One of the worst things about motor neurone disease is watching your loved 
one slowly fading away day by day, while becoming more and more 
dependent on their carer.  (Sackett and Sakel 2011 p. 2) 
Sentiments expressed by MND family carer Brian Sackett in a reflection he wrote about 
the journey of MND.    
 
 
 
 
Chapter Six consists of a published manuscript of 
the study findings relevant to people with MND.  
The paper is entitled, “Feasibility, acceptability, 
and potential effectiveness of dignity therapy for 
family carers of people with motor neurone 
disease.”  This paper was published in the open 
access, peer-reviewed journal BMC Palliative 
Care.  The results showed no significant changes 
on the outcome measures on the group level, but 
there were some decreases in anxiety and 
depression in data analyzed on the individual level 
suggesting dignity therapy may moderate or reduce 
anxiety and depression in distressed family carers.  
Family carers saw benefits from dignity therapy to 
people with MND and to themselves after 
bereavement, but acceptability was mixed at the 
time of the intervention with some indicating 
negative experiences from the therapy.  Dignity 
therapy involving family carers is feasible and 
involvement of family carers had minimal impact 
on the therapy. 
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Background: Dignity therapy is a brief psychotherapy that has been shown to enhance the end of life experience.
Dignity therapy often involves family carers to support patients weakened by illness and family carers are also the
usual recipients of the legacy documents created. No research to date has examined the impact of dignity therapy
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Background
Dignity therapy is a brief psychotherapeutic intervention
which has been shown to enhance the end of life experi-
ence in people with life-limiting conditions [1]. In a dis-
tressed group of terminally ill patients, dignity therapy
has been shown to reduce anxiety and depression [2].
Dignity therapy is based on a theoretical model of dig-
nity in the terminally ill [3] and its purpose is to reduce
dignity-related distress while enhancing hope and mean-
ing [4]. Dignity therapy offers people who are facing
death an opportunity to create a legacy document. In a
recorded interview, guided by a therapist, a person is in-
vited to recount aspects of his/her life to be remem-
bered, discover purpose and meaning in life, and express
final words or advice to loved ones. The therapist and
client work together to edit the interview transcript, and
the therapy concludes when a final document is pro-
duced which can be shared with family and friends [5].
Dignity therapy often involves family carers who may
provide support during the therapy interview (s) and
editing process, and who may also assist a family mem-
ber weakened by illness in providing the narrative [6].
Family members are also the usual recipients of the doc-
uments, making them an important part of the therapy
even when they are not involved in the document’s cre-
ation. Despite the importance of family members’ in-
volvement in dignity therapy, no studies to date have
examined the impact of the therapy on family members
at the time of the intervention, though dignity therapy
has been shown in prior research to moderate the be-
reavement experience of family members after their
loved one had died [7].
This study examined the effects of dignity therapy on
the family carers of people with motor neurone disease
(MND). A person with MND endures progressive par-
alysis and gradually loses the abilities to move, speak, swal-
low and breathe. There is no treatment or cure. Median
life expectancy is 2–4 years after diagnosis and death is
most often caused by respiratory failure [8]. Family
members caring for people with MND often encounter
exceptional strain during the caregiving experience due to
the rapid and progressive nature of MND coupled with
the incapacitating effects of the disease. Research has doc-
umented the distress and burden experienced by MND
family carers [9-12], and shown the close correlation of
distress levels in patient-carer couples [13,14]. Moreover,
carer burden increases in MND family carers over time as
patient function declines [15-17].
Quality of life may be increased and perceived carer
burden decreased in MND family carers who find posi-
tive meaning [13,14] and have a sense of hope [18].
Dignity therapy is an intervention designed to bolster
hope and meaning and could therefore alleviate per-
ceived burden. Dignity therapy also shows promise to
enhance the end of life for people with MND, but its im-
pact on carer distress and burden should be considered
when evaluating its overall impact.
Aims and objectives
The aim of this study was to assess the feasibility, ac-
ceptability, and potential effectiveness of dignity therapy
for family carers of people with MND. The specific ob-
jectives were to assess the impact of dignity therapy on
family carers at the time of the intervention by deter-
mining whether:
a) dignity therapy decreases perceived caregiver
burden, anxiety, depression, and increases hope in
MND family carers;
b) dignity therapy is acceptable to MND family carers;
and
c) it is feasible to involve MND family carers in the
delivery of dignity therapy.
Methods
Study design
This cross-sectional study utilized a single treatment
group and a pre-test post-test design. A control group
was not utilized due to 1) the need to test the feasibility
of dignity therapy with people with MND because they
are a new research population for this intervention [19];
2) access issues to the small MND population in Western
Australia; and 3) ethical concerns over making a poten-
tially useful intervention unavailable to a control group.
More information about the design is available in the
study protocol [20].
Ethical approval
This study was approved by the Curtin University Human
Research Ethics Committee (19/2011).
Setting
MND family carers were recruited from Western Australia
(WA) as a result of outreach from the Motor Neurone
Disease Association of WA (MNDAWA). MNDAWA
provides services to 100–120 diagnosed people with MND
at any one time.
Participants
Family carers of adults diagnosed with MND who could
communicate in English were eligible for the study. En-
rolment occurred between June 2011 and July 2013.
Family carers were invited to participate in the study
when a person with MND enrolled to complete dignity
therapy as a part of a larger research study. If the family
carer did not elect to participate, or if the participant did
not have a family carer, the person with MND remained
eligible to continue with the study. People with MND
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and their family carers were excluded if the person with
MND could not provide informed consent (based on the
ALS-Cognitive Behavioural Screen [21] and/or the Blessed
Orientation Memory Concentration Test (BOMC) [22]),
were too ill to complete dignity therapy, or were unable to
communicate in English. There was no selection criteria
based on distress levels, stage of disease or proximity to
death.
The intervention and study procedures
The intervention was administered by the first author as
part of her PhD studies, who was trained in dignity ther-
apy by Harvey Max Chochinov who developed dignity
therapy [1,4]. The therapy interviews were audio-recorded
and transcribed verbatim. Consistent with the dignity
therapy protocol, some family carers provided support
and assisted with the interview at the request of the per-
son with MND [5]. The researcher shaped the transcribed
interviews using the prescribed editing process [5]. The
legacy document was finalised with the aid of the person
with MND and, where relevant, his or her family carer.
The researcher read the document to each person with
MND and to family members who wished to attend the
reading. Post-testing occurred via mail or a visit from a
second researcher to mitigate response bias. To assure ad-
herence to the dignity therapy protocol, the researcher en-
gaged in regular supervision from Prof. Chochinov and
three experienced researchers (two trained in dignity ther-
apy) reviewed three recordings, transcripts and completed
documents (10%), which were deemed to be adherent.
Measures and outcomes
Effectiveness
Outcome data to measure potential effectiveness were
collected from family carers at baseline and one week
after completion of dignity therapy. The primary out-
come is the family carers’ sense of perceived burden,
measured by the Zarit Burden Inventory [23], a reliable
(α = 0.87) validated instrument with a summative score
ranging from 0–48 where higher scores indicate more
burden. Secondary outcomes were: 1) hopefulness
assessed with the Herth Hope Index [24,25], a reliable
(α = 0.97) validated instrument developed for people
confronting terminal illness and their families with a
score ranging from 12–48 and where higher scores in-
dicate more hopefulness; 2) anxiety and 3) depression,
measured with the Hospital Anxiety and Depression
Scale (HADS) [26], an instrument often used with fam-
ily caregivers showing strong reliability (α = 0.89) and
validity. HADS scores range from 0–21 with scores of
8–10 indicating moderate distress and 11–21 indicating
severe distress on both the anxiety and depression sub-
scales.
Acceptability
A family feedback questionnaire was used to collect fam-
ily carers’ opinions and experiences of the intervention.
The questionnaire contained 20 questions answered with
a 5-point Likert scale and space for brief explanation.
Feasibility
Data were collected about the family carers’ involvement
in the therapy sessions, time taken to conduct the dignity
therapy sessions, any special accommodations made in the
delivery of the intervention when family carers were in-
volved, deviations from the dignity therapy protocol, rea-
sons for non-completion and reasons for attrition.
Demographic and health status
Level of impairment of the person with MND and change
in physical function over time was collected from the family
carer using the Amyotrophic Lateral Sclerosis Functional
Rating Scale-R (ALS-FRS) where scores range from 0–48
(lower scores indicating more impairment) [27,28]. Possible
cognitive behavioural impairment of the person with MND
was assessed with the ALS-CBS, which contains a ques-
tionnaire for the person with MND and a separate ques-
tionnaire for the family carer [21]. Demographic data on
age, gender, relationship to the person with MND, children
in the home, caring hours per day, support received, em-
ployment status, spirituality, and health history were also
collected.
Analysis
Data were analysed with generalized mixed models
(GLMM) as implemented through SPSS’s (Version 20)
GENLINMIXED procedure. Model parameters were es-
timated with robust standard errors to accommodate
potential violations of the model assumptions. Partici-
pant was treated as a random effect and Time (pre-test,
post-test) was treated as a fixed effect. Caregiver age,
gender, level of education, employment status, spiritual-
ity, relationship length, and caring hours were treated as
fixed effects and analysed individually as potential mod-
erators of the intervention effect. In order to optimise
the likelihood of convergence, a separate GLMM ana-
lysis was run for each of the four outcome measures.
The GLMM maximum likelihood procedure is a full in-
formation estimation procedure that uses all data
present at each assessment point, which reduced sam-
pling bias associated with participant attrition. GPower
(Version 3.1) indicated that 18 participants would be
sufficient to capture relatively ‘large’ (f = .36) pre-post
changes on the outcome variables. Descriptive statistics
were used to summarize demographic variables and
feedback responses.
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Results
Response rate
We recruited 18 family carers from the study group of
29 people with MND. Six people with MND had family
carers who were unwilling or unable to participate
(family carer response rate 75%). The reasons for non-
participation were either the person with MND did not
wish to ask their partner to participate (n = 3), or the
family carer declined stating they did not have the time
(n = 3). Five people with MND had no family carers. All
18 family carers completed the study, though one
returned only the feedback questionnaire and not the
post-test measures.
Demographic information
Family carers (13 women, 5 men) were aged from 38 to
80 years with a median age of 61. All 18 were spouses/
partners who resided with the person with MND. See
Table 1 for more demographic information on our study
group.
Baseline levels of impairment and distress for clients
and carers
People with MND who were cared for by family carers
had low to moderate physical impairment (mean ALS-
FRS score was 32.61). Seven carers cared for family
members who were mildly to moderately cognitively im-
paired as measured by the ALS-CBS. The carers re-
ported moderate baseline levels of distress. Half of the
family carers had moderate (n = 6) to severe (n = 3)
scores for anxiety. Depression was less common with
three carers reporting moderate scores for depression.
Effectiveness
Family carers reported a significant pre-post increase in
burden in conjunction with a significant pre-post de-
crease in the physical functioning of the patient. After
controlling for the pre-post decrease in physical func-
tioning of the person with MND, the pre-post increase
in the carer burden was no longer significant (F [1,32] =
3.32, p = .078, d = .30). There were no significant pre-
post changes in self-reported hopefulness, anxiety, or de-
pression. Pre-test and post-test descriptive statistics and
test statistics for pre-post differences are reported for all
outcome variables in Table 2.
Potential moderators of the intervention effect (care-
giver age, gender, level of education, employment status,
spiritual beliefs, how long carers had known the patient,
caring hours per day, and the number of children living
at home) were individually entered in the regression
model in order to determine whether positive pre-post
changes would emerge at certain levels of the moderator.
There was no significant Moderator x Time interactions
for any outcomes (all ps > .1).
Table 1 Demographic characteristics of the study group
Characteristic N
Gender
Male 5
Female 13
Age
30-39 2
40-49 2
50-59 3
60-69 7
70-79 3
80-89 1
Relationship to person with MND
Spouse/partner 18
Length of relationship to person with MND
5 to 10 years 1
10 to 25 years 3
More than 25 years 14
Residence area
Urban/metropolitan 14
Rural 4
Highest level of education attained
Primary/elementary school 1
Secondary/high school 11
University/technical 5
Postgraduate 1
Number of minor children living at home
0 15
1 2
3 1
Current employment status
None 13
Full-time 3
Part-time 2
Caring hours per day
Less than 4 hours 5
4 to 8 hours 2
8 to 12 hours 1
More than 12 hours 10
Time since MND diagnosis of family member
Less than one year 4
One to two years 9
Two to three years 2
Three to four years 0
More than four years 3
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A reliable change (RC) score for each carer [29] was
computed to investigate the presence of reliable pre-post
change at the individual rather than group level. The RC
score is the degree to which the person changes on the
outcome variable divided by the standard error of differ-
ence between the pre- and post-test scores. When the
absolute value of the RC score is greater than 1.96,
(Wise [30] has argued that this value can be reduced in
some situations), it is likely that the post-test score reflects
a real or reliable change. The results suggest potential
prevention effects for anxiety and depression, and both in-
creases and decreases in hopefulness (see Table 3).
Acceptability
The reported benefits and acceptability of dignity ther-
apy to the family carers of people with MND was mixed.
There were many feedback responses indicating it was
helpful, some indicating it was not helpful or even harm-
ful, and some showing ambivalence. Half (n = 9) of the
family carers agreed or strongly agreed that dignity ther-
apy was helpful to them, while about a quarter (n = 4) dis-
agreed or strongly disagreed. More family carers disagreed
than agreed that dignity therapy helped to reduce their
feelings of stress as a carer (n = 5 v n = 6) and an equal
numbers agreed as disagreed that it helped them feel
closer to their partner (n = 6 v n = 6). Some family carers
appeared to find dignity therapy confronting and men-
tioned the attention it brought to their partners’ impend-
ing death.
Family carers were more positive about seeing benefits
to their partner, with 16 agreeing or strongly agreeing
that dignity therapy had been helpful to their family
member, 11 reporting it was an important component of
their care, 10 reporting it had increased meaning in their
partner’s life, and 9 indicating it had helped their family
member prepare for the end of life. Despite mixed feel-
ings about the therapy, 13 believe the document would
be an ongoing source of comfort and 14 would recom-
mend dignity therapy to other people with MND and
their families. The complete results of the feedback
questionnaire are reported in Table 4. Selected com-
ments are available in Table 5.
Feasibility
Twelve of the 18 family carers assisted with the inter-
view and editing process. Ten family carers provided
support by attending the therapy sessions and contribut-
ing to the narrative when requested by their partner, one
served as a proxy for her husband who had lost the abil-
ity to speak and write (completing the entire interview
Table 1 Demographic characteristics of the study group
(Continued)
Are you currently being treated for a major medical condition?
No 6
Yes 12
Have you been prescribed medication to help you cope?
Anti-depressant 1
Anti-anxiety 1
No 16
Do you consider yourself to be a spiritual person?
Yes 3
Somewhat 10
No 5
Cognitive screening scores of person with MND
No impairment 11
Suspected mild to moderate impairment 7
Formal support received to help cope with family
member’s MNDa
None 7
Support group 3
Home care 4
Respite 1
Counselling 1
Psychologist/Psychiatrist 2
Other:
MND Association 3
Church 1
Massage 1
Medication 1
Note. aParticipants could list more than one type of support.
Table 2 Mean pre-test post-test scores (and standard de-
viations) for measures of burden, hopefulness, anxiety,
depression, and physical function
Outcome Pre-test
N = 18
Post-test
N = 17
F (1.33) P d
Caregiver burden (ZBI) 12.44 (7.89) 16.29(11.22) 5.58 .024 0.95
Hopefulness (HHI) 38.39 (4.46) 36.71 (4.52) 3.19 .083 0.62
Anxiety (HADS) 7.28 (3.71) 6.88 (4.33) 1.33 .257 0.26
Depression (HADS) 4.17 (3.33) 4.41 (3.91) 0.03 .860 0.39
Physical function
(ALS-FRS)
32.61 (9.76) 30.12 (9.62) 7.00 .012 1.19
Table 3 Number of carers showing reliable improvement,
deterioration, and no change for burden, hopefulness,
anxiety, and depression
Outcome Improved Deteriorated No change N
Caregiver burden (ZBI) 0 4 13 17
Hopefulness (HHI) 3 8 6 17
Anxiety (HADS) 2 0 15 17
Depression (HADS) 1 1 15 17
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Table 4 Results of the Family Feedback Questionnaire
Item Family carers (N = 18)
Mean SD n Agree
(SA + A)
n Disagree
(SD + D)
DT was helpful to my family member 4.22 0.647 16 0
DT has given my family member a heightened sense of purpose or meaning 3.87 1.060 10 2
DT helped increase my family member’s sense of dignity 3.56 0.984 8 2
DT helped prepare my family member for the end of life, whenever that may occur 3.33 0.970 9 3
DT was an important component of my family member’s care as any other aspect of their
care, including symptom management
3.61 0.979 11 3
DT helped reduce my family member’s suffering 3.22 1.003 7 5
DT helped increase my family member’s hopefulness about the future 3.17 0.857 6 4
The DT document helped me during this time of our life 3.33 1.085 9 4
DT has helped me prepare for the end of life of my family member, whenever that may occur 3.11 0.832 5 4
DT was helpful in reducing my feelings of stress as a carer 3.00 0.907 5 6
DT helped me feel closer to my family member 2.94 0.938 6 6
DT has increased my hopefulness about the future 3.11 0.758 6 4
The DT document will continue to be a source of comfort for my family and me 3.83 0.618 13 0
I would recommend DT to other patients of family members who are dealing with MND 4.00 0.686 14 0
Scoring: 1 strongly disagree, 2 disagree, 3 neither agree or disagree, 4 agree, 5 strongly agree.
Table 5 Selected comments from the family feedback questionnaire
Item Comment
The dignity therapy document helped me during this
time of our life.
“It has provided a source of information and inspiration”.
“I didn’t learn anything about him I didn’t already know”.
“I put my husband first and yet what I read I didn’t feel very appreciated or loved”.
Dignity therapy was helpful in reducing my feelings of
stress as a carer.
“Answering the questions actually increases the stress”.
“When the real suffering begins the stress is going to come no matter what”.
“[There is] more understanding, less tension”.
Dignity therapy helped me feel closer to my family
member.
“Some days we are on the same page, but other days we are upset, angry and not close at all”.
“Nothing replaces 50+ years of constant close companionship and mutual caring”.
“We have always been close but I feel more protective now”.
Dignity therapy has helped me prepare for the end
of life of my family member, whenever that may occur.
“I don’t see how relating his life in a few short pages could prepare me”.
“One thing it did do was focus on the end and not to live and enjoy the journey
along the way the best we can”.
“[It helped] from pushing aside the situation to more acceptance”.
Dignity therapy was helpful to my family member. “Just for him to think of the past and what he has achieved in his life is satisfying”.
“She expressed emotions which she normally suppresses”.
“He enjoyed the opportunity to put memories on paper and have something concrete for
others to read”.
Dignity therapy helped prepare my family member
for the end of life, whenever that may occur.
“[We] recently went on a family holiday and he was able to talk to his children about
his condition”.
“He’s been in denial but has recently come to terms with his diagnosis and the dignity
therapy helped through giving an opportunity to talk about these issues”.
“It has made him face up to his situation and to express himself to family and friends”.
The dignity therapy document will continue to
be a source of comfort for my family and me.
“If we are missing him, we can just read the booklet”.
“The document will provide a basis for reference and reflection”.
“We will treasure his story forever”.
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in his presence with minimal contribution from her hus-
band), and one carer of a speech impaired wife was sig-
nificantly involved in providing detail and elaborating on
her responses which were written on a whiteboard.
However, not all speech impaired participants required
or requested assistance from their family carers as sev-
eral relied on assisted communication, including email,
to complete the interview and editing. We analysed the
data using descriptive statistics to determine if the dis-
tress levels or acceptability levels differed between the
family carers involved and those not involved in the in-
terviews and editing and we found no significant differ-
ences. The family member who served as a proxy was
the only deviation from the dignity therapy protocol,
though Chochinov and colleagues report instances of
dignity therapy conducted via family proxies and it ap-
pears that this is an acceptable deviation [6].
Generally, individual dignity therapy meetings involv-
ing family carers (n = 12) were of a longer duration than
those completed by the client alone (n = 17). Family
carers added to the session dialog, asked questions, and
often provided refreshments or engaged in other caring
tasks that made their partner more comfortable. All of
these actions extended sessions. Nonetheless, involve-
ment of family carers did not equate to longer legacy
documents. For clients assisted by family carers, docu-
ments were 7 to 47 pages (mean 20.42, SD 13.35), while
documents were 11 to 57 pages (mean 22.94, SD 10.615)
for clients who completed the therapy alone. The number
of sessions required to complete the therapy was fewer in
the group assisted by family carers (mean 3.75 v 4.41), and
the days to complete the intervention slightly more in the
group assisted by family carers (mean 46 v 39).
Discussion
Dignity therapy has been shown to moderate the be-
reavement experience in family carers when they were
interviewed 9 to 12 months after death [7], but no previ-
ous studies have looked at the impact of the therapy on
family carers at the time of the intervention. We
hypothesised post-intervention decreases in burden, anx-
iety and depression scores and an increase in hope, but
there were no significant changes. Rather, our population
showed an increase in burden which correlated to a de-
cline in the physical function of the patient during the
study period. This effect is consistent with research of
burden over time in MND family carers [15-17]. With-
out a control group, we are unable to ascertain whether
dignity therapy had a prevention effect against expected
increases in burden, anxiety, and depression, or a decline
in hopefulness.
The individual results on anxiety and depression are
more encouraging and suggest that dignity therapy has
the potential to decrease anxiety and depression in family
carers who are experiencing moderate to high levels of
distress. This is similar to the findings for terminally ill
cancer patients, where distressed individuals had a de-
crease in anxiety and depression scores [2], but those with
low baseline levels of distress showed no change [1].
Acceptability of dignity therapy was mixed. Family
carers felt that the therapy provided a benefit to their fam-
ily members and that the document would help them in
bereavement, and most rated the experience as satisfac-
tory and one they would recommend to others. Whether
a family carer was directly involved in the therapy had lit-
tle impact on the acceptability or feasibility of dignity ther-
apy. Rather, the comments provided on the feedback
questionnaire suggest that family carers’ level of accept-
ance of their partner’s imminent death, or the quality of
the relationship between family carer and partner, may
lead to dignity therapy having a potentially negative im-
pact on family carers at the time of the intervention.
Strengths and limitations
The strengths of this study were the high response rate
and high completion rate of MND family carers, the use of
MND-specific cognitive and health status measures, and
the demographic characteristics of the sample are generally
representative of MND family carers. The limitations in-
clude inadequate power to discover small to moderate ef-
fects, mild to moderate levels of distress at baseline, and
the lack of a control group. The study group may not be
representative of all MND family carers because those who
declined to participate may have been more distressed, and
people with MND with severe cognitive impairment and
their family carers were excluded from the study.
Implications for future research
The effectiveness of dignity therapy in decreasing per-
ceived caregiver burden, anxiety or depression, or in-
creasing hopefulness in MND family carers could not be
determined in this study. A randomised controlled trial
with a greater number of participants is needed, perhaps
incorporating a stepped-wedge or cluster design. An ex-
perimental study focusing on distressed family carers is
warranted to determine if dignity therapy has the poten-
tial to decrease anxiety and depression. A qualitative
study with family carers is indicated to explore more
fully the mixed acceptability results provided in the feed-
back questionnaire. Further, a longitudinal study would
determine if the document was helpful to carers follow-
ing bereavement.
Ethical challenges
Dignity therapy may trigger emotional upset in people
with MND who are experiencing emotional lability and
this was frequently encountered. Emotional lability, also
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known as pseudobulbar affect, is an MND symptom
which has the potential to cause distress to the person
with MND and their family carer if it is not treated sen-
sitively and therapeutically. In our study, we provided a
supportive and safe environment, information and
psycho-education, and normalised the symptom. Other
ethical challenges encountered include negotiating com-
plex relationships of participants and family carers, mini-
mising harm to both parties as well as extended family
members through what was written in (or left out of )
the generativity document, and balancing the interests of
the family carers with those of the patient. These chal-
lenges suggest that the skillful application of dignity ther-
apy by a trained psychotherapist who is knowledgeable
about MND is paramount in any future research.
Conclusions
The findings of this study suggest that dignity therapy is
not likely to alleviate the burden encountered by MND
family carers during caring, but it may have the ability to
decrease or moderate anxiety and depression in dis-
tressed MND family carers. Dignity therapy is feasible
and generally acceptable to family carers of people with
MND, who recognize benefits to their ill family member
and also the potential benefits to themselves during be-
reavement as a result of having the legacy document.
Comments from carers indicate that it is important for a
dignity therapist to be aware of acceptance levels and
dynamics in partner relationships in order to best pro-
vide a satisfactory experience for family carers.
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CHAPTER SEVEN 
7.  Feasibility and Implementation Issues 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I’m not sure how much more of this disease I can take.  The deterioration of 
my tongue and throat muscles is making it harder for me to speak.  I think as 
clearly as I ever have, but I just can’t mouth my words clearly any more.  
Even though it saddens me beyond belief, I can’t cry, because when I cry I 
can’t breathe.  When I can’t breathe I panic because I feel I am closer to 
death. (Finlay 2008 p. 128). 
 
Maree Finlay of Western Australia was diagnosed with MND at age 37 in 2004.  During 
her illness, she wrote a memoir documenting her early life and her journey with MND.  
The above passage was written shortly before her death in December 2007.   
Chapter Seven expands on issues related to the 
feasibility of dignity therapy with people who have 
MND that were introduced in Chapters Five and Six.  
It explores the ways common MND symptoms 
discussed in Chapter Two including speech loss and 
impairment, emotional lability, cognitive impairment 
and paralysis can affect the provision of dignity 
therapy and psychotherapy more generally.  This 
chapter also provides a detailed account of the 
practical aspects of performing dignity therapy with 
people with MND, including the time and costs 
involved and characteristics of completed documents, 
and adds to the body of literature addressing the 
delivery of dignity therapy in a clinical setting first 
introduced in Chapter Three.  A personal reflection 
published in the Journal of Palliative Medicine 
entitled “It Takes the Time that it Takes” is 
incorporated to provide insight into time delays and 
endorsement from dignity therapy’s creator for 
acceptance of these delays in certain cases. Ethical 
considerations relating to the delivery of dignity 
therapy with people with speech or cognitive 
impairment are discussed.  Future directions for 
research relating to the feasibility and implementation 
of dignity therapy as part of standard palliative 
psychosocial care are discussed. 
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7.1 Introduction 
 As established in Chapter Two, MND is a terminal disease of short prognosis, 
and management of MND focuses on controlling symptoms and maintaining QOL from 
diagnosis until death (Simmons 2005, McDermott and Shaw 2008).  A review of the 
literature in Chapter Three suggests that providing psychosocial support to both people 
with MND and their family carers is critical to maintaining QOL (Ganzini, Johnston et 
al. 1999, Simmons, Bremer et al. 2000, Clarke, Hickey et al. 2001, Cupp, Simmons et al. 
2011); yet only a small percentage of MND research is dedicated to the psychosocial 
aspects of MND and intervention studies are rare (Pagnini, Simmons et al. 2012, Aoun, 
Bentley et al. 2013).  Moreover, there is no research dedicated to the practical aspects of 
delivering psychosocial care to people with MND, a group that has challenging physical 
symptoms including cognitive-behavioral impairment, speech loss or speech 
impairment, emotional lability, and paralysis.  In order to provide effective psychosocial 
care in palliative care settings, an exploration of how common MND symptoms can 
affect the efficacy and feasibility of psychotherapeutic interventions is needed (Kasl-
Godley, King et al. 2014).  This study of dignity therapy with people with MND and 
their family carers provides an opportunity for such an examination. 
7.2 Background 
 As described in Chapter Three, dignity therapy is an end-of-life psychosocial 
intervention that was developed and tested for a palliative care population where 95% to 
97% have malignant conditions (Chochinov, Hack et al. 2005, Chochinov, Kristjanson et 
al. 2011).  The results of prior dignity therapy research with cancer patients is not 
directly transferable to people with MND as demographic features, baselines levels of 
distress, ability to communicate, physical impairment, and cognitive acuity are some of 
the factors that differ between these groups and may impact on the delivery of the 
intervention.  A close examination of feasibility issues is necessary (Craig, Dieppe et al. 
2008), which will inform the feasibility of dignity therapy with people with MND 
specifically, and  also the use of psychosocial and psychotherapeutic interventions with 
people with MND and their families more generally.   
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 Previous research examining practical details about the delivery of dignity 
therapy, including the required clinical time and costs, the length of time needed to 
complete dignity therapy from start to finish, and the length of dignity therapy 
documents, has reported incomplete and inconsistent results (See Chapter 3, section 
3.4.4.8).  A detailed appraisal of practical aspects of implementing dignity therapy 
gleaned from the present study will provide information about delivering psychosocial 
interventions to people with MND, and add to the knowledge base on the time and 
resources needed to implement dignity therapy into clinical practice. 
 The aim of this chapter is to explore further feasibility issues related to 
conducting a psychotherapeutic intervention with people who have MND and their 
family carers, to present data on the practical aspects of dignity therapy with this group, 
and to add to the knowledge base on the time and resources needed to implement dignity 
therapy into clinical practice.  In Chapter Five, it was reported that the increased time 
required to deliver dignity therapy to some people with MND may be prohibitive.  Key 
challenges include: the increased time required to deliver the intervention to people who 
may have impaired speech and time to travel to a palliative care group who are primarily 
cared for at home.  However, common symptoms like mild to moderate cognitive 
impairment, speech impairment and emotional lability did not detract from the perceived 
benefits or acceptability of the therapy based on the outcome measures (p. 85-86).  In 
Chapter Six, it was reported that it is feasible to involve MND family carers in dignity 
therapy even though the meeting times were of a longer duration in this group than in 
people with MND who did not involve family in the therapy sessions.  There did not 
appear to be any differences in acceptability levels between family carers who were 
involved in the therapy and those who were not involved based on responses in the 
feedback questionnaire (p. 93-94).  This chapter expands upon these findings by 
providing a detailed report and analysis of the feasibility issues involved in providing 
dignity therapy to people with MND, which will inform practice guidelines for 
psychotherapists working with this group. 
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7.3  Methods 
 7.3.1 Study design 
 This cross-sectional study utilized a one-group pre-test post-test design with 29 
people with MND and 18 MND family carers.  (For more information on the 
methodology, see Chapters 4-6).   
 7.3.2   Measures and outcomes 
  7.3.2.1   Demographic and health status 
 Demographic data including age, gender, location, and marital status were 
collected.  Disease specific health related QOL was measured with the ALSAQ-5, where 
scores range from 0-20 and higher scores denote decreased health related QOL 
(Jenkinson, Fitzpatrick et al. 2007).  Probable FTD/cognitive behavioral impairment was 
screened with the ALS-CBS with scores ranging from 0-20 and lower scores indicating 
impairment (Woolley, York et al. 2010). 
  7.3.2.2   Contact sheet  
 A contact sheet was used to record data at each participant meeting, including the 
number of dignity therapy sessions and the duration of each session.  Details about final 
documents produced in dignity therapy were recorded, such as the number of copies 
requested, the length of documents, and any materials added to documents.  The contact 
sheet also contained space for the researcher to write brief notes related to the impact of 
MND symptoms on the delivery of the intervention, including observations and 
impressions of physical symptoms, non-verbal behaviors, challenges encountered, and 
notable comments from participants and family carers. 
  7.3.2.3    Audio recordings and transcription cost 
 The total duration of audio recordings per participant was determined and the 
cost of transcriptions was calculated.  Most audio recordings were transcribed by a 
professional transcriber at a cost of $1.80 AUD per recorded minute which is the usual 
rate in WA.  In some recordings, where speech impairment made the recordings very 
difficult to understand, the transcriptions were completed by the researcher at no cost.  
However, the overall cost of transcriptions has been calculated by noting the minutes per 
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recording and multiplying them by the transcription rate per minute for all recordings, 
including those completed by the researcher.     
 7.3.3  Analysis 
 Descriptive statistics were used to summarize the variables using SPSS version 
20.   
7.4 Results 
 7.4.1 Demographic information   
 Participants with MND were 20 men and 9 women who ranged in age from 32 to 
81.  MND family carers who participated were 13 women and 5 men who ranged in age 
from 38 to 80.  Participants resided throughout WA where the one-way travel distance 
ranged from 0 kilometers (km) for one participant who preferred to work at the 
researcher’s office and another who completed the intervention via Skype, to 430 km 
with a median of 24 km.  In all instances, both people with MND and MND family 
carers engaged in the research from the same location (See Table 7-1 for more 
demographic information). 
 7.4.2 Impairment  
 Twenty-four participants had low to moderate health-related QOL according to 
the ALSAQ-5, and 13 had mild to moderate suspected cognitive impairment according 
to scores on the ALS-CBS.  Five symptoms that affected the delivery of dignity therapy 
were noted on the contact sheets and include: emotional lability, speech loss, speech 
impairment, cognitive impairment, and paralysis. Over 80% (N=24) of participants 
displayed at least one of these symptoms during the intervention.  Often more than one 
symptom was present in the same individual. Seven participants, or about one-quarter, 
had multiple symptoms that were consistent with bulbar presentation of MND, where 
upper motor neurons are affected and speech loss or impairment, cognitive impairment 
and/or emotional lability occur early in the disease.  (See Table 7-2 for more information 
on ALSAQ-5 scores, ALS-CBS scores, and symptoms observed during dignity therapy, 
which together create impairment profiles for each participant with MND).   
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 Table 7-1  Participant Demographic Information 
 
NO. 
 
AGE 
 
MARRIED? 
SPOUSE 
PARTICIPATED? 
ONE-WAY 
TRAVEL (KM) 
1 64 YES YES 22 
2 65 YES YES 430 
3 65 YES YES 352 
4 75 YES YES 17 
5 32 YES  5 
6 63 YES YES 17 
7 63   8 
8 71   28 
9 80 YES YES 38 
10 55 YES YES 164 
11 68 YES YES 300 
12 58 YES YES 6 
13 42 YES YES 0 
14 69 YES  319 
15 54 YES YES 169 
16 52 YES YES 18 
17 76 YES  22 
18 77   24 
19 71 YES  3 
20 64 YES YES 17 
21 81   50 
22 69 YES YES 17 
23 69 YES YES 33 
24 68 YES  93 
25 63 YES YES 300 
26 60 YES  0 
27 62 YES YES 30 
28 64   21 
29 72 YES YES 164 
  
  7.4.2.1 Emotional lability 
 The most commonly observed symptom that had an impact on the intervention 
was emotional lability.  This was observed in 9 participants - 6 men and 3 women - who 
experienced periods of uncontrollable crying during dignity therapy.  A few participants, 
both people with MND and their family carers, knew this type of crying was a symptom 
of MND but other participants were surprised when the symptom occurred.  For 
example, in one observation of emotional lability the researcher noted, “X said he has a 
problem with emotional lability and reports that sometimes he starts crying and can’t 
stop,” and in another noted, “X found she was crying while telling parts of her childhood 
story and didn’t understand why she was so emotional when she didn’t feel sad.”  One 
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participant, who experienced uncontrollable crying during the completion of the pre-test 
questionnaires and expressed embarrassment, discontinued involvement with the study 
explaining that the process was “stirring things up that I don’t want stirred up.”  One 
participant, who was ventilator dependent, had irregular breath patterns and was gasping 
while crying, which was startling for the researcher, though based on the behavior of 
family members present during data collection, these symptoms seemed routine for the 
family. 
Table 7-2  Impairment profile of participants with MND 
No. Health-
related QOL* 
Suspected 
cognitive 
impairment** 
Observed 
cognitive 
impairment 
Observed 
speech 
impairment 
Observed 
speech 
loss 
Observed 
emotional 
lability 
Observed  
paralysis 
of hands 
1 Moderate Mild YES     
2 Moderate Moderate YES     
3 High Normal     YES 
4 Moderate Normal  mild  YES  
5 Low Normal     YES 
6 Moderate Normal   YES   
7 High Normal     YES 
8 Low Normal   YES   
9 Moderate Moderate   YES   
10 Moderate Mild YES mild  YES  
11 Moderate Normal      
12 Low Normal  YES  YES  
13 High Normal     YES 
14 Moderate Normal    YES  
15 Moderate Moderate YES  YES YES  
16 Moderate Moderate  YES    
17 High Normal      
18 High Moderate      
19 Moderate Moderate     YES 
20 Moderate Normal    YES  
21 Moderate Mild YES     
22 High Normal      
23 Moderate Moderate   YES YES  
24 Moderate Normal  mild    
25 Low Moderate   YES YES  
26 Moderate Normal  YES    
27 Moderate Mild  mild  YES  
28 High Mild      
29 Low Normal  mild    
*ALSAQ-5 score = 1-6 high, 7-13 mod, 14-20 low 
**ALS-CBS score = 17-20 normal, 13-16 mild, 10-12 moderate  
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 Though numbers are small and only tentative conclusions can be reached, 
women with MND did not seem to be as disturbed by emotional lability as men with 
MND.  This may be due to the influence of masculine norms where crying is less 
socially acceptable for men than for women (Mahalik, Locke et al. 2003).  On the whole, 
men with MND expressed embarrassment and often appeared to avoid emotionally 
evocative areas during the dignity therapy interview, focusing more on biographical 
information and accomplishments, and less on messages of love and hope.   
 When emotional lability was encountered, the Protocol for Minimizing Risk of 
Emotional and Psychological Harm (see Appendix X) was activated and participants 
were offered continued emotional support through MNDAWA.  No participants 
expressed that they were distressed by dignity therapy or symptoms of emotional 
lability, and none sought continued support.   
  7.4.2.2 Speech loss 
 Six participants had lost the ability to communicate verbally and relied on AAC 
to complete dignity therapy.  Two, who primarily used tablet devices to communicate, 
completed the intervention entirely by email.  After the initial meeting, dignity therapy 
questions were asked and answered via email in one or two interactions per week.  
These interactions were compiled and edited in a similar fashion to the oral interview 
transcripts, creating a comprehensive document identical to the other dignity therapy 
transcripts.  One participant completed the process via email with ease but the second 
participant became discouraged after a few interactions and commented “there’s not a 
lot of plot to this novel.”  A visit was arranged to read aloud to the participant the 
document that had been produced.  The participant was pleased with the meeting and 
thereafter completed the interview through email with enthusiasm.     
 The third participant with speech loss completed the intervention using a 
Lightwriter, a portable type-input voice out-put device.  This participant was a retired 
secretary who easily adapted to typing on the device which would then speak aloud what 
she had written in an electronic voice.  The interview was completed in two sessions 
which were audio recorded and transcribed following the usual protocol.  Another 
participant who had only recently begun using the Lightwriter, and was having difficulty 
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adapting to using it, used a combination of the Lightwriter, handwritten notes, gestures 
and verbalizations.  This interview was audio recorded and the handwritten notes were 
read aloud by the researcher, along with the meaning of gestures and verbalizations.  
This recording was not coherent and difficult to transcribe.  The participant also wrote 
out some notes between interview sessions which were added to the document. 
 A fifth participant with speech loss used a whiteboard to write cues and then had 
her spouse provide details for the narrative. This participant also experienced emotional 
lability and her cognitive screen score suggested moderate impairment.  This was 
evidenced by nonsensical phrases (aphasia) on the whiteboard but these were understood 
by her spouse.  The sixth participant was ventilator dependent and could not speak.  This 
participant relied exclusively on his spouse to tell his life story, though he guided his 
wife’s storytelling with hand gestures.  On a few occasions when meaning could not be 
deciphered from the gestures, the participant wrote a brief note, which took considerable 
time and effort.   
  7.4.2.3 Speech impairment 
 Eight people had impaired speech.  Of these, five exhibited mild impairment 
which resulted in occasions where words or phrases were not immediately understood, 
but overall this level of impairment had minimal impact on the intervention.  In 3 
people, the impairment was considerable and the participants did not use AAC, which 
made comprehension difficult.  Interviews were performed and audio recordings were 
created, though the transcripts were difficult and extremely time consuming to create as 
there were many unintelligible words, sentences or paragraphs that had to be revisited in 
subsequent meetings.  In each of these cases, the researcher/interviewer performed the 
transcription as the recordings were too difficult for the transcriptionist to understand.  
This also created the opportunity for the researcher to re-listen to interviews during 
which time the researcher noticed that there was a substantial amount of content that was 
not understood and not responded to during the interview.  For example, one participant 
revealed childhood abuse and another said he had disgraced his family name.  There was 
no response from the researcher to either of these comments as the researcher had not 
understood what was said at the time (though the comments were addressed in 
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subsequent meetings, and the participants were provided information and referral for 
psychological support, which they refused).  The three participants with significant 
speech impairment expressed frustration but only with themselves, and they did not 
become disillusioned or stop dignity therapy.  Ultimately, each of these participants 
requested to do some of their own editing via email.  These three participants had the 
longest completion times and some of the longest documents.   
  7.4.2.4 Cognitive impairment 
 Cognitive impairment was observed in 5 participants whose ALS-CBS scores 
indicated mild to moderate impairment.  One participant, whose screen suggested mild 
FTD, had short and long term memory impairment.  The participant’s spouse was visibly 
anxious and distressed by the participant’s memory loss during the dignity therapy 
interview.  After the spouse tried different methods to prompt memories, the issue was 
discussed and a decision was made for the spouse to leave the session and go for a drive 
in order to avoid further distress.  This participant created one of the shortest documents, 
though the spouse was very happy and comforted by the document, stating “It really 
helped me – I read it all the time.  When I’m worried about what I will do in the future, I 
read the booklet.” 
 A second participant with a score approaching the cut-off on the cognitive 
screening measure appeared to have behavioral variant FTD.  While this participant 
reported he was employed in a position of authority from time-to-time and managed the 
family finances, there appeared to be impairment in his executive functioning.  This 
participant made inappropriate, insensitive and sometimes bizarre comments during 
dignity therapy, including some that were hurtful to his spouse.  This participant’s 
transcript was edited and reduced more than any other to remove nonsensical or 
objectionable content.  In the end, the participant was pleased with dignity therapy, who 
said it was “of the upmost importance” while the spouse was not, stating, “Hearing him 
put me down to someone else ... only increased my stress.” 
 The cognitive impairment observed in the remaining 3 participants, such as 
memory lapses or aphasia, had minimal impact on the intervention.  It should be noted 
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that 8 other participants had scores suggesting cognitive impairment on the ALS-CBS 
but impairment was not observed during the intervention.   
  7.4.2.5 Paralysis 
 Six participants had paralysis that led to an inability to type or grip a writing 
instrument.  As a result, these participants could not hold or write on their documents, 
correspond with the researcher or use non-voice activated AAC methods.  In all 
instances, this symptom had minimal impact on the intervention and the necessary 
adjustments were easily made.   
Table 7-3  Time and costs to perform dignity therapy 
 Minimum* Maximum Median Mean Std. 
Deviation 
Total Visits 3 7 4 4.14 10.94 
Total Contact Hours 3.25 11.25 5.75 5.82 1.87 
Total Days 7 152 26 42 36.25 
Recorded Minutes  31 254 91 98.48 50.76 
Transcription Cost $55.80 $457.20 $163.80 $177.27 $91.37 
 
* Note: Email clients with no recorded interview time were excluded in the above figures on recorded 
minutes and transcription cost.  The median and range are reported as the data are not normally 
distributed, and mean and SD are also included for use in comparison with other studies. 
 
 7.4.3 Time and costs associated with dignity therapy 
 Total intervention visits (excluding post-testing) ranged from 3 to 7 visits with a 
median of 4.  Hours of clinician/participant contact time ranged from 3.25 to 11.25 with 
a median of 5.75 hours.  This time includes obtaining consent and the completion of pre-
test questionnaires in the initial meeting where dignity therapy was explained (see p. 53) 
but does not include the completion of post-test questionnaires as this occurred after 
dignity therapy had concluded and was collected by a second researcher or by mail to 
reduce response bias.  Days from the initial visit to providing the final document ranged 
from 7 days to 152 days with a median of 26.  Recorded interview minutes ranged from 
0 (with two participants who were unable to speak and who completed dignity therapy 
exclusively via email) to 254 (median of 81).  When the two participants with no 
recordings were excluded, the range was 31 to 254 minutes with a median of 91 minutes 
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per recording.  The median cost per recording for all participants was $145.80.  When 
the two participants with no transcriptions were excluded, the range was $55.80 to 
$457.20 with a median of $163.80.  (Note: this method does not take into account the 
actual time spent transcribing which could be considerably longer in those with speech 
impairment; See Table 7-3). 
 7.4.4 Characteristics of documents 
 Participants requested from 1 to 20 copies of their finished document with a 
median of 4.  Documents ranged from 2,025 words to 11,978 words with a median of 
6,003.  Upon request to the researcher, participants were able to add material to their 
documents prior to completion.  Ten participants requested to add material, most 
commonly a photograph on the cover page and/or a collection of photographs added as 
an appendix.  Other materials appended to documents included poetry and songs 
authored by two participants, a timeline of important dates, a record showing dates of 
postings on naval vessels, and two participants included letters of commendation from 
previous employers.  Nineteen participants did not request the addition of materials, but 
5 of these requested an electronic copy of their document and said they or a family 
member would add material such as photographs in the future.  Children of two of these 
participants began adding photographs before the final documents were delivered in hard 
copy form (see Table 7-4). 
Table 7-4  Final document characteristics 
 Minimum Maximum Median Mean Std. 
Deviation 
# of Copies Requested 1 20 4 5.21 3.77 
Page Length 7 57 20 21.90 11.66 
Word Length 2025 11978 6003 6202.1 2989.09 
 
* Note:  The median and range are reported as the data are not normally distributed, and mean and SD are 
also included for use in comparison with other studies. 
 
7.5 Discussion 
 7.5.1. Effect of physical impairment and symptoms on dignity therapy 
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 While people with MND and their families are often advised to seek support 
from mental health professionals to help cope with MND (MND Association 2014, State 
Government of Victoria 2014), and research articles addressing QOL and psychosocial 
distress in MND frequently recommend increased psychosocial support for people with 
MND and their family carers (Mitsumoto, Bromberg et al. 2005, McLeod and Clarke 
2007, Aoun, Bentley et al. 2013), there is a paucity of evidence available to practitioners 
about the practical aspects of providing psychosocial support, including how common 
symptoms and physical impairments encountered in people with MND may affect 
counseling and the efficacy of interventions.   In this study, the majority of participants 
had MND impairments which had at least some effect on the delivery of dignity therapy 
and participation in psychotherapy more generally.  In most instances, the presence of 
MND symptoms posed minor challenges during the delivery of the intervention.  
Paralysis, minor speech impairment, and speech loss where participants used AAC had 
little effect on dignity therapy as long as allowances were made, such as a slower pace of 
conversation, to accommodate the symptoms and enhance communication between the 
researcher and participant.   
 Mild to moderate cognitive impairment was not an issue in most cases, though 
there were two exceptions.  In the first, an MND family carer became distressed by the 
observed memory loss of her spouse and his difficulty with telling his story.  Even 
though this MND participant had passed a cognitive screen, cognitive decline has been 
shown to have a profound negative impact on MND family carers, with increases in 
burden and depression and decreases in QOL (Chio, Vignola et al. 2010).  Relieving the 
family carer of her responsibilities of care during the intervention allowed dignity 
therapy to be completed to the satisfaction of both parties; however, Chochinov warns 
that performing the intervention with people who have cognitive impairment has the 
potential for harm if it results in a dignity therapy document that is a distorted 
representation of the person (Chochinov 2012).  In the second case, the participant with 
MND was suspected of behavioral variant FTD based on his score on a cognitive screen 
and observed behavior, which included impulsivity, self-centeredness and lack of 
empathy, although the participant and family carer did not appear to recognize the 
presence of cognitive impairment.  Research has found that people with MND with FTD 
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lack insight of the magnitude of their behavioral change and  suggests that MND family 
carers may fail to recognize neurobehavioral symptoms that develop slowly (Woolley, 
Moore et al. 2010). Though this participant found dignity therapy to be acceptable and 
reported benefits, the difficulty of performing the intervention, along with the distress 
caused to the MND family carer as a result of hearing her husband criticize her, together 
indicate dignity therapy may not be suitable for people suspected to have behavioral 
variant FTD.  Increased education and screening is indicated to improve awareness 
about this symptom and to provide better care in the multidisciplinary setting (Wicks 
and Frost 2008).     
 Emotional lability was encountered most often and had the potential to cause 
distress for both the participant and family carer.  Not only can emotional lability be 
distressing for people with MND (Moore, Gresham et al. 1997, Mitchell and Borasio 
2007), but previous research has found a relationship between psychological distress in 
MND family carers and demonstrations of emotional lability by care recipients 
(Goldstein, Atkins et al. 2006).  Often, participants and MND family carers in this study 
were unaware that the behavior was a symptom of MND, a finding that is consistent 
with previous research (Elman, Houghton et al. 2007).  Chochinov states that dignity 
therapy “is often quite emotional; even emotionally neutral material can resonate in 
ways that are quite poignant” (Chochinov and McKeen 2011  p. 87).  While information 
exists on the medical management of emotional lability for people with MND and other 
neurological disorders (Meininger 2005, Ahmed and Simmons 2013), no guidance can 
be found on performing psychotherapy or psychological interventions with people who 
have this symptom.  Drawing on counseling theories and practices (Kleinke 2002, Corey 
2005), when emotional lability occurred, the researcher created a safe and supportive 
environment by providing information and education about the symptom, and 
normalizing the occurrences.  However, the efficacy of psychotherapeutic interventions 
is presumably affected in instances where clients are unable or unwilling to discuss 
emotionally evocative topics through fear of triggering a potentially embarrassing and 
distressing symptom such as emotional lability (Moore, Gresham et al. 1997).  Increased 
education about emotional lability is needed for health care providers, people with 
MND, and family members to increase awareness about this symptom (Goldstein, 
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Atkins et al. 2006, Wicks and Frost 2008, Ahmed and Simmons 2013).  The use of 
screening measures may help identify people with MND who are struggling with this 
symptom and improve care (Moore, Gresham et al. 1997).  A possible solution for 
people distressed by symptoms of emotional lability is providing the option of online 
therapy, as research shows that some people prefer online therapy due to the reduced 
emotional exposure experienced through the use of this method (King, Bambling et al. 
2006).   
 Significant speech impairment where participants did not use AAC had the most 
effect on the intervention and on the delivery of psychotherapy more generally.  
Verbatim transcripts of interviews were very difficult to create and more visits were 
required over a longer period of time to obtain and clarify the narrative.  Research 
examining unaided communication between a person with significant speech impairment 
and a speech therapist demonstrates not only the difficulty of communication but also 
the intense effort that must be expended by both parties in the dyad for a negligible level 
of comprehension to occur (Damico, Simmons-Mackie et al. 2006).  Research 
addressing the communication effectiveness of people with MND has determined that 
communication is difficult in all situations when intelligibility falls below 70% on a 
communication measure (Ball, Beukelman et al. 2004).  Previous research addressing 
the provision of psychotherapy to people with speech loss and impairment suggests that 
AAC devices are a necessity, with one author stating “The devices do not merely 
facilitate the therapeutic process; they enable it to occur” (Crawford 1987 p. 97).  
Similarly, Chochinov affirms, “Conditions that interfere with a patient’s ability to 
communicate can be challenging and, in some instances, may preclude their being able 
to participate” (Chochinov 2012 p. 56).  He also states that the participant, therapist and 
transcriptionist “must all speak the same language” (Chochinov 2012 p. 58).  Chochinov 
does not elaborate or provide strategies for a dignity therapist to assess an acceptable 
level of comprehension, but he implies understanding between the parties is a paramount 
concern.   
 In this study, the amount of important content that was not heard or 
comprehended while performing dignity therapy with people who had significant speech 
impairment, including instances of painful self-disclosure, undermined the creation of a 
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therapeutic relationship and environment.  A central principle of person-centered 
psychotherapy is that a therapist must demonstrate empathic understanding of their 
clients.  Corey (2005) states, “One of the main tasks of the therapist is to understand 
clients’ experience and feelings sensitively and accurately as they are revealed in the 
moment-to-moment interaction during the therapy session” (p. 173) and Chochinov 
confirms, “therapists must pay careful attention to everything that is happening between 
them, including what is said, how it is said …” during dignity therapy (Chochinov 2012 
p. 77).  In participants with significant speech impairment, the ability of the researcher to 
understand and respond to content was diminished.  These findings suggest that dignity 
therapy with people with significant speech impairment, for example those scoring 
below a determined cut-off point on the Modified Communication Effectiveness Index 
(CETI-m) (Ball, Beukelman et al. 2004) or the Assessment of Intelligibility of 
Dysarthric Speech (AIDS) (Yorkston, Beukelman et al. 1984), may best be 
accomplished through an alternate method rather than a verbal interview, such as 
through the use of AAC or email.   
 While dignity therapy took the longest to perform with the three people who had 
significant speech impairment in this study, this is not a sufficient reason to discourage 
the use of the intervention with this group.  Chochinov states, “Conditions that interfere 
with a patient’s ability to communicate can be challenging” and “creative thinking, 
patience and ingenuity” should be used in these cases (Chochinov 2012 p. 56).  Research 
with people living with dysarthria has documented the psychological distress, including 
threats to self-image and isolation, that occur when barriers to societal participation are 
encountered due to their disability (Walshe and Miller 2011), and speech impairment 
adversely affects the QOL of people with MND and their family members (Murphy 
2004).  Research on the interactions between health care providers and people with 
speech impairment has shown that patients are controlled and often feel judged during 
interactions, and that a culture of partnership is needed to provide meaningful 
interventions (Gordon, Ellis-Hill et al. 2009, Walshe and Miller 2011).  Based on the 
needs of this group, a longer completion time is of little importance.  The researcher also 
consulted with Professor Chochinov who created dignity therapy about the long 
completion time with one of the speech impaired participants.  The personal reflection at 
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the end of this chapter, “It Takes the Time That It Takes” was written and published as a 
result.  In summary, Professor Chochinov highlighted the necessity of psychosocial care 
and suggested that the length of time taken to complete the intervention was less 
important than the potential benefits experienced as a result of dignity therapy.  The 
experience detailed in the reflection supports this position. 
 Participants with speech loss who used AAC were able to complete dignity 
therapy and they reported comparable benefits to those who could speak.  The most 
efficient and novel AAC method was the use of email.  The use of email to perform 
psychotherapy is new and evolving with themes about its clinical use both suggesting 
optimism about reaching new client populations balanced by caution over the significant 
changes to traditional counseling methods brought about by technology (Goss and 
Anthony 2009).  As in this research, the use of technology in psychotherapy is often 
guided by client needs rather than by practitioners (Goss and Anthony 2009).  While one 
participant using email to complete dignity therapy did become discouraged by the 
relative isolation of this method, a face-to-face interaction restored the enthusiasm and 
resolve of the participant.  The resulting positive experience of both people who had lost 
the ability to speak and who completed dignity therapy by email indicates that dignity 
therapy may be successful even in the absence of a personal therapeutic relationship.  
Averill et al (2013) found that people with MND who had difficulty expressing 
themselves experienced increased psychological wellbeing as a result of a written 
expressive disclosure intervention where people with MND wrote or spoke into a tape 
recorder about their deepest thoughts and feelings for 20 minutes a day on three 
occasions over the course of a week.  Dignity therapy may present a similar opportunity 
for those who have lost the ability to speak to benefit from personal written expression.   
 7.5.2 Feasibility and implementation 
 In this study, dignity therapy averaged 4 sessions with client contact time of 6 
hours.  This is similar to the studies by Hall (2012) with 29 aged care residents and 
Montross (2011) with 23 cancer patients.  Clinician editing time completed out of the 
presence of the client was not tracked with every participant in this research, but where 
tracked it ranged from 4 to 8 hours of clinician editing time per recorded hour of 
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interview.  An estimate of the average editing time performed outside of the presence of 
the participant in this study was 9 hours per participant, which is only slightly above the 
8.69 hours reported by Hall (2012), and both this research and Hall’s report a similar 
average of approximately 15 hours of clinician time per participant.  The mean total 
recorded interview time per participant was 1 hour 38 minutes in this study, which is 
comparable to the 1 hour 36 minutes reported by Hall (2012), but more than the 66 
minutes reported by Johns (2013) with 4 cancer patients.  The mean duration of the 
therapy from start to finish was 42 days, while Hall (2012) reported 31.81 days.   
 Despite similarities between this study and the Montross (2011) study in number 
of sessions and client contact time, the documents in the present research were 
considerably longer.  In the Montross study, the mean number of words per document 
was 2,993, while documents in this study were 6,202 words long.  (Documents averaged 
5,878 in Johns’ (2013) study while Hall (2012) did not report on the length of dignity 
therapy documents).  The mean cost of transcription in the Montross study was $56 USD 
(Montross, Winters et al. 2011), while it was $165 AUD here.  Accounting for currency 
exchanges, the transcription cost for the present study in Australia was about three times 
more expensive than in the US; however, it was less than the “$200 CAD” per transcript 
that Chochinov suggests as a budget (Chochinov 2012 p. 176).  While inconsistencies 
and incomplete data continue to exist, the picture is becoming clearer on the time 
commitment and other practical aspects required to perform dignity therapy. 
 While the cost of transcription was detailed in two studies, previous studies have 
not tracked other costs such as travel costs, the cost of paper, copies and binding 
supplies, phone, mail and internet costs, and equipment costs for audio recorders, 
computers and printers, (which was also the case in the present study).  Moreover, while 
recent research is providing clarity concerning the number of visits and time required to 
meet with clients and edit documents, travel time, time spent arranging visits, waiting 
time, and cancelled appointments have not been considered fully in this or other 
research, although Hall (2012) noted these were common issues that increased the time 
commitment required.   
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 Delivering dignity therapy to rural and remote participants in this study was 
particularly time intensive.   Dignity therapy with four participants, who all resided over 
300 km from the Perth metropolitan area, required considerable travel time and at least 
one night’s accommodation.  In addition, precision planning and around the clock work 
by both the transcriptionist and researcher were needed to accomplish parts of the 
intervention during each two-day/one-night period, which may not be feasible in all 
settings.  An additional 3 participants resided over 150 km from Perth and required a full 
day for each client visit when travel was considered.  However, it should be noted that 
challenges such as these which result from the cost of travelling across vast geographical 
distances are not unique to dignity therapy.  
 The use of e-health methods, including videoconferencing and email, present a 
time and cost-efficient method to deliver dignity therapy to rural and remote locations.  
In addition to the two participants who completed dignity therapy via email, one 
participant who resided on the opposite side of Australia successfully completed dignity 
therapy using videoconferencing and reported numerous benefits.  This supports 
previous research by Passik and colleagues (2004) that dignity therapy can be effectively 
delivered using e-health methods.  In addition, research has shown that psychological 
interventions using e-health technologies are just as effective as face-to-face therapeutic 
interventions for people who are unable to access ‘traditional’ forms of care (Barak, Hen 
et al. 2008), although users require training to use these technologies competently and 
ethically (Shandley, Klein et al. 2011).   
 7.5.3 Implications for future research 
 Future research detailing the time required to complete dignity therapy is 
indicated, along with a cost analysis exploring its use in inpatient, outpatient and 
rural/remote settings.  Larger studies of delivering dignity therapy using e-health, 
including email and videoconferencing, are also indicated to overcome speech loss and 
impairment, provide an optional environment of reduced emotional exposure for those 
experiencing emotional lability, and to deal with the expense and difficulties 
encountered in serving rural and remote populations.   
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 An additional avenue of research concerns appropriate cognitive screening tools 
and cut-off scores for potential recipients of dignity therapy, with an emphasis on 
detecting behavioral variant FTD.  Chochinov states “One of the most important reasons 
to exclude patients from dignity therapy is impaired cognitive ability, limiting the 
patient’s capacity to providing meaningful and reflective responses (Chochinov 2012 p. 
60); however, there is little guidance on appropriate screening tools or cut-off scores to 
exclude participants from receiving dignity therapy.  Several dignity therapy studies, 
including the IRCT, used the Blessed Orientation Memory Concentration (BOMC) test 
(Katzman, Brown et al. 1983) to exclude participants with dementia, although brief 
measures like the BOMC to assess cognitive ability have been shown to be unreliable in 
screening for FTD in people with MND (Floris, Borghero et al. 2012).    
 7.5.4 Ethical challenges 
 None of the participants in this study had been screened or tested for cognitive 
impairment previously, and no participant disclosed to the researcher that cognitive 
impairment had been discussed with them by their health care providers.  In addition, 
several participants were not informed that emotional lability was a physical symptom of 
MND.  These factors presented an ethical challenge to the researcher, who was in the 
position of disclosing information about physical symptoms to patients outside the care 
received through their multi-disciplinary care team.  When this occurred, the researcher 
encouraged participants and family carers to discuss these symptoms with their health 
care providers.  When given permission by the participant, the researcher also attempted 
to liaise with one or more health care providers.  
 Performing psychotherapy in an environment where a considerable amount of 
the content is not understood by the therapist creates an ethical challenge relating to 
therapist competence and the potential for harm.  Corey states, “Competence is required 
of practitioners if they are to avoid doing harm to their clients” (Corey, Schneider Corey 
et al. 2007 p. 314).  Performing dignity therapy with someone who has severe speech 
impairment but does not use AAC is akin to performing psychotherapy with a client who 
speaks in a language the therapist barely understands, a task described by a psychiatrist 
writing to the Lancet in 1963 as “well-nigh impossible” (Enoch 1963 p. 1163) and one 
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that is contrary to Chochinov’s (2012) inclusion criteria that the therapist, 
transcriptionist and participant are fluent in the same language.  The potential for harm is 
compounded in instances where disclosures of trauma, such as childhood sexual abuse, 
are missed and as a result ignored during the therapeutic interaction, as occurred in this 
research.  Numerous studies have found that negative responses from those receiving a 
traumatic disclosure, such as minimizing the event or an absence of a supportive 
response, can result in harm to the client (Ullman 1996, Andrews, Brewin et al. 2003, 
Becker-Blease and Freyd 2006).   
7.6 Conclusion 
 This chapter explored the ways in which common MND symptoms affect dignity 
therapy, and indicates that behavioral variant FTD, emotional lability and significant 
speech impairment are issues that need to be further addressed.  It examined the time 
and resources necessary to deliver dignity therapy with people who have MND and 
compared this evidence with information from other studies.  The results of these 
investigations suggest that psychosocial care providers for people with MND should be 
educated about common symptoms and the disease trajectory.  Screenings may help 
identify people with MND with cognitive behavioral impairment, emotional lability, and 
speech impairment, which will enable psychotherapists to engage with participants and 
their families in optimal ways.  E-health methods, including e-mail and 
videoconferencing, may provide satisfactory alternatives for providing dignity therapy to 
people with speech impairment and emotional lability.  The use of e-health methods may 
also address concerns about the cost-effectiveness of dignity therapy, which research 
suggests is more time intensive and expensive than originally reported, as well as 
provide a viable option for serving those in rural and remote areas who may not 
otherwise have access to this form of support. 
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7.7  Bentley, B. (2012). "It takes the time that it takes." Journal of Palliative  
 Medicine 15(8) 
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CHAPTER EIGHT 
8.  Discussion 
 
  
 
 
 
 
 
 
 
 
No One 
Time, passing away 
You’re here for a day, and then you are gone 
No time for a song, listened along, with no-one 
I, I could have sailed fast 
I should have done more to get us to shore 
But that’s in the past, I’m tied to a mast, with no-one 
What’s the point of regret? 
You give what you get and get what you give 
The life that you live, is yours, it belongs to no-one 
You play, you win or you lose, 
It’s all down to chance, there’s nothing to choose 
There’s nothing to bet, you can’t be in debt, to no-one 
And now you see, looking at me 
Far from the life I could have achieved 
I whistle my song, I’m singing along, with no-one, no-one 
Chapter Eight concludes this thesis with a 
discussion of the key findings of this research in 
relation to people with MND, MND family carers, 
and dignity therapy.  The findings advance the 
empirical knowledge base in three key areas 
relevant to palliative care research and practice.  
These findings highlight recommendations 
regarding the use of dignity therapy with people 
with MND and their family carers, including: the 
use of screening measures for cognitive-behavioral 
impairment, speech impairment, and emotional 
lability; choices for people with MND about how 
to complete dignity therapy, including the use of e-
health methods; and caution when dealing with 
families who have complex histories, conflictual 
patterns of relating or other dysfunction, with 
families who are struggling to accept the terminal 
nature of MND, and with participants and family 
members from non-Western cultures.  It reports the 
strengths and limitations of the research, and 
recommendations for future research are outlined 
in the areas of efficacy, family members, and 
translation of dignity therapy into practice.   
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Time, passing away 
You’re here for a day, and then you are gone 
No time for a song, listened along, with no-one (Banks 2011) 
 
Lyrics from the song “No One” by Alistair Banks.  Banks was diagnosed with MND in 
July 2010 and became known as “Alistair the Optimist” when he was chosen to 
represent a campaign to raise awareness about MND in the UK.  During this time, Banks 
wrote songs and recorded a CD in fulfilment of a final wish to raise funds for MND 
research and to leave a legacy for his family and friends. Banks died in January 2013. 
 
 
8.1 Introduction 
 A diagnosis of MND is a shocking and devastating experience for people with 
MND and their families (O'Brien, Whitehead et al. 2011a, Mistry and Simpson 2013).  
People with MND experience unremitting loss during the course of the disease as they 
gradually lose physical function and abilities (Foley, Timonen et al. 2014).  Because 
there is no curative treatment, care goals for people with MND and their families focus 
on maintaining QOL (Simmons 2013).  QOL for people with MND does not correlate 
with physical impairment and does not decline over time despite declining abilities 
(Simmons, Bremer et al. 2000, Robbins, Simmons et al. 2001, Cupp, Simmons et al. 
2011).  Rather, psychological, psychosocial and existential factors, such as depression, 
hopefulness, spirituality, family, and relationships, play the most important roles in 
maintaining QOL (Chio, Gauthier et al. 2004, Roach and Averill 2009, Gibbons, 
Thornton et al. 2013).  Compared to other disease groups, people with MND are at an 
increased risk of suicide (Fang, Valdimarsdottir et al. 2008) and seek out hastened death 
more frequently (Ganzini, Silveira et al. 2002) as a result of psychosocial distress and 
decreased QOL.  Like people with MND, QOL in MND family carers is not related to 
disease severity (Rabkin, Wagner et al. 2000, Murphy, Felgoise et al. 2009) and is 
instead related to psychological and psychosocial factors (Trail, Nelson et al. 2004, Lo 
Coco, Lo Coco et al. 2005, Calvo, Moglia et al. 2011).  Considering the importance of 
psychological and psychosocial distress in maintaining QOL in people with MND and 
their family carers, there is a lack of interventions (Aoun, Bentley et al. 2013) and an 
absence of research and direction on providing this type of care (Pagnini, Simmons et al. 
2012). 
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 The aims of this study were to explore the feasibility, acceptability and potential 
benefits of dignity therapy for people with MND and their families.  Dignity therapy is 
based on an empirical understanding of dignity-related distress in the terminally ill 
(Chochinov, Hack et al. 2002b) and has been shown to enhance the end of life 
experience in people with cancer (Chochinov, Kristjanson et al. 2011).  Through an 
exploration of dignity therapy with people with MND, this study has advanced the 
knowledge base in three key areas for palliative care today as outlined in Chapter One.  
These areas include the expansion of end of life care that is historically grounded in 
cancer care to providing care to all people equitably at the end of life regardless of 
disease; the provision of support to family carers of the terminally ill who form part of 
the unit of care according to palliative care definitions; and the provision of psychosocial 
care to people at the end of life in order to address their ‘total pain,’ including 
psychological, psychosocial, and existential dimensions of distress.  Specifically, it has 
investigated the potential of dignity therapy to enhance the end of life experience for 
people with MND thus extending this supportive end of life intervention to people other 
than those with cancer, examined the effect of dignity therapy on MND family carers 
who shoulder substantial burden and experience distress, and advanced research 
addressing psychosocial care at the end of life through making a novel and significant 
contribution to dignity therapy research and practice.   
 This chapter concludes the thesis by presenting key findings in the three key 
areas outlined in Chapter One: people with MND, MND family carers, and dignity 
therapy research and practice.  It provides recommendations for the clinical use of 
dignity therapy with people with MND and their families, reports the strengths and 
limitations of the research, and makes recommendations for future research in the areas 
of efficacy for people with MND, the effects of dignity therapy on MND family carers, 
and translation of dignity therapy into practice. 
8.2 Expansion of end of life care beyond cancer: People with MND 
 8.2.1 Key findings  
 The findings indicate that people with MND report satisfaction with dignity 
therapy.  Satisfaction with dignity therapy in this study was comparable to previous 
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dignity therapy studies involving people with cancer (Chochinov, Hack et al. 2005, 
Chochinov, Kristjanson et al. 2011, Hall, Goddard et al. 2011), and was higher than 
satisfaction levels reported in a Danish study of people with cancer (Houmann, 
Chochinov et al. 2014) where all studies used the same measure.  Reported benefits in 
this study include enhanced meaning and purpose, improved family relationships, 
increased acceptance, strengthened identity, and decreased aftermath concerns.  In the 
context of living with a diagnosis of MND, distress is frequently experienced by people 
with MND and their family carers and psychological interventions are suggested 
(McLeod and Clarke 2007, Aoun, Bentley et al. 2013), but there is an absence of 
theoretically driven, empirically tested psychosocial interventions (Pagnini, Simmons et 
al. 2012) and an unmet need reported by people with MND and their family carers for 
emotional, psychosocial and existential support (Foley, O'Mahony et al. 2007, 
Whitehead, O'Brien et al. 2012).  These findings are a promising step to meet the 
psychological support needs of people with MND and their family carers.   
 There were no significant pre-test post-test changes on the outcomes measuring 
hopefulness, spirituality and dignity, most likely due to the small sample size achievable 
in Western Australia, but there were increases (N=4) and decreases (N=7) in hopefulness 
at the individual level.  Although numbers are small, there appears to be a relationship 
between hopefulness and spirituality as all participants with increased hope after dignity 
therapy reported they were both spiritual and religious on a demographic questionnaire, 
while almost half of those with decreased hope indicated they were neither spiritual nor 
religious.  A strong relationship between these variables was also reported in other 
research, including a recent review which found that 29 of 40 studies examining the 
relationship between hope and spirituality reported a significant positive relationship, 
while no studies found an inverse relationship (Koenig 2012).  There also appears to be 
a relationship between hope and spirituality in people with MND, and previous research 
has reported that people with MND who are spiritual are more hopeful (Murphy, Albert 
et al. 2000).  In addition, hope has been described as the key to maintaining QOL in 
people with MND (Worthington 1996).  Dignity therapy’s potential to increase hope in 
people with MND who identify as spiritual warrants further investigation.   
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 In terms of physical impairment, twenty-four participants (over 80%) had at least 
one physical symptom which affected the delivery of dignity therapy.   Physical 
symptoms observed during dignity therapy included speech loss, speech impairment, 
emotional lability, cognitive impairment, and paralysis.  Seven participants, or about 
one-quarter, had multiple symptoms.  In all seven participants, the multiple symptoms 
observed were consistent with bulbar presentation of MND, where upper motor neurons 
are affected and speech loss or impairment, cognitive impairment and/or emotional 
lability occur early in the disease.  Emotional lability was encountered most often during 
dignity therapy, which required appropriate knowledge, training and support from the 
therapist in order to manage therapeutically.  Paralysis and minor speech impairment had 
the least impact on the delivery of dignity therapy and allowances were easily made to 
accommodate these symptoms.  In most cases, mild to moderate cognitive impairment 
did not affect the intervention.  However, in one case the difficulty of conducting dignity 
therapy along with the negative impact on the family carer indicates that the intervention 
may not be feasible, acceptable and/or beneficial in cases where behavioral variant FTD 
is suspected.  Cognitive and behavioral decline in people with MND relates to increased 
distress and decreased QOL in MND family carers (Chio, Vignola et al. 2010, Merrilees, 
Klapper et al. 2010), and behavioral changes have the greatest impact on caregiver 
burden (Lillo, Mioshi et al. 2012).  Providing dignity therapy to people suspected of 
behavioral variant FTD has the potential to worsen the already high levels of distress 
and burden reported in MND family carers who care for those with symptoms of FTD 
(Chio, Vignola et al. 2010, Merrilees, Klapper et al. 2010, Lillo, Mioshi et al. 2012), as 
those participants may lack the empathy, insight, and deliberation required to complete 
dignity therapy (Lillo, Mioshi et al. 2011). 
 The findings relating to the impact of MND symptoms on dignity therapy 
indicates that it is imperative for clinicians who provide dignity therapy to be 
knowledgeable about MND symptoms and the disease trajectory, and that they develop 
the necessary skills and expertise to work with this group.  Previous research has shown 
that people with MND and their families indicate that health care professionals often 
lack knowledge, skills, and training about MND (Hughes, Sinha et al. 2005, O'Brien, 
Whitehead et al. 2011b, Foley, Timonen et al. 2012).  These are also pertinent concerns 
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for psychosocial care providers.  While there are undoubtedly many counsellors and 
psychologists currently supporting people with MND, there is an absence of empirical 
research to guide practice, theoretically grounded interventions, training, and protocols 
in this area (Haley, Larson et al. 2003, Pagnini, Simmons et al. 2012, Kasl-Godley, King 
et al. 2014). 
 Delivery of dignity therapy to people with significant speech impairment who 
did not use AAC presented challenges that may be insurmountable due to a number of 
practical and ethical issues, including: the extended length of time needed to complete 
dignity therapy with these participants; the difficulties encountered preparing transcripts; 
the resulting increased costs; and the ethical challenges created by the amount of content 
that was missed, misunderstood or misinterpreted by the researcher/therapist.  
Participants with speech loss who used AAC required some modification to the dignity 
therapy protocol to accommodate the use of AAC methods, including performing the 
intervention through e-mail or through a family member proxy.  In previous research, 
videoconferencing was used to deliver dignity therapy (Passik, Kirsh et al. 2004) and 
one study allowed participants to help edit their documents via email (Johns 2013), but 
this study is the first to explore delivery of the intervention using email, including the 
dignity therapy interview.  Family member proxies have been used in previous dignity 
therapy research where participants had dementia (Chochinov, Cann et al. 2012) but this 
is the first study to explore the use of a family member proxy due to speech loss and 
physical impairment.  Psychologists in palliative care settings are challenged to evaluate 
and modify practices to accommodate patient symptoms (Kasl-Godley, King et al. 
2014).  The findings of this study indicate the use of family member proxies and email 
are viable methods of delivery for people with MND who have speech loss or 
impairment.   
 While dignity therapy was designed for people with advanced cancer in the final 
weeks of life, dignity therapy may be offered to people with MND any time after 
diagnosis as people with MND have no hope for a cure.  As such, modifications to the 
delivery of dignity therapy were necessary to accommodate people with MND.  The 
diagnosis of MND is highly distressing (O'Brien, Whitehead et al. 2011a, Mistry and 
Simpson 2013) and people with MND and their families express the need for greater 
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psychosocial support at diagnosis (O'Brien, Whitehead et al. 2011a).  In this research, 
one family carer suggested that dignity therapy would be better if provided soon after 
diagnosis, while others felt it would be better delivered closer to death.  Other options 
for the delivery of dignity therapy with people with MND include using e-health 
methods to accommodate people located a distance from services who may not 
otherwise have access to this form of support, with people with speech loss who rely on 
assistive forms of communication, and with people with emotional lability who may 
prefer the reduced emotional exposure of this method.  Another option for people with 
MND is allowing them to take the time they need to complete their generativity 
document to their satisfaction, whether it is a week or even months (Bentley 2012).  
When  there is limited evidence available about the potential efficacy of different 
psychotherapeutic approaches in palliative care settings among different disease groups, 
therapists should extrapolate best practices (Kasl-Godley, King et al. 2014), as occurred 
in this research.   
 The findings indicate that providing choices about whether and how to engage in 
dignity therapy is important for people with MND.  Recent research has found that 
people with MND have unmet expectations concerning their care (Foley, Timonen et al. 
2012) and an expressed need for a broad range of services, including psychosocial care 
(Whitehead, O'Brien et al. 2012).  However, exercising choice about whether and how to 
participate in an intervention is paramount as people with MND adapt to unremitting 
losses by exerting control over health care services and by choosing how and when they 
will engage with services (O'Brien, Whitehead et al. 2011b, Foley, Timonen et al. 2014).   
A central concern for people with MND is their perception of control over their 
treatment choices (Hogden, Greenfield et al. 2012).    
 Based on the findings, dignity therapy may not appeal to people who are 
distressed, including people with MND who are experiencing hopelessness, loss of 
meaning, or who request a hastened death.  The majority of people who responded to 
recruitment efforts in this research had low baseline levels of distress.  Similarly, 
participants recruited to other dignity therapy studies also had low baseline levels of 
distress (Chochinov, Kristjanson et al. 2011, Hall, Goddard et al. 2011, Houmann, 
Chochinov et al. 2014).  There is conflicting research findings on whether dignity 
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therapy may alleviate distress in people with elevated distress, with one study reporting 
the potential to alleviate anxiety and depression in cancer patients with high baseline 
levels of distress (Juliao, Oliveira et al. 2012) and others reporting the complexities of 
delivering the intervention to distressed people may preclude the use of dignity therapy 
with this group (Johns 2013, Hall, Goddard et al. 2013c).  Previous research has found 
that dignity therapy is considered “too big” of an undertaking for some patients 
(Houmann, Chochinov et al. 2014 p. 9), including people who are absorbed with coping 
with the physical, psychosocial and existential stressors encountered as a result of their 
condition (Houmann, Rydahl-Hansen et al. 2010, Johns 2013, Hall, Goddard et al. 
2013c, Houmann, Chochinov et al. 2014).  For example, in Johns’ study (2013), three 
people did not complete dignity therapy stating it required too much energy and time, 
and they preferred to focus on other things, and Hall concluded “It is difficult to find the 
essence of patients when they are worried or unhappy” (Hall, Goddard et al. 2013c p. 
1751). 
 Interestingly, it appears some cultural groups find dignity therapy too 
confronting (Houmann, Rydahl-Hansen et al. 2010, Akechi, Akazawa et al. 2012), and it 
may conflict with cultural norms such as aversions to self-praise and self-pride 
(Houmann, Rydahl-Hansen et al. 2010) or to open discussions about death (Akechi, 
Akazawa et al. 2012).   One example from this research was an immigrant from 
Southeast Asia who engaged in dignity therapy in order to create a document for his 
Western wife and children, but cautioned that he did not want his document shared with 
his parents as it could be construed as disrespectful and culturally unacceptable.  This 
area warrants further exploration.  As dignity therapy has not been widely tested with 
non-Western cultural groups, caution and careful consideration is needed when working 
with these participants.  
8.3 Providing support to family carers of the terminally ill: MND family carers 
 8.3.1 Key findings  
 There were no significant pre-test post-test changes on the outcomes measuring 
caregiver burden, anxiety, depression or hope in the small sample group of 18 MND 
family carers.  There were increases (N=3) and decreases (N=8) in hopefulness on the 
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individual level, but unlike the findings in people with MND, we found no relationship 
between changes in hopefulness and reported spirituality.  The MND family carers in 
this study were moderately distressed according to baseline scores on the HADS, and 3 
had decreases in anxiety (N=2) and depression (N=1) post-intervention according to RC 
scores.  Though the numbers are small, these preliminary results indicate that dignity 
therapy may have the potential to decrease anxiety and depression in MND family 
carers.  This finding warrants further investigation. 
 Slightly lower scores were reported on the family feedback questionnaire in this 
study than the scores reported in previous research.  This could be due to data collection 
times, as in this study responses were collected two weeks after completion of the 
therapy, while responses were collected 6 to 12 months after death in previous dignity 
therapy research (McClement, Chochinov et al. 2007).  Here, 89% of family carers 
reported that dignity therapy was helpful to the participant and 72% reported the dignity 
therapy document would be a continuing source of comfort after bereavement, while the 
numbers were 95% and 77% respectively in the dignity therapy pilot study with cancer 
patients (McClement, Chochinov et al. 2007).  Previous research has found that MND 
family carers express a need for emotional support and counselling during their caring 
experience and bereavement (Martin and Turnbull 2001, Foley, Timonen et al. 2012, 
O'Brien, Whitehead et al. 2012, Whitehead, O'Brien et al. 2012); however, these services 
are not routinely provided (Aoun, Connors et al. 2012, O’Brien, Whitehead et al. 2012) 
despite MND best practice guidelines which recommend such support (Leigh, S 
Abrahams et al. 2003, Mitchell and Borasio 2007).  Moreover, MND family carers 
appear vulnerable to prolonged grief (Hebert, Lacomis et al. 2005, Aoun, Connors et al. 
2012).  With this in mind, the findings here that almost three-quarters of MND family 
carers believe the generativity document will provide comfort during bereavement is 
salient.  Support for dignity therapy’s potential to provide comfort during bereavement 
can be found in the comments of MND family carers, where most reported they would 
“treasure,” reread, and reflect upon the document in the future.  
 Despite reports that dignity therapy was helpful to participants and that the 
generativity document would be helpful during bereavement, some family carers 
expressed ambivalence about the possible benefits of dignity therapy to themselves at 
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the time of the intervention.  While generally expressing positive feelings about dignity 
therapy, some family carers also criticized that the information presented in the 
document was not comprehensive nor did it present anything new, and others said a 
document could not replace years of memories and time together.  Some family carers 
also pointed out the intervention was not capable of alleviating the overwhelming 
feelings of stress, loss and grief they were experiencing.  However, comments such as 
these are indicative of normal preparatory or anticipatory grief responses (Kubler-Ross 
1969, Worden 2009) and would likely be said about any psychotherapeutic intervention 
implemented at this time, rather than criticisms of dignity therapy.  
 Interestingly, there were also some responses in this study indicating dignity 
therapy was not beneficial for family carers.  Some family members said dignity therapy 
resulted in feeling confronted by death which detracted from their ability to enjoy the 
present.  Accepting the reality of death is a primary task encountered by people facing 
the loss of a loved one (Worden 2009), but family members of the terminally ill 
commonly vacillate between tensions of denial and acceptance over time (Lynn and 
Harrold 1999).  Several studies have documented the emotional difficulties encountered 
by MND family carers as a result of the confronting nature of an MND diagnosis 
(O'Brien, Whitehead et al. 2011a, Hogden, Greenfield et al. 2013), and research has 
determined that some MND family carers cope by not looking too far into the future 
(Bolmsjo and Hermeren 2003) or openly discussing death (Ray, Brown et al. 2012).  
Therefore, it is important to consider whether family members who provide support in 
the dignity therapy interview (and/or those who receive the generativity documents) are 
ready to participate in the creation and reading of a ‘eulogistic’ document (Schryer, 
McDougall et al. 2012) like that created in dignity therapy.  Chochinov cautions that 
dignity therapy participants may not wish to acknowledge or discuss their impending 
death during dignity therapy, and he advises using ambiguous language around death 
awareness unless led by the participant to discuss death more concretely (Chochinov 
2012).  This caution should also be extended to involved family members, and an 
assessment should be made by the therapist about their level of acceptance.   
 Other family members said they were hurt by things the participant said during 
the dignity therapy interview or by the content of the generativity document. One of the 
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goals in the first dignity therapy meeting is to establish a “frame” for dignity therapy that 
includes the names and ages of important family members, and to determine who in the 
family will receive the dignity therapy document (Chochinov 2012 p. 75).  However, 
what is missing is a family assessment where family systems, areas of conflict, and 
longstanding problems, such as substance abuse and physical abuse, are identified 
(Kissane, Bloch et al. 1998, Fisher 2003, Kasl-Godley, King et al. 2014).  Terminal 
illness can add additional stressors on families, and trigger changes in roles, 
relationships, and communication that can increase conflict (Kasl-Godley, King et al. 
2014).  Moreover, families vary in their ability to communicate effectively about 
distressing issues, to make collaborative decisions, and to remain attached and secure 
through transitions and crises (Kissane, Bloch et al. 1994, Fisher 2003, Breen and 
O'Connor 2011).  Dignity therapists require a basic knowledge of family systems, and 
they should assess and plan for problem areas of potential conflict, dysfunction and 
disagreement in order to avoid creating lasting generativity documents that can cause or 
add to distress in families.   
 In this study, almost a quarter of family carers listed negative effects at two 
weeks post intervention.  In research by Hall et al. (2013b), two-thirds of family 
members reported negative effects.  Hall et al. did not state at what time point family 
members were interviewed although it is implied it was at least four weeks post-
intervention.  It is possible that the increased numbers were a result of the longer period 
families had to consider the document.  Support for this conjecture is found in Houmann 
et al.’s study (2014), which found as time went on, people who received dignity therapy 
were less confident that the document brought increased appreciation from their 
families.  In this study, a participant and his daughters were highly satisfied with dignity 
therapy; however, two weeks post-intervention the participant requested changes to the 
document to mitigate the hurt feelings of the participant’s second wife, who felt her role 
in his life was underplayed in the document.  It is interesting that Chochinov mentions 
only a few instances of family member dissatisfaction with dignity therapy in his 
research, which he relates to cognitive impairment in the participant (Chochinov, 
Kristjanson et al. 2011, Chochinov 2012) and to a family member reading the document 
to which he or she was not supposed to be given access (Chochinov 2012).  This area 
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warrants further inquiry.  While dignity therapy was designed for people with terminal 
illness rather than for family carers, its impact on family members must be taken into 
consideration as they are part of the unit of care for palliative care providers (National 
Consensus Project for Quality Palliative Care 2014, World Health Organization 2014).  
It is important that the therapist considers the potential benefits of dignity therapy, along 
with potential negative effects, and proceed only if the former outweighs the latter.   
8.4 Towards addressing ‘total pain’: Dignity therapy 
 8.4.1 Key findings  
 Best practice for evidence-based evaluation of palliative care interventions 
includes assessment of cost-effectiveness along with efficacy (Evans, Harding et al. 
2013).  In this research, dignity therapy appears to be a relatively time consuming and 
expensive intervention.  Dignity therapy with people with MND averaged 4 sessions 
with client contact time of 6 hours over 42 days.  The average audio recorded interview 
was 1 hour 38 minutes.  It is estimated that the average time spent editing the interview 
transcripts outside the presence of the participant was about 9 hours, and the average 
transcription cost was $165 AUD.  Previous research has documented similar findings 
on the average number of sessions and client contact time (Montross, Winters et al. 
2011, Hall, Goddard et al. 2012), and in the total interview time, editing time and 
clinician time (Hall, Goddard et al. 2012).  However, in other reported areas, including 
completion time and transcription cost, dignity therapy took longer and was more 
expensive to perform with people with MND than was reported in research with cancer 
patients (Montross, Winters et al. 2011, Johns 2013) and people in aged care (Hall, 
Goddard et al. 2012).  It should be noted that these figures exclude dignity therapy 
performed by email with two participants because there was there was no oral interview, 
no transcription, and editing time was substantially reduced.  This method was less time 
intensive and also did not involve time and costs associated with travel, and though the 
numbers are small, acceptability and effectiveness were not compromised with these 
participants.   
 Dignity therapy involved considerable time and costs that were not tracked in 
this or other research (Montross, Winters et al. 2011, Hall, Goddard et al. 2012) 
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including; travel costs and costs for supplies; and travel time, time spent arranging visits, 
time spent waiting, and cancelled appointments.  In a palliative care environment, where 
many are cared for in their homes and where physical status is often unpredictable, this 
amount of time can be substantial.  In addition, travel time and costs in WA, where the 
population is dispersed over a large area, were considerable.  Delivery of dignity therapy 
to people in rural and remote areas was prohibitively time consuming, expensive and 
difficult to coordinate.  While previous research has documented issues such as 
extensive editing time and frequent delays which may decrease feasibility (Passik, Kirsh 
et al. 2004, Hall, Goddard et al. 2012), incomplete information in previous research has 
made assessment of cost-effectiveness difficult.   
 In their dignity therapy pilot study and IRCT, Chochinov and colleagues did not 
provide data about the time and resources required for dignity therapy (Chochinov, Hack 
et al. 2005, Chochinov, Kristjanson et al. 2011).  However, Chochinov does provide 
guidelines in instructional materials for therapists.  In the Handbook of Psychotherapy in 
Cancer Care (Chochinov and McKeen 2011), Chochinov asserts that dignity therapy 
comprises a 1 hour interview, 3 to 4 hours to edit the transcription, and another 1 hour 
meeting to edit and finalize the document.  This totals 2 sessions with 2 hours of patient 
contact time and 5 to 6 hours in total to carry out the intervention.  In the book Dignity 
Therapy: Final Words for Final Days (Chochinov 2012), Chochinov provides guidelines 
different to his previous advice and writes that dignity therapy requires 4 or more 
sessions between the therapist and client: an initial meeting of 20 minutes, a 1 hour 
interview, a 20 minute meeting to edit the document, and a fourth, brief meeting where 
the final document is handed over.  This totals a minimum of 4 visits with less than 2 
hours of patient contact time.  While providing these guidelines, Chochinov asserts “the 
most important factor determining the number and duration of sessions will be the 
patient’s general state of health, energy and cognitive capacity” (Chochinov 2012 p. 95).   
 The reality of required clinician time appears to differ substantially from the 
guidelines provided by Chochinov above (Chochinov and McKeen 2011, Chochinov 
2012).  This study and two others (Montross, Winters et al. 2011, Hall, Goddard et al. 
2012) have reported consistent findings that dignity therapy averages 4 contact sessions 
per participant with approximately 6 hours of contact time; however, when editing time 
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was included, both this study and Hall (2012) found the intervention took approximately 
15 hours of therapist time per participant.  Thus, the clinician hours are about 3 times 
greater than the guidelines presented by Chochinov in instructional materials.  
Moreover, Chochinov estimates the total cost of dignity therapy to be “$400 to $500” 
CAD per participant, which he calculates as $200 CAD spent on transcription, and 2 to 3 
hours of therapist time billed at $100 CAD per hour (Chochinov 2012 p. 177).  A more 
accurate estimate of the total cost of dignity therapy using Chochinov’s transcription 
cost and billable rate based on research findings appears to be 3 to 4 times greater, or 
approximately $1,700 CAD per participant. 
 The mean total days to complete the intervention in this study was 42 days, 
which is longer than the estimate of 7 days provided by Chochinov in his manual, who 
advises “to aim to have all patient contacts completed in about one week” (Chochinov 
2012 p. 97).  An extended completion time was also found by Hall (2012), who reported 
a mean duration of 32 days.  One can surmise that sessions and duration of the therapy 
would be closer to Chochinov’s estimation of 7 days in people very close to death who 
have limited time and energy to complete the intervention; however, in the IRCT the 
mean survival time was 110 days (Chochinov, Kristjanson et al. 2011).  Moreover, it 
does not appear that Chochinov intended to limit dignity therapy to people very close to 
death, as the manual states that dignity therapy is for “anyone facing life-threatening or 
life-limiting circumstances” (Chochinov 2012 p. 56) and that it “can be a welcome 
opportunity for anyone who wishes for a way to enhance meaning, purpose or wellbeing 
in their final months, weeks or days of life” (Chochinov and McKeen 2011 p. 83).  
Chochinov and others have also expanded the use of dignity therapy from palliative care 
settings into aged care settings (Chochinov, Cann et al. 2012, Hall, Goddard et al. 2012), 
where proximity to death is not an important consideration.  These factors demonstrate 
that dignity therapy need not be completed quickly in cases where death is not imminent. 
 It should be noted that the researchers in the dignity therapy studies that have 
reported time and cost data, including this study, have been trained in dignity therapy by 
Professor Chochinov (Montross, Winters et al. 2011, Bentley, Aoun et al. 2012, Hall, 
Goddard et al. 2012).  This fact negates differences in the delivery of the intervention 
due to education and training of the therapist/researcher.  The exception is the study by 
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Johns (2013), where a health psychologist and licensed clinical social worker performed 
dignity therapy with cancer patients using only the manual for reference.   
 An unaddressed area in the literature is who should provide dignity therapy.  The 
dignity therapy manual contained in the Handbook of Psychotherapy in Cancer Care 
(Chochinov and McKeen 2011) is targeted to psycho-oncologists; however, Chochinov 
is vague about who should perform dignity therapy in his book (Chochinov 2012) and 
trainings.  Regular training workshops offered by Chochinov are aimed at “clinicians 
working in palliative care and/or geriatric patients,” “researchers,” and “health care and 
nursing home administrators” (Dignity in Care 2014 para. 5).  In previous dignity 
therapy research, the intervention has been carried out by psychiatrists (Chochinov, 
Kristjanson et al. 2011, Avery and Baez 2012, Juliao, Oliveira et al. 2012), medical 
students (Tait and Hodges 2013), research nurses (Chochinov, Hack et al. 2005, 
Chochinov, Kristjanson et al. 2011), social workers (Johns 2013), social work students 
(Davis Berman 2014), psychologists (Chochinov, Kristjanson et al. 2011, Montross, 
Winters et al. 2011, Bentley, Aoun et al. 2012, Johns 2013, Houmann, Chochinov et al. 
2014), and researchers who had unspecified backgrounds (Passik, Kirsh et al. 2004, 
Hall, Goddard et al. 2011, Hall, Goddard et al. 2012, Vaghee, Javadi et al. 2012).  In 
clinical settings, dignity therapy appears to be conducted by a wide range of 
practitioners, including pastoral care providers, aged care workers, and volunteers 
(Squires 2014, Zahn 2014).  Based on the findings of this research that dignity therapy 
requires specialized knowledge, skills and education, including: education in psychology 
and assessment; knowledge of end of life issues, symptom management, and 
bereavement; and skills in person-centered counseling and family therapy, it is proposed 
here that the practice of dignity therapy should be limited to trained mental health 
providers with expertise in palliative care and who have specific knowledge about the 
disease symptoms and trajectory of the participants with whom they work. 
 Despite the emerging empirical challenges to dignity therapy (Hall, Goddard et 
al. 2013a, Hall, Goddard et al. 2013b), and the time, costs, and difficulties sometimes 
encountered while delivering the intervention, dignity therapy appears to be a favored 
intervention often endorsed in palliative care literature and practice (Ferrell 2005, 
Nekolaichuk 2011, Kumar, Morse et al. 2012).  There are few other palliative care 
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interventions where people speak with regularity about the “honor” and “privilege” of 
their work (Chochinov 2012 p. 99, Schryer, McDougall et al. 2012 p. 2, Tait and Hodges 
2013 p. 734), or of the meaning and purpose the therapy experience has given to the 
practitioner (Bentley 2012, Davis Berman 2014).  Chochinov says, “Of the things I have 
done in palliative care over the past twenty years, none have been quite as gratifying or 
personally engaging as Dignity Therapy” (Chochinov 2012 p. ix).  It can be difficult and 
emotionally draining to work in palliative care, where one is regularly confronted by 
pain, suffering and death (Martins Pereira, Fonseca et al. 2011, Breen, O'Connor et al. 
2014).  In an environment where there is often little one can ‘do,’ dignity therapy may 
present an option for palliative care providers to feel they are making a difference 
through an intervention they perceive as positive, meaningful and enduring for the 
patient, the patient’s family, and, less consciously, themselves.  Inquiry into the benefits 
experienced by dignity therapists through the intervention is warranted. 
8.5 Recommendations for therapists using dignity therapy with people with 
MND and MND family carers 
 Dignity therapy is a viable psychosocial intervention for people with MND that 
can be offered whenever a person has a desire to complete the intervention.  Based on 
the support found in Hall’s research (2013b) that dignity therapy addresses generativity 
concerns, people with MND who express a desire to document their contribution and 
leave messages for future generations are good candidates for the therapy.  Ideally, 
dignity therapy would be provided by a psychotherapist who is a member of a multi-
disciplinary team where information, education, and screenings about symptoms would 
be provided as a part of the comprehensive care provided to people with MND and their 
family carers.  There are three main recommendations for clinicians that may be gleaned 
from the present study. 
 First, the use of screenings to assess cognitive impairment, speech impairment, 
and emotional lability are suggested prior to beginning dignity therapy with people with 
MND.  The use of an MND specific cognitive screening measure, such as the ALS-CBS 
(Woolley, York et al. 2010), will help to determine whether participants have the 
cognitive capacity to complete the intervention, as well as the ability to provide 
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informed consent.  Even with a passing score, extra care should be taken in determining 
the suitability of people suspected of behavioral variant FTD, who may lack the insight 
and empathy required to complete a generativity document that is satisfactory to family 
members.  A screening measure, such as the CETI-m (Ball, Beukelman et al. 2004), is 
recommended for people who have speech impairment to determine the participant’s 
level of speech intelligibility.  Those who score below a specified level (e.g. 70% on the 
CETI-m) should be encouraged to use an AAC method during the dignity therapy 
interview.  A screen for emotional lability, such as the Center for Neurologic Study-
Lability Scale (CNS-LS) (Moore, Gresham et al. 1997), is recommended to help educate 
participants and family members, as well as inform the therapist of this potential issue.  
Discussion should take place with potential participants before dignity therapy begins 
about common MND symptoms encountered during dignity therapy and their potential 
effects on the participant and family carer so people with MND and their family carers 
have the opportunity to consider this information, speak with their health care providers 
if they have questions or concerns, and make informed decisions about their care.   
  Second, people with speech loss, significant speech impairment, and emotional 
lability should be given the option to complete dignity therapy via email or other 
computerized method.  In order to serve people in rural and remote areas, using e-health 
methods, including email or videoconferencing, is indicated in order to address cost-
effectiveness and practical issues with delivering dignity therapy.  As people with MND 
exercise control over healthcare to adapt to their continuing losses (Foley, Timonen et al. 
2014), it is argued here that giving every participant control over the decision on how to 
best complete dignity therapy, including using e-health methods, is appropriate 
whenever possible.    
 Third, therapists should exercise care when working with families with complex 
histories, such as those with multiple marriages, or those who have conflicting or 
estranged relationships, and endeavor to prevent harm to family members through the 
permanent generativity document that will be left behind.  Even where complex family 
systems are not evident, therapists should not assume that there is no conflict or 
dysfunction in the family (Breen and O'Connor 2011).  Though a person with MND may 
accept their diagnosis and wish to complete dignity therapy, therapists should also 
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exercise care when engaging family members who are struggling to accept the terminal 
nature of MND as dignity therapy may be too confronting.  Therapists should also 
exercise caution when dealing with participants or family members from non-Western 
cultures as dignity therapy may be culturally incompatible for these participants and/or 
the recipients of the generativity document. 
8.6 Strengths and limitations  
 8.6.1 Empirical strengths 
 A strength of this research is its use of a quantitative descriptive design to 
explore the feasibility, acceptability and potential benefits of dignity therapy for people 
with MND using instruments and an approach that can be replicated in future research.  
Prior to this study, there was no evidence for dignity therapy for people with MND and 
their carers.  The high completion rates and recruitment of an intervention group 
representative of people with MND and MND family carers in demographic and health 
status characteristics are additional strengths of the study and provide the basis on which 
an RCT may be based (see section 8.7 below).   
 8.6.2 Methodological strengths 
 Methodological strengths include the use of MND-specific cognitive and health 
status measures.  The self-report feedback questionnaires used to assess acceptability for 
both people with MND and MND family carers in this study were nearly identical to the 
questionnaires used in the IRCT, pilot study and other dignity therapy research, which 
allowed for comparisons.  The use of outcomes measuring hope, spirituality, and 
dignity-related distress were beneficial in determining whether dignity therapy had the 
potential to alleviate the types of distress it was designed to address.  Post-testing took 
place through mail or through a visit by a second researcher to mitigate response bias.  
The researcher was trained in dignity therapy by Professor Harvey Max Chochinov and 
received advice and supervision from him during the course of the research.   
 8.6.3 Clinical strengths 
 The people with MND in this study all had a verified diagnosis of MND, and all 
family carers were spouse/partners.  A flexible approach to modifications to the 
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intervention to accommodate disease symptoms allowed for a realistic appraisal of 
feasibility issues, as well as the special considerations needed to perform dignity therapy 
with people with MND.  To optimize adherence to the dignity therapy protocol, 10% of 
recordings, transcripts and completed documents (N=3) were randomly selected and 
reviewed by three experienced researchers (2 trained in dignity therapy and the other a 
Registered Psychologist) who deemed them to be adherent to the dignity therapy 
manualized intervention. 
 8.6.4 Limitations 
 The main limitations of this study were inadequate power to discover small 
effects, low levels of distress at baseline, and the use of outcome measures not validated 
for people with MND.  However, the approach used was congruent with the level of 
evidence needed in the application of an established therapy in a novel group (Craig, 
Dieppe et al. 2008).  While it was anticipated that the short duration of the intervention 
would minimize confounding variables, dignity therapy took longer to complete which 
may affect the validity of the findings.  The study group may not be representative of 
people with MND as those who selected to participate may have been less distressed, 
more likely to think dignity therapy would be beneficial, and some may have had 
symptoms such as speech loss or emotional lability which discouraged participation.  
Likewise, the study group may not be representative of MND family carers as people 
with MND with severe cognitive impairment and their family carers were excluded from 
the study, and MND family carers who declined to participate may have been more 
distressed.  The feedback questionnaire developed by Chochinov and colleagues, and 
which was used in this study, is phrased with a positive orientation and this may 
generate more positive responses.  Limitations also include using estimations to track 
editing time in this study, and the inability to track reasons for non-participation with 
people with MND and MND family carers.  Finally, the researcher also performed the 
intervention.  As such, she was in a dual role.  This created a potential threat to 
objectivity and the possibility that the relationship that developed between the researcher 
and participants during dignity therapy distorted the findings.  However, this dual role is 
common in other dignity therapy and intervention studies.  Checks and balances were 
maintained, including reflective journaling and ongoing professional supervision. 
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 8.7 Recommendations for future research 
 8.7.1 Efficacy research 
 This feasibility study has set the stage for a future RCT of dignity therapy with 
people with MND.  In addition, research with people with MND with elevated distress is 
warranted to explore whether low baseline levels of distress provide too little room for 
change on the outcome measures used or, in the alternative, whether dignity therapy is 
unsuitable for distressed participants.  Use of an outcome measure validated to detect 
distress in people with MND is warranted, such as the HADS or the ALS Depression 
Inventory (ADI) (Ferentinos, Paparrigopoulos et al. 2011).  It is also recommended that 
future research continues to explore the relationship between hopefulness and dignity 
therapy using the HHI, and examines the possible relationship between a person’s level 
of spirituality and changes to hopefulness as a result of dignity therapy.    
 The IRCT allocated an equal amount of meetings and participant contact hours 
between the dignity therapy and client-centered care arms of the study; however, the 
research design did not take into account the number of therapist hours needed for 
editing the document that was completed outside the presence of the client and which is 
essential to dignity therapy.  Thus, future research should focus on examining whether 
an equal amount of total therapist time spent on person-centered care results in 
differences in the outcomes.  In addition, comparing dignity therapy to a self-guided 
expressive disclosure intervention would be helpful to determine if expression is one of 
the primary benefits of dignity therapy.  Finally, additional research inquiring into the 
empirical basis of dignity therapy is warranted as there is scant evidence that dignity 
therapy is addressing the dignity related distress it was designed to reduce, evidenced by 
qualitative research (Hall, Goddard et al. 2013a, Hall, Goddard et al. 2013b) as well as 
no detectable reductions in distress using the PDI designed by Chochinov and 
colleagues, as was found in the study reported here and other studies (Chochinov, 
Kristjanson et al. 2011, Hall, Goddard et al. 2011, Hall, Goddard et al. 2012, Houmann, 
Chochinov et al. 2014).   
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 8.7.2 Effects on MND family carers 
 MND family carers should be included in a future RCT to further explore the 
effects of dignity therapy on families in comparison to other treatment methods.  An 
experimental study focusing on distressed MND family carers is needed to determine if 
dignity therapy has the ability to reduce anxiety and depression using the HADS.  A 
qualitative study exploring more fully the mixed acceptability results provided in the 
feedback questionnaire including interviews with all family members who have read the 
generativity documents would increase knowledge about the potential benefits or 
negative effects on families of the terminally ill as a result of dignity therapy.  Finally, 
longitudinal research is warranted to explore changing attitudes to the document over 
time, along with dignity therapy’s ability to decrease distress on family members 
following bereavement.  This could include ongoing qualitative interviews to track 
changing attitudes to dignity therapy and the generativity document.   
 8.7.3 Translational research: Cultural issues, e-health, implementation 
and sustainability 
 Future research exploring the suitability of dignity therapy for different cultural 
groups is indicated, including an examination of the dignity therapy question protocol 
within different cultures to determine if modifications to the question protocol are 
needed in certain instances.  Given the difficulties of delivering interventions to people 
residing in rural areas (Breen and O'Connor 2013) and the growing impetus for cost-
effective interventions at the end of life (Breen, Aoun et al. 2014), larger studies aimed 
at exploring the efficacy and cost-effectiveness of dignity therapy delivered through e-
health is warranted, as well as future studies that focus on tracking the total time and 
resources required to provide dignity therapy so that the costs and benefits of dignity 
therapy can be evaluated.  Qualitative research with clinicians who deliver dignity 
therapy would shed light on the challenges and perceived benefits to palliative care 
providers who provide dignity therapy, which could add new insight into potential costs 
and/or benefits of the intervention.  More studies examining the themes found in 
generativity documents are needed, as well as comparisons of the themes discussed in 
documents between people of different disease groups, different genders, different ages, 
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and different cultures.  Even though the dignity therapy questions are the same for 
everyone, participants emphasize different aspects of their lives in dignity therapy 
making the content of documents varied and unique.  Discourse analysis would shed 
light on what people find important and meaningful, as well as what they wish to 
document at the end of life. 
8.8 Closing words 
 People with MND and their families frequently express the need for 
psychological and emotional support in the literature, but the support they receive 
continues to focus on practical aspects of care such as nutrition, mobility, and respiratory 
support.  Research has shown that MND family carers also need increased bereavement 
support, and despite being a best practice guideline, adequate bereavement support is 
lacking.  Many people with MND and their families chose to participate in this study of 
dignity therapy because there were few other options available to them, and all appeared 
to benefit in some way simply by having someone to talk to where they could safely 
express themselves, who showed them unconditional positive regard and listened 
attentively, and where the topic of conversation did not always focus on their declining 
abilities and continuing losses.   
 This research is among the first to investigate a psychosocial intervention for use 
with people with MND.  It answers a frequent call in the literature to test psychological 
and psychosocial interventions to alleviate distress and improve QOL, and is a 
promising step in providing an option for people with MND who desire to address areas 
of psychosocial and existential distress, and for palliative care providers to better address 
the ‘total pain’ of their patients.  This research may lead to meaningful advancements in 
improving QOL and reducing distress in people with MND and their family carers, but it 
also indicates that dignity therapy is not suitable for, nor will it appeal to, everyone with 
MND.  More options and opportunities for psychological, psychosocial and emotional 
support need to be developed.  We need to do much better at providing support to people 
with MND and their families. 
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‘Mitch,’ he continued, softly now, ‘you don’t understand.  I want to tell you 
about my life.  I want to tell you before I can’t tell you anymore.’  
His voice dropped to a whisper.  ‘I want someone to hear my story.  Will you?’ 
(Albom 1997 p. 63). 
 
Words spoken by Morrie Schwartz, a retired professor and a man with MND, to Mitch 
Albom, his former student and journalist, in Albom’s memoir “Tuesdays with Morrie.”  
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